window.__IS_SSR__=true
window.__INITIAL_STATE__={
"attachmentsReducer": {
"audio_0": {
"type": "attachments",
"id": "audio_0",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background0.jpg"
}
}
},
"audio_1": {
"type": "attachments",
"id": "audio_1",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background1.jpg"
}
}
},
"audio_2": {
"type": "attachments",
"id": "audio_2",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background2.jpg"
}
}
},
"audio_3": {
"type": "attachments",
"id": "audio_3",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background3.jpg"
}
}
},
"audio_4": {
"type": "attachments",
"id": "audio_4",
"imgSizes": {
"kqedFullSize": {
"file": "https://ww2.kqed.org/news/wp-content/themes/KQED-unified/img/audio_bgs/background4.jpg"
}
}
},
"placeholder": {
"type": "attachments",
"id": "placeholder",
"imgSizes": {
"thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"medium": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"medium_large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-768x512.jpg",
"width": 768,
"height": 512,
"mimeType": "image/jpeg"
},
"large": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"1536x1536": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-lrg": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1536x1024.jpg",
"width": 1536,
"height": 1024,
"mimeType": "image/jpeg"
},
"fd-med": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"fd-sm": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-800x533.jpg",
"width": 800,
"height": 533,
"mimeType": "image/jpeg"
},
"post-thumbnail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"twentyfourteen-full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1038x576.jpg",
"width": 1038,
"height": 576,
"mimeType": "image/jpeg"
},
"xxsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-160x107.jpg",
"width": 160,
"height": 107,
"mimeType": "image/jpeg"
},
"xsmall": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"small": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-672x372.jpg",
"width": 672,
"height": 372,
"mimeType": "image/jpeg"
},
"xlarge": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1020x680.jpg",
"width": 1020,
"height": 680,
"mimeType": "image/jpeg"
},
"full-width": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1-1920x1280.jpg",
"width": 1920,
"height": 1280,
"mimeType": "image/jpeg"
},
"guest-author-32": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 32,
"height": 32,
"mimeType": "image/jpeg"
},
"guest-author-50": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 50,
"height": 50,
"mimeType": "image/jpeg"
},
"guest-author-64": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 64,
"height": 64,
"mimeType": "image/jpeg"
},
"guest-author-96": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 96,
"height": 96,
"mimeType": "image/jpeg"
},
"guest-author-128": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 128,
"height": 128,
"mimeType": "image/jpeg"
},
"detail": {
"file": "https://cdn.kqed.org/wp-content/uploads/2025/01/KQED-Default-Image-816638274-1333x1333-1-160x160.jpg",
"width": 160,
"height": 160,
"mimeType": "image/jpeg"
},
"kqedFullSize": {
"file": "https://cdn.kqed.org/wp-content/uploads/2024/12/KQED-Default-Image-816638274-2000x1333-1.jpg",
"width": 2000,
"height": 1333
}
}
},
"science_1968265": {
"type": "attachments",
"id": "science_1968265",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1968265",
"found": true
},
"parent": 1968259,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/CovidWinter_Illustration_MollyFerguson_080720-1600x900-1-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/CovidWinter_Illustration_MollyFerguson_080720-1600x900-1-160x90.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 90
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/CovidWinter_Illustration_MollyFerguson_080720-1600x900-1-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/CovidWinter_Illustration_MollyFerguson_080720-1600x900-1.jpg",
"width": 1600,
"height": 900
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/CovidWinter_Illustration_MollyFerguson_080720-1600x900-1-1020x574.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 574
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/CovidWinter_Illustration_MollyFerguson_080720-1600x900-1-1536x864.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 864
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/CovidWinter_Illustration_MollyFerguson_080720-1600x900-1-800x450.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 450
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/CovidWinter_Illustration_MollyFerguson_080720-1600x900-1-768x432.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 432
}
},
"publishDate": 1597081526,
"modified": 1597084633,
"caption": null,
"description": null,
"title": "CovidWinter_Illustration_MollyFerguson_080720-1600x900",
"credit": "Molly Ferguson/STAT",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1968065": {
"type": "attachments",
"id": "science_1968065",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1968065",
"found": true
},
"parent": 1968038,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-160x146.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 146
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-scaled.jpg",
"width": 2560,
"height": 2343
},
"2048x2048": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-2048x1874.jpg",
"width": 2048,
"mimeType": "image/jpeg",
"height": 1874
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-1020x933.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 933
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-1536x1406.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 1406
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-1920x1757.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1757
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-800x732.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 732
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/GettyImages-1209490986-768x703.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 703
}
},
"publishDate": 1596668449,
"modified": 1596674405,
"caption": "Vials of the antiviral drug remdesivir, which has been shown in trials to effectively treat hospitalized COVID-19 patients.",
"description": null,
"title": "GERMANY-HEALTH-VIRUS",
"credit": "Ulrich Perrey/Pool/AFP via Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1968016": {
"type": "attachments",
"id": "science_1968016",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1968016",
"found": true
},
"parent": 1968013,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/RS44231_GettyImages-1248828505-qut-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/RS44231_GettyImages-1248828505-qut-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/RS44231_GettyImages-1248828505-qut-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/RS44231_GettyImages-1248828505-qut.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/RS44231_GettyImages-1248828505-qut-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/RS44231_GettyImages-1248828505-qut-1536x1024.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 1024
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/RS44231_GettyImages-1248828505-qut-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/RS44231_GettyImages-1248828505-qut-768x512.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 512
}
},
"publishDate": 1596587203,
"modified": 1596655719,
"caption": "The Clemson campus remains open in a limited capacity due to the coronavirus pandemic. ",
"description": null,
"title": "Clemson University Operates In Limited Capacity Amid Coronavirus Pandemic",
"credit": "Maddie Meyer/Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1946768": {
"type": "attachments",
"id": "science_1946768",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1946768",
"found": true
},
"parent": 1946766,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2019/08/RS8259_IMG_4445-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2019/08/RS8259_IMG_4445-160x120.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 120
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2019/08/RS8259_IMG_4445-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2019/08/RS8259_IMG_4445-e1566606462465.jpg",
"width": 1925,
"height": 1444
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2019/08/RS8259_IMG_4445-1020x765.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 765
},
"complete_open_graph": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2019/08/RS8259_IMG_4445-1200x900.jpg",
"width": 1200,
"mimeType": "image/jpeg",
"height": 900
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2019/08/RS8259_IMG_4445-1920x1440.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1440
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2019/08/RS8259_IMG_4445-800x600.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 600
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2019/08/RS8259_IMG_4445-768x576.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 576
}
},
"publishDate": 1566606443,
"modified": 1596665375,
"caption": "Poor air quality in December, 2013.",
"description": null,
"title": "RS8259_IMG_4445",
"credit": "Craig Miller/Vox Terra",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1967975": {
"type": "attachments",
"id": "science_1967975",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1967975",
"found": true
},
"parent": 1967970,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM-1038x576.png",
"width": 1038,
"mimeType": "image/png",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM-160x82.png",
"width": 160,
"mimeType": "image/png",
"height": 82
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM-672x372.png",
"width": 672,
"mimeType": "image/png",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM.png",
"width": 2880,
"height": 1474
},
"2048x2048": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM-2048x1048.png",
"width": 2048,
"mimeType": "image/png",
"height": 1048
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM-1020x522.png",
"width": 1020,
"mimeType": "image/png",
"height": 522
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM-1536x786.png",
"width": 1536,
"mimeType": "image/png",
"height": 786
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM-1920x983.png",
"width": 1920,
"mimeType": "image/png",
"height": 983
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM-800x409.png",
"width": 800,
"mimeType": "image/png",
"height": 409
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/08/Screen-Shot-2020-08-03-at-11.37.12-AM-768x393.png",
"width": 768,
"mimeType": "image/png",
"height": 393
}
},
"publishDate": 1596479972,
"modified": 1596480001,
"caption": null,
"description": null,
"title": "Screen-Shot-2020-08-03-at-11.37.12-AM",
"credit": "YouTube/Nicholas Braun",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1967932": {
"type": "attachments",
"id": "science_1967932",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1967932",
"found": true
},
"parent": 1967921,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/GettyImages-1219070979-1600x900-1-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/GettyImages-1219070979-1600x900-1-160x90.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 90
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/GettyImages-1219070979-1600x900-1-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/GettyImages-1219070979-1600x900-1.jpg",
"width": 1600,
"height": 900
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/GettyImages-1219070979-1600x900-1-1020x574.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 574
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/GettyImages-1219070979-1600x900-1-1536x864.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 864
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/GettyImages-1219070979-1600x900-1-800x450.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 450
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/GettyImages-1219070979-1600x900-1-768x432.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 432
}
},
"publishDate": 1596221285,
"modified": 1596243122,
"caption": "Researchers work in a lab at Yisheng Biopharma, one of a number of Chinese companies racing to create a COVID-19 vaccine.\n",
"description": null,
"title": "GettyImages-1219070979-1600x900",
"credit": "Noel Celis/AFP via Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1967927": {
"type": "attachments",
"id": "science_1967927",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1967927",
"found": true
},
"parent": 1967925,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44167_GettyImages-474897535-qut-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44167_GettyImages-474897535-qut-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44167_GettyImages-474897535-qut-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44167_GettyImages-474897535-qut.jpg",
"width": 1920,
"height": 1287
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44167_GettyImages-474897535-qut-1020x684.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 684
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44167_GettyImages-474897535-qut-1536x1030.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 1030
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44167_GettyImages-474897535-qut-800x536.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 536
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44167_GettyImages-474897535-qut-768x515.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 515
}
},
"publishDate": 1596219793,
"modified": 1596226744,
"caption": "A tractor plows a field on Feb. 25, 2014, in Firebaugh, California. ",
"description": null,
"title": "Statewide Drought Forces Californians To Take Drastic Measures For Water Conversation",
"credit": "Justin Sullivan/Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1967585": {
"type": "attachments",
"id": "science_1967585",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1967585",
"found": true
},
"parent": 1967579,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44037_GettyImages-1212788785-1-qut-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44037_GettyImages-1212788785-1-qut-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44037_GettyImages-1212788785-1-qut-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44037_GettyImages-1212788785-1-qut.jpg",
"width": 1920,
"height": 1287
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44037_GettyImages-1212788785-1-qut-1020x684.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 684
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44037_GettyImages-1212788785-1-qut-1536x1030.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 1030
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44037_GettyImages-1212788785-1-qut-800x536.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 536
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44037_GettyImages-1212788785-1-qut-768x515.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 515
}
},
"publishDate": 1595616546,
"modified": 1595627299,
"caption": "A medical worker guides a car that is going through a coronavirus drive-thru test clinic at the San Mateo County Event Center on March 16, 2020, in San Mateo, California. ",
"description": null,
"title": "Google Sister Company Verily Opens Coronavirus Testing Sites In Bay Area",
"credit": "Justin Sullivan/Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1967770": {
"type": "attachments",
"id": "science_1967770",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1967770",
"found": true
},
"parent": 1967769,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-160x108.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 108
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-scaled.jpg",
"width": 2560,
"height": 1724
},
"2048x2048": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-2048x1379.jpg",
"width": 2048,
"mimeType": "image/jpeg",
"height": 1379
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-1020x687.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 687
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-1536x1034.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 1034
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-1920x1293.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1293
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-800x539.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 539
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/rtx7dyrz_enl-895ae9e8120d1fc367e8c64a5eabb23ff4d9fb89-768x517.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 517
}
},
"publishDate": 1596043992,
"modified": 1596046074,
"caption": "A phlebotomist shows a full bag of donated convalescent plasma from a person who recovered from coronavirus. ",
"description": null,
"title": "Blood plasma — the yellowish, cell-free portion that remains after red and white blood cells have been filtered out by a machine and returned to the plasma donor — is rich with antibodies. Plasma from recovered COVID-19 patients might prove useful in preventing infection as well as in treatment, scientists say.",
"credit": "Lindsey Wasson/NPR",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1967733": {
"type": "attachments",
"id": "science_1967733",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1967733",
"found": true
},
"parent": 1967728,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44109_GettyImages-1227123586-qut-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44109_GettyImages-1227123586-qut-160x107.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 107
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44109_GettyImages-1227123586-qut-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44109_GettyImages-1227123586-qut.jpg",
"width": 1920,
"height": 1280
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44109_GettyImages-1227123586-qut-1020x680.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 680
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44109_GettyImages-1227123586-qut-1536x1024.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 1024
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44109_GettyImages-1227123586-qut-800x533.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 533
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44109_GettyImages-1227123586-qut-768x512.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 512
}
},
"publishDate": 1595973921,
"modified": 1595981715,
"caption": "A girl and her father wear face masks while they push their bikes in Hermosa Beach, California, on July 14, 2020.",
"description": "A girl and her father wear facemasks while they push their bikes in Hermosa Beach, Los Angeles, California, on July 14, 2020.",
"title": "US-HEALTH-VIRUS-CALIFORNIA",
"credit": "Apu Gomes/AFP via Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1967705": {
"type": "attachments",
"id": "science_1967705",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1967705",
"found": true
},
"parent": 1967695,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44090_GettyImages-1052438324-1-qut-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44090_GettyImages-1052438324-1-qut-160x103.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 103
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44090_GettyImages-1052438324-1-qut-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44090_GettyImages-1052438324-1-qut.jpg",
"width": 1920,
"height": 1231
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44090_GettyImages-1052438324-1-qut-1020x654.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 654
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44090_GettyImages-1052438324-1-qut-1536x985.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 985
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44090_GettyImages-1052438324-1-qut-800x513.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 513
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/RS44090_GettyImages-1052438324-1-qut-768x492.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 492
}
},
"publishDate": 1595958984,
"modified": 1596036773,
"caption": "Employees work in Facebook's nerve center for the fight against misinformation on the platform during a media demonstration on Oct. 17, 2018, in Menlo Park, California. ",
"description": null,
"title": "DOUNIAMAG-US-IT-POLITICS-MEDIA-FACEBOOK",
"credit": "Noah Berger/AFP via Getty Images",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
},
"science_1967711": {
"type": "attachments",
"id": "science_1967711",
"meta": {
"index": "attachments_1716263798",
"site": "science",
"id": "1967711",
"found": true
},
"parent": 1967710,
"imgSizes": {
"twentyfourteen-full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-1038x576.jpg",
"width": 1038,
"mimeType": "image/jpeg",
"height": 576
},
"thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-160x120.jpg",
"width": 160,
"mimeType": "image/jpeg",
"height": 120
},
"post-thumbnail": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-672x372.jpg",
"width": 672,
"mimeType": "image/jpeg",
"height": 372
},
"kqedFullSize": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-scaled.jpg",
"width": 2560,
"height": 1920
},
"2048x2048": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-2048x1536.jpg",
"width": 2048,
"mimeType": "image/jpeg",
"height": 1536
},
"large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-1020x765.jpg",
"width": 1020,
"mimeType": "image/jpeg",
"height": 765
},
"1536x1536": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-1536x1152.jpg",
"width": 1536,
"mimeType": "image/jpeg",
"height": 1152
},
"full-width": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-1920x1440.jpg",
"width": 1920,
"mimeType": "image/jpeg",
"height": 1440
},
"medium": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-800x600.jpg",
"width": 800,
"mimeType": "image/jpeg",
"height": 600
},
"medium_large": {
"file": "https://ww2.kqed.org/app/uploads/sites/35/2020/07/ap_20157495874204-47ee4e43656584df4a03acc44614d157c39bcf55-768x576.jpg",
"width": 768,
"mimeType": "image/jpeg",
"height": 576
}
},
"publishDate": 1595959396,
"modified": 1595965547,
"caption": "Jess Baddams, a paramedic, holds a blood sample as she poses for a photograph during an antibody testing program at the Hollymoor Ambulance Hub in Birmingham, England, on June 5, 2020. Making antibody tests widely available may help Britain lift its lockdown restrictions, because they show who has already had the COVID-19 and might have a degree of immunity from coronavirus. ",
"description": null,
"title": "Researchers have been investigating how long antibodies to the coronavirus last in people who have recovered from infections.",
"credit": "Simon Dawson/Via NPR",
"status": "inherit",
"isLoading": false,
"fetchFailed": false
}
},
"audioPlayerReducer": {
"postId": "stream_live",
"isPaused": true,
"isPlaying": false,
"pfsActive": false,
"pledgeModalIsOpen": true,
"playerDrawerIsOpen": false,
"liveAudioPlayStartedAt": 0,
"liveAudioPlayContext": ""
},
"authorsReducer": {
"byline_science_1968259": {
"type": "authors",
"id": "byline_science_1968259",
"meta": {
"override": true
},
"slug": "byline_science_1968259",
"name": "Helen Branswell \u003cbr />STAT\u003cbr>",
"isLoading": false
},
"byline_science_1967921": {
"type": "authors",
"id": "byline_science_1967921",
"meta": {
"override": true
},
"slug": "byline_science_1967921",
"name": "Andrew Joseph \u003cbr />STAT\u003cbr>",
"isLoading": false
},
"byline_science_1967925": {
"type": "authors",
"id": "byline_science_1967925",
"meta": {
"override": true
},
"slug": "byline_science_1967925",
"name": "Dan Gearino \u003cbr />InsideClimate News\u003cbr>",
"isLoading": false
},
"byline_science_1967769": {
"type": "authors",
"id": "byline_science_1967769",
"meta": {
"override": true
},
"slug": "byline_science_1967769",
"name": "Richard Harris \u003cbr />NPR\u003cbr>",
"isLoading": false
},
"byline_science_1967695": {
"type": "authors",
"id": "byline_science_1967695",
"meta": {
"override": true
},
"slug": "byline_science_1967695",
"name": " Erin Brodwin \u003cbr />STAT\u003cbr>",
"isLoading": false
},
"byline_science_1967710": {
"type": "authors",
"id": "byline_science_1967710",
"meta": {
"override": true
},
"slug": "byline_science_1967710",
"name": "Richard Harris \u003cbr />NPR\u003cbr>",
"isLoading": false
},
"lklivans": {
"type": "authors",
"id": "8648",
"meta": {
"index": "authors_1716337520",
"id": "8648",
"found": true
},
"name": "Laura Klivans",
"firstName": "Laura",
"lastName": "Klivans",
"slug": "lklivans",
"email": "lklivans@kqed.org",
"display_author_email": true,
"staff_mastheads": [
"news",
"science"
],
"title": "Reporter",
"bio": "Laura Klivans is an award-winning science reporter for KQED News, where she covers climate change with an eye on both groundbreaking progress and gaps in action. She is the former host of KQED's blockbuster video series about tiny, amazing animals, \u003cem>Deep Look\u003c/em>. Her work reaches national audiences through NPR, \u003cem>Here & Now, \u003c/em>PRI, and other major outlets. \r\n\r\nLaura’s won five Northern California Area Emmy Awards for Deep Look and First Place in the Greater Bay Area Journalism Awards for a podcast exploring how one Oakland neighborhood teamed up to reduce planet-heating pollution.\r\n\r\nBeyond her reporting, she hosts and moderates events. In the past, she taught audio storytelling at the UC Berkeley Graduate School of Journalism, led international education programs, worked with immigrants and refugees along the Thai-Burmese border, taught high schoolers sex ed, and was an actress. \r\n\r\nShe's a former UC Berkeley Human Rights Fellow, USC Center for Health Journalism's California Fellow and Coro Fellow in Public Affairs. Laura has a master’s in journalism from UC Berkeley, a master’s in education from Harvard, and an undergraduate degree from Northwestern University.\r\n\r\nShe loves trying to riddle the meaning out of vanity license plates.",
"avatar": "https://secure.gravatar.com/avatar/2d2ecd1550a494cc10ad4a503406965585902124739e775a9b3817eebf1d88be?s=600&d=blank&r=g",
"twitter": "lauraklivans",
"bluesky": null,
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "news",
"roles": [
"editor"
]
},
{
"site": "stateofhealth",
"roles": [
"contributor",
"editor"
]
},
{
"site": "science",
"roles": [
"editor"
]
},
{
"site": "forum",
"roles": [
"editor"
]
}
],
"headData": {
"title": "Laura Klivans | KQED",
"description": "Reporter",
"ogImgSrc": "https://secure.gravatar.com/avatar/2d2ecd1550a494cc10ad4a503406965585902124739e775a9b3817eebf1d88be?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/2d2ecd1550a494cc10ad4a503406965585902124739e775a9b3817eebf1d88be?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/lklivans"
},
"parcuni": {
"type": "authors",
"id": "11368",
"meta": {
"index": "authors_1716337520",
"id": "11368",
"found": true
},
"name": "Peter Arcuni",
"firstName": "Peter",
"lastName": "Arcuni",
"slug": "parcuni",
"email": "parcuni@KQED.org",
"display_author_email": false,
"staff_mastheads": [
"science"
],
"title": "Reporter",
"bio": "Peter reports radio and online stories for \u003cem>KQED Science\u003c/em>. His work has also appeared on the \u003cem>The California Report\u003c/em> morning show and \u003cem>KQED News\u003c/em>. His production credits include \u003cem>The California Report, The California Report Magazine\u003c/em> and KQED's local news podcast \u003cem>The Bay\u003c/em>. Other credits include NPR's \u003cem>All Things Considered\u003c/em>, WNYC's \u003cem>Science Friday\u003c/em>, WBUR's \u003cem>Here & Now\u003c/em>, WIRED and SFGate. Peter graduated from Brown University and earned a master's degree in journalism from Stanford. He's covered everything from homelessness to wildfires, health, the environment, arts and Thanksgiving in San Quentin prison. In other lives, he played rock n roll music and studied neuroscience. You can email him at: parcuni@kqed.org",
"avatar": "https://secure.gravatar.com/avatar/d5032f6f27199d478af34ad2e1d98732?s=600&d=blank&r=g",
"twitter": "peterarcuni",
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "news",
"roles": [
"editor"
]
},
{
"site": "science",
"roles": [
"editor"
]
}
],
"headData": {
"title": "Peter Arcuni | KQED",
"description": "Reporter",
"ogImgSrc": "https://secure.gravatar.com/avatar/d5032f6f27199d478af34ad2e1d98732?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/d5032f6f27199d478af34ad2e1d98732?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/parcuni"
},
"jasminegarnett": {
"type": "authors",
"id": "11530",
"meta": {
"index": "authors_1716337520",
"id": "11530",
"found": true
},
"name": "Jasmine Garnett",
"firstName": "Jasmine",
"lastName": "Garnett",
"slug": "jasminegarnett",
"email": "JGarnett@KQED.org",
"display_author_email": false,
"staff_mastheads": [
"news"
],
"title": "Senior Engagement Platforms Producer",
"bio": "Jasmine is a Senior Engagement Platforms Producer on the KQED News team. She is also a freelance writer, with work appearing in KQED, Bitch Media, and Kotaku among others. Jasmine graduated from UC Berkeley with a degree in Media Studies, where she was also an Arts and Entertainment reporter at the Daily Californian.",
"avatar": "https://secure.gravatar.com/avatar/a6ea8b0641874311533b7401bee15c8e?s=600&d=blank&r=g",
"twitter": "JFLGarnett",
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "arts",
"roles": [
"author"
]
},
{
"site": "news",
"roles": [
"editor"
]
},
{
"site": "about",
"roles": [
"editor"
]
},
{
"site": "science",
"roles": [
"editor"
]
},
{
"site": "forum",
"roles": [
"editor"
]
},
{
"site": "pressroom",
"roles": [
"editor"
]
}
],
"headData": {
"title": "Jasmine Garnett | KQED",
"description": "Senior Engagement Platforms Producer",
"ogImgSrc": "https://secure.gravatar.com/avatar/a6ea8b0641874311533b7401bee15c8e?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/a6ea8b0641874311533b7401bee15c8e?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/jasminegarnett"
},
"kevinstark": {
"type": "authors",
"id": "11608",
"meta": {
"index": "authors_1716337520",
"id": "11608",
"found": true
},
"name": "Kevin Stark",
"firstName": "Kevin",
"lastName": "Stark",
"slug": "kevinstark",
"email": "kstark@kqed.org",
"display_author_email": true,
"staff_mastheads": [
"science"
],
"title": "Senior Editor",
"bio": "Kevin is a senior editor for KQED Science, managing the station's health and climate desks. His journalism career began in the Pacific Northwest, and he later became a lead reporter for the San Francisco Public Press. His work has appeared in Pacific Standard magazine, the Energy News Network, the Center for Investigative Reporting's Reveal and WBEZ in Chicago. Kevin joined KQED in 2019, and has covered issues related to energy, wildfire, climate change and the environment.",
"avatar": "https://secure.gravatar.com/avatar/365aaa4b597d3a8374f67504ff0facd323d7906e8eb4be0a7efd2427408e802c?s=600&d=blank&r=g",
"twitter": "starkkev",
"bluesky": null,
"facebook": null,
"instagram": null,
"linkedin": null,
"sites": [
{
"site": "",
"roles": [
"editor"
]
},
{
"site": "news",
"roles": [
"editor"
]
},
{
"site": "science",
"roles": [
"administrator"
]
}
],
"headData": {
"title": "Kevin Stark | KQED",
"description": "Senior Editor",
"ogImgSrc": "https://secure.gravatar.com/avatar/365aaa4b597d3a8374f67504ff0facd323d7906e8eb4be0a7efd2427408e802c?s=600&d=blank&r=g",
"twImgSrc": "https://secure.gravatar.com/avatar/365aaa4b597d3a8374f67504ff0facd323d7906e8eb4be0a7efd2427408e802c?s=600&d=blank&r=g"
},
"isLoading": false,
"link": "/author/kevinstark"
}
},
"pagesReducer": {
"science_category_health": {
"type": "terms",
"id": "science_39",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "39",
"score": 10.889561
},
"featImg": null,
"name": "Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Health Archives | KQED Science",
"ogDescription": null
},
"ttid": 41,
"slug": "health",
"isLoading": false,
"title": "Health",
"pageMeta": {
"site": "science",
"WpPageTemplate": "page-topic-editorial",
"currentPage": 18
},
"blocks": [
{
"blockName": "kqed/post-list",
"attrs": {
"layout": "cardArticle2",
"query": "posts/science?category=health",
"seeMore": false,
"paginated": true,
"page": 18
}
},
{
"blockName": "kqed/ad"
}
]
}
},
"pfsSessionReducer": {},
"postsReducer": {
"stream_live": {
"type": "live",
"id": "stream_live",
"audioUrl": "https://streams.kqed.org/kqedradio",
"title": "Live Stream",
"excerpt": "Live Stream information currently unavailable.",
"link": "/radio",
"featImg": "",
"label": {
"name": "KQED Live",
"link": "/"
}
},
"stream_kqedNewscast": {
"type": "posts",
"id": "stream_kqedNewscast",
"audioUrl": "https://www.kqed.org/.stream/anon/radio/RDnews/newscast.mp3?_=1",
"title": "KQED Newscast",
"featImg": "",
"label": {
"name": "88.5 FM",
"link": "/"
}
},
"science_1968259": {
"type": "posts",
"id": "science_1968259",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1968259",
"score": null,
"sort": [
1597082540000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1597082540,
"format": "standard",
"title": "The US Has a Dwindling Number of Months to Contain COVID-19 Before a Winter Surge",
"headTitle": "The US Has a Dwindling Number of Months to Contain COVID-19 Before a Winter Surge | KQED",
"content": "\u003cp>\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">T\u003c/span>\u003c/span>he good news: The United States has a window of opportunity to beat back COVID-19 before things get much, much worse.\u003c/p>\n\u003cp>The bad news: That window is rapidly closing. And the country seems unwilling or unable to seize the moment.\u003c/p>\n\u003cp>Winter is coming. Winter means cold and flu season, which is all but sure to complicate the task of figuring out who is sick with COVID-19 and who is suffering from a less threatening respiratory tract infection. It also means that cherished outdoor freedoms that link us to pre-COVID life — pop-up restaurant patios, picnics in parks, trips to the beach — will soon be out of reach, at least in northern parts of the country.\u003c/p>\n\u003cp>Unless Americans use the dwindling weeks between now and the onset of “indoor weather” to tamp down transmission in the country, this winter could be Dickensianly bleak, public health experts warn.\u003c/p>\n\u003cp>“I think November, December, January, February are going to be tough months in this country without a vaccine,” said Michael Osterholm, director of the Center for Infectious Diseases Research and Policy at the University of Minnesota.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>It is possible, of course, that some vaccines could be approved by then, thanks to \u003ca href=\"https://www.statnews.com/2020/07/30/a-huge-experiment-how-the-world-made-so-much-progress-on-a-covid-19-vaccine-so-fast/\" target=\"_blank\" rel=\"noopener noreferrer\">historically rapid scientific work\u003c/a>. But there is little prospect that vast numbers of Americans will be vaccinated in time to forestall the grim winter Osterholm and others foresee.\u003c/p>\n\u003cp>Human coronaviruses, the distant cold-causing cousins of the virus that causes COVID-19, circulate year-round. Now is typically the low season for transmission. But in this summer of America’s failed COVID-19 response, the SARS-CoV-2 virus is widespread across the country, and pandemic-weary Americans seem more interested in resuming pre-COVID lifestyles than in suppressing the virus to the point where schools can be reopened, and stay open, and restaurants, movie theaters, and gyms can function with some restrictions.\u003c/p>\n\u003cp>“We should be aiming for no transmission before we open the schools and we put kids in harm’s way — kids and teachers and their caregivers. And so, if that means no gym, no movie theaters, so be it,” said Caroline Buckee, associate director of the Center for Communicable Disease Dynamics at Harvard’s T.H. Chan School of Public Health.\u003c/p>\n\u003cp>“We seem to be choosing leisure activities now over children’s safety in a month’s time. And I cannot understand that trade-off.”\u003c/p>\n\u003cp>While many countries managed to suppress the spread of SARS-CoV-2, the United States has failed miserably. Countries in Europe and Asia are worrying about a second wave. Here, the first wave rages on, engulfing rural as well as urban parts of the country. Though there’s been a slight decline in cases in the past couple of weeks, more than 50,000 Americans a day are being diagnosed with COVID-19. And those are just the confirmed cases.\u003c/p>\n\u003cp>To put that in perspective, at this rate the U.S. is racking up more cases in a week than Britain has accumulated since the start of the pandemic.\u003c/p>\n\u003cp>Public health officials had hoped transmission of the virus would abate with the warm temperatures of summer and the tendency — heightened this year — of people to take their recreational activities outdoors. Experts do believe people are less likely to transmit the virus outside, especially if they are wearing face coverings and keeping a safe distance apart.\u003c/p>\n\u003cp>But in some places, people have been throwing COVID cautions to the wind, flouting public health orders in the process. Kristen Ehresmann, director of infectious disease epidemiology, prevention, and control for the Minnesota Department of Health, points to a \u003ca href=\"http://www.citypages.com/news/minnesota-sues-rodeo-for-flouting-coronavirus-rules/571995611\" target=\"_blank\" rel=\"noopener noreferrer\">large, three-day rodeo\u003c/a> that was held recently in her state. Organizers knew they were supposed to limit the number of attendees to 250 but refused; thousands attended. In Sturgis, South Dakota, an estimated quarter of a million motorcyclists were expected to descend on the city this past weekend for an annual rally that spans 10 days.\u003c/p>\n\u003cp>Even on smaller scales, public health authorities know some people are letting down their guard. Others have never embraced the need to try to prevent the spread of the virus. Ehresmann’s father was recently invited to visit some friends; he went, she said, but wore his mask, elbow bumping instead of shaking proffered hands. “And the people kind of acted like … ‘Oh, you drank that Kool-Aid,’ rather than, ‘We all need to be doing this.’”\u003c/p>\n\u003cp>Ehresmann and others in public health are flummoxed by the phenomenon of people refusing to acknowledge the risk the virus poses.\u003c/p>\n\u003cp>“Just this idea of, ‘I just don’t want to believe it so therefore it’s not going to be true’ — honestly, I have not really dealt with that as it relates to disease before,” she said.\u003c/p>\n\u003cp>Buckee, the Harvard expert, wonders if the \u003ca href=\"https://www.statnews.com/2020/04/20/the-months-of-magical-thinking-as-the-coronavirus-swept-over-china-some-experts-were-in-denial-about-what-was-to-come/\" target=\"_blank\" rel=\"noopener noreferrer\">magical thinking\u003c/a> that seems to have infected swaths of the country is due to the fact many of the people who have died were elderly. For many Americans, she said, the disease has not yet touched their lives — but the movement restrictions and other response measures have.\u003c/p>\n\u003cp>“I think if children were dying, this would be … a different situation, quite honestly,” she said.\u003c/p>\n\u003cp>Epidemiologist Michael Mina despairs that an important chance to wrestle the virus under control is being lost, as Americans ignore the realities of the pandemic in favor of trying to resume pre-COVID life.\u003c/p>\n\u003cp>“We just continue to squander every bit of opportunity we get with this epidemic to get it under control,’’ said Mina, an assistant professor at Harvard’s T.H. Chan School of Public Health and associate medical director of clinical microbiology at Boston’s Brigham and Women’s Hospital.\u003c/p>\n\u003cp>“The best time to squash a pandemic is when the environmental characteristics slow transmission. It’s your one opportunity in the year, really, to leverage that extra assistance and get transmission under control,” he said, his frustration audible.\u003c/p>\n\u003cp>Driving back transmission would require people to continue to make sacrifices, to accept the fact that life post-COVID cannot proceed as normal, not while so many people remain vulnerable to the virus. Instead, people are giddily throwing off the shackles of coronavirus suppression efforts, seemingly convinced that a few weeks of sacrifice during the spring was a one-time solution.\u003c/p>\n\u003cp>Osterholm has for months warned that people were being misled about how long the restrictions on daily life would need to be in place. He now thinks the time has come for \u003ca href=\"https://www.nytimes.com/2020/08/07/opinion/coronavirus-lockdown-unemployment-death.html?searchResultPosition=1\" target=\"_blank\" rel=\"noopener noreferrer\">another lockdown\u003c/a>. “What we did before and more,” he said.\u003c/p>\n\u003cp>The country has fallen into a dangerous pattern, Osterholm said, where a spike in cases in a location leads to some temporary restraint from people who eventually become alarmed enough to start to take precautions. But as soon as cases start to plateau or decline a little, victory over the virus is declared and people think it’s safe to resume normal life.\u003c/p>\n\u003cp>“It’s like an all or nothing phenomenon, right?” said Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases. “You all locked down or you get so discouraged with being lockdown that you decide you’re going to be in crowded bars … you can have indoor parties with no masks. You can do all the things that are going to get you in trouble.”\u003c/p>\n\u003cp>Osterholm said with the K-12 school year resuming in some parts of the country or set to start — along with universities — in a few weeks, transmission will take off and cases will start to climb again. He predicted the next peaks will “exceed by far the peak we have just experienced. Winter is only going to reinforce that. Indoor air,” he said.\u003c/p>\n\u003cp>Buckee thinks that if the country doesn’t alter the trajectory it is on, more shutdowns are inevitable. “I can’t see a way that we’re going to have restaurants and bars open in the winter, frankly. We’ll have resurgence. Everything will get shut down again.”\u003c/p>\n\u003cp>Fauci favors a reset of the reopening measures, with a strong messaging component aimed at explaining to people why driving down transmission now will pay off later. Young people in particular need to understand that even if they are less likely to die from COVID-19, statistically speaking, transmission among 20-somethings will eventually lead to infections among their parents and grandparents, where the risk of severe infections and fatal outcomes is higher. (Young people can also develop long-term health problems as a result of the virus.)\u003c/p>\n\u003cp>“It’s not them alone in a vacuum,” Fauci said. “They are spreading it to the people who are going to wind up in the hospital.”\u003c/p>\n\u003cp>Everyone has to work together to get cases down to more manageable levels, if the country hopes to avoid “a disastrous winter,” he said.\u003c/p>\n\u003cp>“I think we can get it under much better control, between now and the mid-to-late fall when we get influenza or we get whatever it is we get in the fall and the winter. I’m not giving up,” Fauci said.\u003c/p>\n\u003cp>But without an all-in effort “the cases are not going to come down,” he warned. “They’re not. They’re just not.”\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>\u003cem>This story was originally published by \u003ca href=\"https://www.statnews.com/2020/08/10/winter-is-coming-as-flu-season-nears-americas-window-of-opportunity-to-beat-back-covid-19-is-narrowing/\" target=\"_blank\" rel=\"noopener noreferrer\">STAT\u003c/a>, an online publication of Boston Globe Media that covers health, medicine, and scientific discovery.\u003c/em>\u003c/p>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1652,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 35
},
"modified": 1704847105,
"excerpt": "Americans must use the weeks between now and the onset of “indoor weather” to tamp down coronavirus transmission, experts warn. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Americans must use the weeks between now and the onset of “indoor weather” to tamp down coronavirus transmission, experts warn. ",
"title": "The US Has a Dwindling Number of Months to Contain COVID-19 Before a Winter Surge | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "The US Has a Dwindling Number of Months to Contain COVID-19 Before a Winter Surge",
"datePublished": "2020-08-10T11:02:20-07:00",
"dateModified": "2024-01-09T16:38:25-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "the-u-s-has-a-dwindling-number-of-months-to-contain-covid-19-before-a-winter-surge",
"status": "publish",
"nprByline": "Helen Branswell \u003cbr />STAT\u003cbr>",
"sticky": false,
"source": "STAT",
"path": "/science/1968259/the-u-s-has-a-dwindling-number-of-months-to-contain-covid-19-before-a-winter-surge",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">T\u003c/span>\u003c/span>he good news: The United States has a window of opportunity to beat back COVID-19 before things get much, much worse.\u003c/p>\n\u003cp>The bad news: That window is rapidly closing. And the country seems unwilling or unable to seize the moment.\u003c/p>\n\u003cp>Winter is coming. Winter means cold and flu season, which is all but sure to complicate the task of figuring out who is sick with COVID-19 and who is suffering from a less threatening respiratory tract infection. It also means that cherished outdoor freedoms that link us to pre-COVID life — pop-up restaurant patios, picnics in parks, trips to the beach — will soon be out of reach, at least in northern parts of the country.\u003c/p>\n\u003cp>Unless Americans use the dwindling weeks between now and the onset of “indoor weather” to tamp down transmission in the country, this winter could be Dickensianly bleak, public health experts warn.\u003c/p>\n\u003cp>“I think November, December, January, February are going to be tough months in this country without a vaccine,” said Michael Osterholm, director of the Center for Infectious Diseases Research and Policy at the University of Minnesota.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>It is possible, of course, that some vaccines could be approved by then, thanks to \u003ca href=\"https://www.statnews.com/2020/07/30/a-huge-experiment-how-the-world-made-so-much-progress-on-a-covid-19-vaccine-so-fast/\" target=\"_blank\" rel=\"noopener noreferrer\">historically rapid scientific work\u003c/a>. But there is little prospect that vast numbers of Americans will be vaccinated in time to forestall the grim winter Osterholm and others foresee.\u003c/p>\n\u003cp>Human coronaviruses, the distant cold-causing cousins of the virus that causes COVID-19, circulate year-round. Now is typically the low season for transmission. But in this summer of America’s failed COVID-19 response, the SARS-CoV-2 virus is widespread across the country, and pandemic-weary Americans seem more interested in resuming pre-COVID lifestyles than in suppressing the virus to the point where schools can be reopened, and stay open, and restaurants, movie theaters, and gyms can function with some restrictions.\u003c/p>\n\u003cp>“We should be aiming for no transmission before we open the schools and we put kids in harm’s way — kids and teachers and their caregivers. And so, if that means no gym, no movie theaters, so be it,” said Caroline Buckee, associate director of the Center for Communicable Disease Dynamics at Harvard’s T.H. Chan School of Public Health.\u003c/p>\n\u003cp>“We seem to be choosing leisure activities now over children’s safety in a month’s time. And I cannot understand that trade-off.”\u003c/p>\n\u003cp>While many countries managed to suppress the spread of SARS-CoV-2, the United States has failed miserably. Countries in Europe and Asia are worrying about a second wave. Here, the first wave rages on, engulfing rural as well as urban parts of the country. Though there’s been a slight decline in cases in the past couple of weeks, more than 50,000 Americans a day are being diagnosed with COVID-19. And those are just the confirmed cases.\u003c/p>\n\u003cp>To put that in perspective, at this rate the U.S. is racking up more cases in a week than Britain has accumulated since the start of the pandemic.\u003c/p>\n\u003cp>Public health officials had hoped transmission of the virus would abate with the warm temperatures of summer and the tendency — heightened this year — of people to take their recreational activities outdoors. Experts do believe people are less likely to transmit the virus outside, especially if they are wearing face coverings and keeping a safe distance apart.\u003c/p>\n\u003cp>But in some places, people have been throwing COVID cautions to the wind, flouting public health orders in the process. Kristen Ehresmann, director of infectious disease epidemiology, prevention, and control for the Minnesota Department of Health, points to a \u003ca href=\"http://www.citypages.com/news/minnesota-sues-rodeo-for-flouting-coronavirus-rules/571995611\" target=\"_blank\" rel=\"noopener noreferrer\">large, three-day rodeo\u003c/a> that was held recently in her state. Organizers knew they were supposed to limit the number of attendees to 250 but refused; thousands attended. In Sturgis, South Dakota, an estimated quarter of a million motorcyclists were expected to descend on the city this past weekend for an annual rally that spans 10 days.\u003c/p>\n\u003cp>Even on smaller scales, public health authorities know some people are letting down their guard. Others have never embraced the need to try to prevent the spread of the virus. Ehresmann’s father was recently invited to visit some friends; he went, she said, but wore his mask, elbow bumping instead of shaking proffered hands. “And the people kind of acted like … ‘Oh, you drank that Kool-Aid,’ rather than, ‘We all need to be doing this.’”\u003c/p>\n\u003cp>Ehresmann and others in public health are flummoxed by the phenomenon of people refusing to acknowledge the risk the virus poses.\u003c/p>\n\u003cp>“Just this idea of, ‘I just don’t want to believe it so therefore it’s not going to be true’ — honestly, I have not really dealt with that as it relates to disease before,” she said.\u003c/p>\n\u003cp>Buckee, the Harvard expert, wonders if the \u003ca href=\"https://www.statnews.com/2020/04/20/the-months-of-magical-thinking-as-the-coronavirus-swept-over-china-some-experts-were-in-denial-about-what-was-to-come/\" target=\"_blank\" rel=\"noopener noreferrer\">magical thinking\u003c/a> that seems to have infected swaths of the country is due to the fact many of the people who have died were elderly. For many Americans, she said, the disease has not yet touched their lives — but the movement restrictions and other response measures have.\u003c/p>\n\u003cp>“I think if children were dying, this would be … a different situation, quite honestly,” she said.\u003c/p>\n\u003cp>Epidemiologist Michael Mina despairs that an important chance to wrestle the virus under control is being lost, as Americans ignore the realities of the pandemic in favor of trying to resume pre-COVID life.\u003c/p>\n\u003cp>“We just continue to squander every bit of opportunity we get with this epidemic to get it under control,’’ said Mina, an assistant professor at Harvard’s T.H. Chan School of Public Health and associate medical director of clinical microbiology at Boston’s Brigham and Women’s Hospital.\u003c/p>\n\u003cp>“The best time to squash a pandemic is when the environmental characteristics slow transmission. It’s your one opportunity in the year, really, to leverage that extra assistance and get transmission under control,” he said, his frustration audible.\u003c/p>\n\u003cp>Driving back transmission would require people to continue to make sacrifices, to accept the fact that life post-COVID cannot proceed as normal, not while so many people remain vulnerable to the virus. Instead, people are giddily throwing off the shackles of coronavirus suppression efforts, seemingly convinced that a few weeks of sacrifice during the spring was a one-time solution.\u003c/p>\n\u003cp>Osterholm has for months warned that people were being misled about how long the restrictions on daily life would need to be in place. He now thinks the time has come for \u003ca href=\"https://www.nytimes.com/2020/08/07/opinion/coronavirus-lockdown-unemployment-death.html?searchResultPosition=1\" target=\"_blank\" rel=\"noopener noreferrer\">another lockdown\u003c/a>. “What we did before and more,” he said.\u003c/p>\n\u003cp>The country has fallen into a dangerous pattern, Osterholm said, where a spike in cases in a location leads to some temporary restraint from people who eventually become alarmed enough to start to take precautions. But as soon as cases start to plateau or decline a little, victory over the virus is declared and people think it’s safe to resume normal life.\u003c/p>\n\u003cp>“It’s like an all or nothing phenomenon, right?” said Dr. Anthony Fauci, director of the National Institute for Allergy and Infectious Diseases. “You all locked down or you get so discouraged with being lockdown that you decide you’re going to be in crowded bars … you can have indoor parties with no masks. You can do all the things that are going to get you in trouble.”\u003c/p>\n\u003cp>Osterholm said with the K-12 school year resuming in some parts of the country or set to start — along with universities — in a few weeks, transmission will take off and cases will start to climb again. He predicted the next peaks will “exceed by far the peak we have just experienced. Winter is only going to reinforce that. Indoor air,” he said.\u003c/p>\n\u003cp>Buckee thinks that if the country doesn’t alter the trajectory it is on, more shutdowns are inevitable. “I can’t see a way that we’re going to have restaurants and bars open in the winter, frankly. We’ll have resurgence. Everything will get shut down again.”\u003c/p>\n\u003cp>Fauci favors a reset of the reopening measures, with a strong messaging component aimed at explaining to people why driving down transmission now will pay off later. Young people in particular need to understand that even if they are less likely to die from COVID-19, statistically speaking, transmission among 20-somethings will eventually lead to infections among their parents and grandparents, where the risk of severe infections and fatal outcomes is higher. (Young people can also develop long-term health problems as a result of the virus.)\u003c/p>\n\u003cp>“It’s not them alone in a vacuum,” Fauci said. “They are spreading it to the people who are going to wind up in the hospital.”\u003c/p>\n\u003cp>Everyone has to work together to get cases down to more manageable levels, if the country hopes to avoid “a disastrous winter,” he said.\u003c/p>\n\u003cp>“I think we can get it under much better control, between now and the mid-to-late fall when we get influenza or we get whatever it is we get in the fall and the winter. I’m not giving up,” Fauci said.\u003c/p>\n\u003cp>But without an all-in effort “the cases are not going to come down,” he warned. “They’re not. They’re just not.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cem>This story was originally published by \u003ca href=\"https://www.statnews.com/2020/08/10/winter-is-coming-as-flu-season-nears-americas-window-of-opportunity-to-beat-back-covid-19-is-narrowing/\" target=\"_blank\" rel=\"noopener noreferrer\">STAT\u003c/a>, an online publication of Boston Globe Media that covers health, medicine, and scientific discovery.\u003c/em>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1968259/the-u-s-has-a-dwindling-number-of-months-to-contain-covid-19-before-a-winter-surge",
"authors": [
"byline_science_1968259"
],
"categories": [
"science_39",
"science_3890",
"science_40",
"science_4450"
],
"tags": [
"science_4329",
"science_4414",
"science_3977"
],
"featImg": "science_1968265",
"label": "source_science_1968259"
},
"science_1968038": {
"type": "posts",
"id": "science_1968038",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1968038",
"score": null,
"sort": [
1596670146000
]
},
"guestAuthors": [],
"slug": "california-ag-wants-more-companies-to-be-able-to-make-covid-19-drug",
"title": "California AG Wants More Companies to Be Able to Make COVID-19 Drug",
"publishDate": 1596670146,
"format": "audio",
"headTitle": "California AG Wants More Companies to Be Able to Make COVID-19 Drug | KQED",
"labelTerm": {},
"content": "\u003cp>Doctors say the antiviral drug remdesivir is one of the few treatments that benefits patients hospitalized with COVID-19. But the drug, made by Gilead Sciences, can cost more than $3,000 for the full course of treatment, and some hospitals — including several in the Bay Area — say it’s in short supply.\u003c/p>\n\u003cp>\u003ca href=\"https://www.gilead.com/\" target=\"_blank\" rel=\"noopener noreferrer\">Foster City-based Gilead\u003c/a> is currently the only company making remdesivir, and \u003ca href=\"https://www.amerisourcebergen.com/\" target=\"_blank\" rel=\"noopener noreferrer\">AmerisourceBergen\u003c/a> is the sole distributor.\u003c/p>\n\u003cp>On Tuesday, California Attorney General Xavier Becerra \u003ca href=\"https://www.oag.ca.gov/system/files/attachments/press-docs/Remdesivir%20Letter%2020200804.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">sent a letter\u003c/a> to federal health officials, urging them to allow other companies to manufacture and distribute the drug.\u003c/p>\n\u003cp>The letter, which was addressed to top officials at the U.S. Department of Health and Human Services, the National Institutes of Health, and the federal Food and Drug Administration, was endorsed by a bipartisan coalition of 34 state attorneys general.\u003c/p>\n\u003cp>Gilead has \u003ca href=\"https://www.gilead.com/purpose/advancing-global-health/covid-19/working-to-supply-remdesivir-for-covid-19\" target=\"_blank\" rel=\"noopener noreferrer\">announced plans\u003c/a> to make 2 million courses of remdesivir, which can be either six or 10 vials, by the end of the year. Becerra’s letter calls that amount “dangerously low” to handle current or future coronavirus outbreaks.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>He says now is the time to produce more of the drug.\u003c/p>\n\u003cp>“If Gilead is not prepared to do it,” he said, “We have the right to say we’re going to try to do whatever we can, go wherever we must, to ramp up the supply.”\u003c/p>\n\u003cp>\u003cstrong>No ‘Secret Sauce’\u003c/strong>\u003c/p>\n\u003cp>Because the development of remdesivir was supported in part by federal tax dollars, including a $30 million NIH-funded clinical trial, Becerra says there are legal grounds for Washington to intervene.\u003c/p>\n\u003cp>“It’s not as if there’s a secret sauce here,” Becerra told KQED. “Folks know how to make this drug and the taxpayers helped make that drug possible. Let’s get it out there to folks.”\u003c/p>\n\u003cp>Under the \u003ca href=\"https://www.govinfo.gov/content/pkg/STATUTE-94/pdf/STATUTE-94-Pg3015.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Bayh-Dole Act\u003c/a>, the letter says, the federal government could make Gilead license its remdesivir patent to third party manufacturers.\u003c/p>\n\u003cp>An HHS spokesperson wrote in an email that because remdesivir wasn’t, “as a whole,” funded by the federal government, it doesn’t believe the Bayh-Dole Act applies in this case.\u003c/p>\n\u003cp>Gilead said in a statement it was “deeply disappointed” by the letter, and that it misrepresented the overall need for its drug:\u003c/p>\n\u003cblockquote>\u003cp>“One significant factual error is the assertion that all 3.5 million current COVID-19 patients should be treated with remdesivir. This assertion ignores the fact that not all COVID-19 patients are eligible to be treated with remdesivir and, thankfully, many will recover prior to hospitalization and never need the drug.”\u003c/p>\u003c/blockquote>\n\u003cp>Remdesivir was shown in one \u003ca href=\"https://www.kqed.org/science/1963229/government-study-shows-patients-responding-to-coronavirus-treatment-drugmaker-gilead-says\" target=\"_blank\" rel=\"noopener noreferrer\">controlled clinical trial\u003c/a> to reduce median COVID-19 hospital stays by about four days.\u003c/p>\n\u003cp>\u003cstrong>Desperate Hospitals\u003c/strong>\u003c/p>\n\u003cp>Dr. Peter Chin-Hong, an infectious disease specialist at UCSF, says that on Tuesday the hospital was down to two vials of remdesivir, with another shipment expected, but not guaranteed, to arrive soon.\u003c/p>\n\u003cp>Chin-Hong says local hospitals have sent each other vials of remdesivir, when able, so that their COVID-19 patients can get the treatment.\u003c/p>\n\u003cp>“We’re definitely desperate for the drug,” said Chin-Hong. “At the clinical end, health care providers currently in 2020 spend a disproportionate amount of time bartering [the] drug, sourcing the drug, trying to play remdesivir Tetris where we’re constantly figuring out, do we have enough?”\u003c/p>\n\u003cp>With the expectation of another coronavirus surge this winter, Chin-Hong says suppliers need to come together to make more remdesivir.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>“The timing of the attorney general’s letter is actually perfect,” he said, “because if we decide to do something now, we could have an impact on that winter surge.”\u003c/p>\n\n",
"blocks": [],
"excerpt": "The drug maker balks as 34 state attorneys general call on Washington to step in and authorize more manufacturers.",
"status": "publish",
"parent": 0,
"modified": 1727135462,
"stats": {
"hasAudio": false,
"hasVideo": false,
"hasChartOrMap": false,
"iframeSrcs": [],
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"hasPolis": false,
"paragraphCount": 23,
"wordCount": 642
},
"headData": {
"title": "California AG Wants More Companies to Be Able to Make COVID-19 Drug | KQED",
"description": "The drug maker balks as 34 state attorneys general call on Washington to step in and authorize more manufacturers.",
"ogTitle": "",
"ogDescription": "",
"ogImgId": "",
"twTitle": "",
"twDescription": "",
"twImgId": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "California AG Wants More Companies to Be Able to Make COVID-19 Drug",
"datePublished": "2020-08-05T16:29:06-07:00",
"dateModified": "2024-09-23T16:51:02-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"source": "Coronavirus",
"audioUrl": "https://traffic.omny.fm/d/clips/0af137ef-751e-4b19-a055-aaef00d2d578/ffca7e9f-6831-41c5-bcaf-aaef00f5a073/75d5e816-e689-45d1-a90c-ac0e00ede99c/audio.mp3",
"sticky": false,
"templateType": "standard",
"featuredImageType": "standard",
"path": "/science/1968038/california-ag-wants-more-companies-to-be-able-to-make-covid-19-drug",
"audioDuration": 109000,
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Doctors say the antiviral drug remdesivir is one of the few treatments that benefits patients hospitalized with COVID-19. But the drug, made by Gilead Sciences, can cost more than $3,000 for the full course of treatment, and some hospitals — including several in the Bay Area — say it’s in short supply.\u003c/p>\n\u003cp>\u003ca href=\"https://www.gilead.com/\" target=\"_blank\" rel=\"noopener noreferrer\">Foster City-based Gilead\u003c/a> is currently the only company making remdesivir, and \u003ca href=\"https://www.amerisourcebergen.com/\" target=\"_blank\" rel=\"noopener noreferrer\">AmerisourceBergen\u003c/a> is the sole distributor.\u003c/p>\n\u003cp>On Tuesday, California Attorney General Xavier Becerra \u003ca href=\"https://www.oag.ca.gov/system/files/attachments/press-docs/Remdesivir%20Letter%2020200804.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">sent a letter\u003c/a> to federal health officials, urging them to allow other companies to manufacture and distribute the drug.\u003c/p>\n\u003cp>The letter, which was addressed to top officials at the U.S. Department of Health and Human Services, the National Institutes of Health, and the federal Food and Drug Administration, was endorsed by a bipartisan coalition of 34 state attorneys general.\u003c/p>\n\u003cp>Gilead has \u003ca href=\"https://www.gilead.com/purpose/advancing-global-health/covid-19/working-to-supply-remdesivir-for-covid-19\" target=\"_blank\" rel=\"noopener noreferrer\">announced plans\u003c/a> to make 2 million courses of remdesivir, which can be either six or 10 vials, by the end of the year. Becerra’s letter calls that amount “dangerously low” to handle current or future coronavirus outbreaks.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>He says now is the time to produce more of the drug.\u003c/p>\n\u003cp>“If Gilead is not prepared to do it,” he said, “We have the right to say we’re going to try to do whatever we can, go wherever we must, to ramp up the supply.”\u003c/p>\n\u003cp>\u003cstrong>No ‘Secret Sauce’\u003c/strong>\u003c/p>\n\u003cp>Because the development of remdesivir was supported in part by federal tax dollars, including a $30 million NIH-funded clinical trial, Becerra says there are legal grounds for Washington to intervene.\u003c/p>\n\u003cp>“It’s not as if there’s a secret sauce here,” Becerra told KQED. “Folks know how to make this drug and the taxpayers helped make that drug possible. Let’s get it out there to folks.”\u003c/p>\n\u003cp>Under the \u003ca href=\"https://www.govinfo.gov/content/pkg/STATUTE-94/pdf/STATUTE-94-Pg3015.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">Bayh-Dole Act\u003c/a>, the letter says, the federal government could make Gilead license its remdesivir patent to third party manufacturers.\u003c/p>\n\u003cp>An HHS spokesperson wrote in an email that because remdesivir wasn’t, “as a whole,” funded by the federal government, it doesn’t believe the Bayh-Dole Act applies in this case.\u003c/p>\n\u003cp>Gilead said in a statement it was “deeply disappointed” by the letter, and that it misrepresented the overall need for its drug:\u003c/p>\n\u003cblockquote>\u003cp>“One significant factual error is the assertion that all 3.5 million current COVID-19 patients should be treated with remdesivir. This assertion ignores the fact that not all COVID-19 patients are eligible to be treated with remdesivir and, thankfully, many will recover prior to hospitalization and never need the drug.”\u003c/p>\u003c/blockquote>\n\u003cp>Remdesivir was shown in one \u003ca href=\"https://www.kqed.org/science/1963229/government-study-shows-patients-responding-to-coronavirus-treatment-drugmaker-gilead-says\" target=\"_blank\" rel=\"noopener noreferrer\">controlled clinical trial\u003c/a> to reduce median COVID-19 hospital stays by about four days.\u003c/p>\n\u003cp>\u003cstrong>Desperate Hospitals\u003c/strong>\u003c/p>\n\u003cp>Dr. Peter Chin-Hong, an infectious disease specialist at UCSF, says that on Tuesday the hospital was down to two vials of remdesivir, with another shipment expected, but not guaranteed, to arrive soon.\u003c/p>\n\u003cp>Chin-Hong says local hospitals have sent each other vials of remdesivir, when able, so that their COVID-19 patients can get the treatment.\u003c/p>\n\u003cp>“We’re definitely desperate for the drug,” said Chin-Hong. “At the clinical end, health care providers currently in 2020 spend a disproportionate amount of time bartering [the] drug, sourcing the drug, trying to play remdesivir Tetris where we’re constantly figuring out, do we have enough?”\u003c/p>\n\u003cp>With the expectation of another coronavirus surge this winter, Chin-Hong says suppliers need to come together to make more remdesivir.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>“The timing of the attorney general’s letter is actually perfect,” he said, “because if we decide to do something now, we could have an impact on that winter surge.”\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1968038/california-ag-wants-more-companies-to-be-able-to-make-covid-19-drug",
"authors": [
"11368"
],
"programs": [
"science_5376"
],
"categories": [
"science_39",
"science_3890",
"science_40",
"science_5141",
"science_4450",
"science_3423"
],
"tags": [
"science_4329",
"science_4368",
"science_4417",
"science_5181"
],
"featImg": "science_1968065",
"label": "source_science_1968038"
},
"science_1968013": {
"type": "posts",
"id": "science_1968013",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1968013",
"score": null,
"sort": [
1596665734000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1596665734,
"format": "standard",
"title": "Here's Why Medical Experts Say College Football Should Be Sidelined During Pandemic",
"headTitle": "Here’s Why Medical Experts Say College Football Should Be Sidelined During Pandemic | KQED",
"content": "\u003cp>Experts say it’s possible for athletes to play football safely during the COVID-19 pandemic — with the right protective measures.\u003c/p>\n\u003cp>But college football poses its own risks. With athletes attending class and living the freewheeling campus lifestyle, it’s a much more challenging prospect, according to leading Bay Area doctors and epidemiologists.\u003c/p>\n\u003cp>“The players are supposed to go to school, too, the last time I checked,” said George Rutherford, an epidemiologist at UCSF. “Locker room, games, practices, weight training, all that can be made safe through testing, cleaning, wearing masks, improved ventilation in weight rooms.”\u003c/p>\n\u003cp>Even in a contact sport like football, the risk of transmission can be lowered if the game is played outside and helmets are outfitted with face-shields.\u003c/p>\n\u003cp>“But the wild card is what happens when they walk out into the general student body,” says Rutherford.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>With confirmed coronavirus cases inside major football programs like \u003ca href=\"https://www.espn.com/college-football/story/_/id/29559800/rutgers-football-covid-19-outbreak-linked-campus-party\" target=\"_blank\" rel=\"noopener noreferrer\">\u003cspan class=\"s1\">Rutgers\u003c/span>\u003c/a> and \u003ca href=\"https://www.si.com/college/2020/06/20/lsu-football-players-quarantined-coronavirus\" target=\"_blank\" rel=\"noopener noreferrer\">\u003cspan class=\"s1\">LSU\u003c/span>\u003c/a>, athletes are growing increasingly concerned about catching and transmitting the virus. Some are accusing league officials of failing to meet calls for improving safety measures, while exploiting the athletes for the economic gain of the school.\u003c/p>\n\u003cp>\u003cstrong>Players Go Public\u003cbr>\n\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">Dissatisfied with how their universities have handled the pandemic, a group of a dozen Pac-12 football players threatened to opt out of the season in an open \u003ca href=\"https://www.theplayerstribune.com/en-us/articles/pac-12-players-covid-19-statement-football-season\">\u003cspan class=\"s1\">letter\u003c/span>\u003c/a> to conference managers, published over the weekend and distributed on social media with the hashtag #WeAreUnited.\u003c/p>\n\u003cp>https://twitter.com/peneisewell58/status/1289974930155569153?s=20\u003c/p>\n\u003cp>“We are being asked to play college sports in a pandemic in a system without enforced health and safety standards, and without transparency about COVID cases on our teams, the risks to ourselves, our families, and our communities,” the letter reads.\u003c/p>\n\u003cp>The players say they’ve been communicating with more than 400 of their peers throughout the Pac-12, the Associated Press \u003ca href=\"https://apnews.com/f23c78cc8d09e6adc1797964d57bd40b\" target=\"_blank\" rel=\"noopener noreferrer\">reported\u003c/a>.\u003c/p>\n\u003cp class=\"p1\">The players tied the actions to what they describe as the league’s failure to meet a broader range of social justice commitments. They demand that universities distribute half of the revenue generated by each sport among the athletes, stop requiring athletes to sign coronavirus liability waivers, provide extended health insurance and develop a social justice task force. In recent years, \u003ca href=\"https://morningconsult.com/2019/03/20/racial-divides-persist-on-compensation-for-student-athletes/\" target=\"_blank\" rel=\"noopener noreferrer\">nearly half\u003c/a> of Division I men’s football players were Black.\u003c/p>\n\u003cp class=\"p3\">“The lack of regard for our health and safety is central to the systemic racial injustices imposed by NCAA sports that disproportionately exploits Black athletes physically, academically, and financially,” they wrote in an \u003ca href=\"https://www.si.com/college/2020/08/04/pac-12-responds-to-players-threatening-boycott-season\" target=\"_blank\" rel=\"noopener noreferrer\">\u003cspan class=\"s1\">email\u003c/span>\u003c/a> to league officials. \u003cspan class=\"s2\">\u003cbr>\n\u003c/span>\u003c/p>\n\u003cp>[pullquote align='right' citation='Brian Feeley, UCSF']‘As much as I love football, as much as I love college sports — my gut instinct is that we should hold off.’[/pullquote]\u003c/p>\n\u003cp class=\"p1\">In a two-page response letter, Pac-12 Commissioner Larry Scott, agreed to speak with the players, Sports Illustrated \u003ca href=\"https://www.si.com/college/2020/08/04/pac-12-responds-to-players-threatening-boycott-season\">\u003cspan class=\"s1\">reported\u003c/span>\u003c/a>.\u003c/p>\n\u003cp>In the letter, Scott said that player health is the league’s \u003cspan class=\"s3\">“No. 1 priority,” and “We support any student-athlete who chooses to opt out for health and safety reasons.” For players with pro football aspirations, opting out of a season could have enormous career consequences.\u003c/span>\u003c/p>\n\u003cp>The Mercury News \u003ca href=\"https://www.mercurynews.com/2020/08/04/pac-12-boycott-threat-examining-the-players-demands-and-commissioner-larry-scotts-response-item-by-item/\" target=\"_blank\" rel=\"noopener noreferrer\">reported\u003c/a> that players and the conference appear close on some matters and “galaxies apart on others.”\u003c/p>\n\u003cp>https://twitter.com/wilnerhotline/status/1290722923943100418?s=20\u003c/p>\n\u003cp>\u003cb>Long-Term Health Risks\u003c/b>\u003c/p>\n\u003cp>Brian Feeley, chief of sports medicine at UCSF, says the long-term health impacts of COVID-19 need to be better understood. By example he points to Eduardo Rodriguez, ace pitcher for the Boston Red Sox, who suffered only minor symptoms of COVID-19, only to be \u003ca href=\"https://www.washingtonpost.com/sports/2020/08/02/red-sox-ace-27-wont-pitch-this-season-because-heart-ailment-linked-covid-19/\">\u003cspan class=\"s1\">sidelined\u003c/span>\u003c/a> for the season due to inflammation around his heart linked to the virus.\u003c/p>\n\u003cp class=\"p1\">“To be honest — as much as I love football, as much as I love college sports — my gut instinct is that we should hold off until we know more about the disease process and potentially even have a vaccine,” Feeley tells KQED.\u003c/p>\n\u003cp>“Sports are important,” he says, adding, “They’re not as important as your livelihood and your life. Setting people up for long-term disability when they’re already inherently at risk from playing sports — it is not worth the risk at this time.”\u003c/p>\n\u003cp>Cassandra Lee, a physician and chief of sports service at UC Davis, agrees that with face shields, aggressive testing and other protective measures, the risk of coronavirus infection during the game is less. But she wonders if athletes kept up with their training during government-mandated shelter-in-place orders, and she worries about players getting hurt while competing in less than peak condition.\u003c/p>\n\u003cp class=\"p1\">“These high-level athletes are working out, training hard and then they get the rug pulled out from under them in early spring,” she says. “We joke that we’ve all gained the ‘COVID 20.'”\u003c/p>\n\u003cp class=\"p1\">Dean Winslow, an infectious disease specialist at Stanford, says the NBA has demonstrated that contact sports can be safer for players with aggressive testing and isolation. The league built a quarantine zone inside Disney World designed to shield players and staff from exposure to the coronavirus.\u003c/p>\n\u003cp>“The NBA did it right,” he says, but questioned whether that could be replicated at universities and state schools with fewer resources and where college athletes are free to eat at restaurants, attend parties and drink at bars.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>“In my mind, these are more significant factors for transmission than athletes acquiring infection from the actual sport,” Winslow says. \u003cspan class=\"s5\">\u003cbr>\n\u003c/span>\u003c/p>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 943,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 20
},
"modified": 1704847120,
"excerpt": "Public health and sports medicine experts say until long-term health impacts of COVID-19 are better understood, it's 'not worth the risk.' ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Public health and sports medicine experts say until long-term health impacts of COVID-19 are better understood, it's 'not worth the risk.' ",
"title": "Here's Why Medical Experts Say College Football Should Be Sidelined During Pandemic | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Here's Why Medical Experts Say College Football Should Be Sidelined During Pandemic",
"datePublished": "2020-08-05T15:15:34-07:00",
"dateModified": "2024-01-09T16:38:40-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "heres-why-medical-experts-say-college-football-should-be-sidelined-during-pandemic",
"status": "publish",
"sticky": false,
"source": "Coronavirus ",
"path": "/science/1968013/heres-why-medical-experts-say-college-football-should-be-sidelined-during-pandemic",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>Experts say it’s possible for athletes to play football safely during the COVID-19 pandemic — with the right protective measures.\u003c/p>\n\u003cp>But college football poses its own risks. With athletes attending class and living the freewheeling campus lifestyle, it’s a much more challenging prospect, according to leading Bay Area doctors and epidemiologists.\u003c/p>\n\u003cp>“The players are supposed to go to school, too, the last time I checked,” said George Rutherford, an epidemiologist at UCSF. “Locker room, games, practices, weight training, all that can be made safe through testing, cleaning, wearing masks, improved ventilation in weight rooms.”\u003c/p>\n\u003cp>Even in a contact sport like football, the risk of transmission can be lowered if the game is played outside and helmets are outfitted with face-shields.\u003c/p>\n\u003cp>“But the wild card is what happens when they walk out into the general student body,” says Rutherford.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>With confirmed coronavirus cases inside major football programs like \u003ca href=\"https://www.espn.com/college-football/story/_/id/29559800/rutgers-football-covid-19-outbreak-linked-campus-party\" target=\"_blank\" rel=\"noopener noreferrer\">\u003cspan class=\"s1\">Rutgers\u003c/span>\u003c/a> and \u003ca href=\"https://www.si.com/college/2020/06/20/lsu-football-players-quarantined-coronavirus\" target=\"_blank\" rel=\"noopener noreferrer\">\u003cspan class=\"s1\">LSU\u003c/span>\u003c/a>, athletes are growing increasingly concerned about catching and transmitting the virus. Some are accusing league officials of failing to meet calls for improving safety measures, while exploiting the athletes for the economic gain of the school.\u003c/p>\n\u003cp>\u003cstrong>Players Go Public\u003cbr>\n\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">Dissatisfied with how their universities have handled the pandemic, a group of a dozen Pac-12 football players threatened to opt out of the season in an open \u003ca href=\"https://www.theplayerstribune.com/en-us/articles/pac-12-players-covid-19-statement-football-season\">\u003cspan class=\"s1\">letter\u003c/span>\u003c/a> to conference managers, published over the weekend and distributed on social media with the hashtag #WeAreUnited.\u003c/p>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "singleTwitterStatus",
"attributes": {
"named": {
"id": "1289974930155569153"
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\n\u003cp>“We are being asked to play college sports in a pandemic in a system without enforced health and safety standards, and without transparency about COVID cases on our teams, the risks to ourselves, our families, and our communities,” the letter reads.\u003c/p>\n\u003cp>The players say they’ve been communicating with more than 400 of their peers throughout the Pac-12, the Associated Press \u003ca href=\"https://apnews.com/f23c78cc8d09e6adc1797964d57bd40b\" target=\"_blank\" rel=\"noopener noreferrer\">reported\u003c/a>.\u003c/p>\n\u003cp class=\"p1\">The players tied the actions to what they describe as the league’s failure to meet a broader range of social justice commitments. They demand that universities distribute half of the revenue generated by each sport among the athletes, stop requiring athletes to sign coronavirus liability waivers, provide extended health insurance and develop a social justice task force. In recent years, \u003ca href=\"https://morningconsult.com/2019/03/20/racial-divides-persist-on-compensation-for-student-athletes/\" target=\"_blank\" rel=\"noopener noreferrer\">nearly half\u003c/a> of Division I men’s football players were Black.\u003c/p>\n\u003cp class=\"p3\">“The lack of regard for our health and safety is central to the systemic racial injustices imposed by NCAA sports that disproportionately exploits Black athletes physically, academically, and financially,” they wrote in an \u003ca href=\"https://www.si.com/college/2020/08/04/pac-12-responds-to-players-threatening-boycott-season\" target=\"_blank\" rel=\"noopener noreferrer\">\u003cspan class=\"s1\">email\u003c/span>\u003c/a> to league officials. \u003cspan class=\"s2\">\u003cbr>\n\u003c/span>\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "‘As much as I love football, as much as I love college sports — my gut instinct is that we should hold off.’",
"name": "pullquote",
"attributes": {
"named": {
"align": "right",
"citation": "Brian Feeley, UCSF",
"label": ""
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp class=\"p1\">In a two-page response letter, Pac-12 Commissioner Larry Scott, agreed to speak with the players, Sports Illustrated \u003ca href=\"https://www.si.com/college/2020/08/04/pac-12-responds-to-players-threatening-boycott-season\">\u003cspan class=\"s1\">reported\u003c/span>\u003c/a>.\u003c/p>\n\u003cp>In the letter, Scott said that player health is the league’s \u003cspan class=\"s3\">“No. 1 priority,” and “We support any student-athlete who chooses to opt out for health and safety reasons.” For players with pro football aspirations, opting out of a season could have enormous career consequences.\u003c/span>\u003c/p>\n\u003cp>The Mercury News \u003ca href=\"https://www.mercurynews.com/2020/08/04/pac-12-boycott-threat-examining-the-players-demands-and-commissioner-larry-scotts-response-item-by-item/\" target=\"_blank\" rel=\"noopener noreferrer\">reported\u003c/a> that players and the conference appear close on some matters and “galaxies apart on others.”\u003c/p>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "singleTwitterStatus",
"attributes": {
"named": {
"id": "1290722923943100418"
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\n\u003cp>\u003cb>Long-Term Health Risks\u003c/b>\u003c/p>\n\u003cp>Brian Feeley, chief of sports medicine at UCSF, says the long-term health impacts of COVID-19 need to be better understood. By example he points to Eduardo Rodriguez, ace pitcher for the Boston Red Sox, who suffered only minor symptoms of COVID-19, only to be \u003ca href=\"https://www.washingtonpost.com/sports/2020/08/02/red-sox-ace-27-wont-pitch-this-season-because-heart-ailment-linked-covid-19/\">\u003cspan class=\"s1\">sidelined\u003c/span>\u003c/a> for the season due to inflammation around his heart linked to the virus.\u003c/p>\n\u003cp class=\"p1\">“To be honest — as much as I love football, as much as I love college sports — my gut instinct is that we should hold off until we know more about the disease process and potentially even have a vaccine,” Feeley tells KQED.\u003c/p>\n\u003cp>“Sports are important,” he says, adding, “They’re not as important as your livelihood and your life. Setting people up for long-term disability when they’re already inherently at risk from playing sports — it is not worth the risk at this time.”\u003c/p>\n\u003cp>Cassandra Lee, a physician and chief of sports service at UC Davis, agrees that with face shields, aggressive testing and other protective measures, the risk of coronavirus infection during the game is less. But she wonders if athletes kept up with their training during government-mandated shelter-in-place orders, and she worries about players getting hurt while competing in less than peak condition.\u003c/p>\n\u003cp class=\"p1\">“These high-level athletes are working out, training hard and then they get the rug pulled out from under them in early spring,” she says. “We joke that we’ve all gained the ‘COVID 20.'”\u003c/p>\n\u003cp class=\"p1\">Dean Winslow, an infectious disease specialist at Stanford, says the NBA has demonstrated that contact sports can be safer for players with aggressive testing and isolation. The league built a quarantine zone inside Disney World designed to shield players and staff from exposure to the coronavirus.\u003c/p>\n\u003cp>“The NBA did it right,” he says, but questioned whether that could be replicated at universities and state schools with fewer resources and where college athletes are free to eat at restaurants, attend parties and drink at bars.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>“In my mind, these are more significant factors for transmission than athletes acquiring infection from the actual sport,” Winslow says. \u003cspan class=\"s5\">\u003cbr>\n\u003c/span>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1968013/heres-why-medical-experts-say-college-football-should-be-sidelined-during-pandemic",
"authors": [
"11608"
],
"categories": [
"science_39",
"science_3890",
"science_40",
"science_4450"
],
"tags": [
"science_4329",
"science_4368",
"science_4414"
],
"featImg": "science_1968016",
"label": "source_science_1968013"
},
"science_1967987": {
"type": "posts",
"id": "science_1967987",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1967987",
"score": null,
"sort": [
1596636017000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1596636017,
"format": "standard",
"title": "Cracking the Potentially Deadly Connection Between Air Quality and Coronavirus",
"headTitle": "Cracking the Potentially Deadly Connection Between Air Quality and Coronavirus | KQED",
"content": "\u003cp class=\"p1\">A possible link between air quality and the coronavirus is about to go under the microscope in a state-sponsored research effort.\u003c/p>\n\u003cp class=\"p1\">Since the early days of this pandemic, public health officials have suspected there is a direct link between dirty air and serious illness or even death from COVID-19.\u003c/p>\n\u003cp class=\"p1\">Air pollution damages the lungs and can cause inflammation and interfere with normal immune functions, two factors that could increase susceptibility to the virus.\u003c/p>\n\u003cp class=\"p1\">In April, researchers at Harvard released a \u003ca href=\"https://www.hsph.harvard.edu/news/hsph-in-the-news/air-pollution-linked-with-higher-covid-19-death-rates/\">\u003cspan class=\"s1\">nationwide study\u003c/span>\u003c/a> that found a large overlap between counties with long-term exposure to pollution and deaths from this coronavirus.\u003cspan class=\"Apple-converted-space\"> \u003c/span>\u003c/p>\n\u003cp>The research, published as a preprint study, concluded that COVID-19 patients in areas with high levels of air pollution before the pandemic are more likely to die from the virus than people who live in places with cleaner air.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>In the months since the study was published, the virus has spread to all corners of California, which recently passed the grim milestone of being the first state in the nation with a half-million infections. Statistics \u003ca href=\"https://www.kqed.org/news/11813696/latinos-around-the-bay-area-are-disproportionately-affected-by-covid-19\">\u003cspan class=\"s1\">show\u003c/span>\u003c/a> the disease disproportionately affects communities of color.\u003c/p>\n\u003cp>Now, researchers with the \u003ca href=\"https://www.phi.org/\">\u003cspan class=\"s1\">Public Health Institute\u003c/span>\u003c/a>, an Oakland-based nonprofit health organization, and UCSF are launching a joint study funded by the California Air Resources Board to examine the link between dirty air and disparate health outcomes at the neighborhood level.\u003c/p>\n\u003cp>“It’s already evident that low-income communities of color in California are at disproportionate risk of getting COVID-19, and also at increased risk of hospitalization and death,” said \u003ca href=\"https://www.phi.org/experts/gina-solomon/\" target=\"_blank\" rel=\"noopener noreferrer\">Gina Solomon\u003c/a>, the lead researcher on the study.\u003cspan class=\"Apple-converted-space\"> \u003c/span>“That’s a stark and horrifying fact already from the data.”\u003c/p>\n\u003cp>An open question, she says, is the extent to which air pollution is contributing to these health impacts.\u003c/p>\n\u003cp>The Harvard study examined data at the county level, but research has shown that air quality can vary wildly among neighborhoods and even individual\u003ca href=\"https://www.kqed.org/science/1955755/a-fleet-of-cars-will-collect-bay-area-air-quality-data-block-by-block-24-7\">\u003cspan class=\"s1\"> city blocks\u003c/span>\u003c/a>.\u003c/p>\n\u003cp>Solomon says it’s important for researchers to examine the “differences in air quality and health vulnerabilities across the counties,” as well as to examine the impact of recent exposure to air pollution along with long-term exposure.\u003c/p>\n\u003cp class=\"p1\">Her team will be analyzing local air quality models and exposure to particulate matter, ozone, smog, nitrogen oxides from diesel trucks and other air pollutants.\u003c/p>\n\u003cp>“We’re already seeing higher rates of COVID in communities,” said Solomon. “For example, in the L.A. area, in Imperial County, Riverside County, where we see bad air locally.”\u003c/p>\n\u003cp class=\"p1\">The researchers will look closely at data in the neighborhoods of West Oakland, Bayview-Hunters Point, Richmond and other communities in the Bay Area with heavy diesel truck traffic and dirtier air.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Solomon says the results of the study could be available as soon as the end of the year.\u003c/p>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 484,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 11
},
"modified": 1704847122,
"excerpt": "Researchers are launching a study to examine the link between dirty air and disparate health outcomes from COVID-19 in California. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Researchers are launching a study to examine the link between dirty air and disparate health outcomes from COVID-19 in California. ",
"title": "Cracking the Potentially Deadly Connection Between Air Quality and Coronavirus | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Cracking the Potentially Deadly Connection Between Air Quality and Coronavirus",
"datePublished": "2020-08-05T07:00:17-07:00",
"dateModified": "2024-01-09T16:38:42-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "cracking-the-potentially-deadly-connection-between-air-quality-and-coronavirus",
"status": "publish",
"sticky": false,
"source": "Coronavirus",
"path": "/science/1967987/cracking-the-potentially-deadly-connection-between-air-quality-and-coronavirus",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp class=\"p1\">A possible link between air quality and the coronavirus is about to go under the microscope in a state-sponsored research effort.\u003c/p>\n\u003cp class=\"p1\">Since the early days of this pandemic, public health officials have suspected there is a direct link between dirty air and serious illness or even death from COVID-19.\u003c/p>\n\u003cp class=\"p1\">Air pollution damages the lungs and can cause inflammation and interfere with normal immune functions, two factors that could increase susceptibility to the virus.\u003c/p>\n\u003cp class=\"p1\">In April, researchers at Harvard released a \u003ca href=\"https://www.hsph.harvard.edu/news/hsph-in-the-news/air-pollution-linked-with-higher-covid-19-death-rates/\">\u003cspan class=\"s1\">nationwide study\u003c/span>\u003c/a> that found a large overlap between counties with long-term exposure to pollution and deaths from this coronavirus.\u003cspan class=\"Apple-converted-space\"> \u003c/span>\u003c/p>\n\u003cp>The research, published as a preprint study, concluded that COVID-19 patients in areas with high levels of air pollution before the pandemic are more likely to die from the virus than people who live in places with cleaner air.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>In the months since the study was published, the virus has spread to all corners of California, which recently passed the grim milestone of being the first state in the nation with a half-million infections. Statistics \u003ca href=\"https://www.kqed.org/news/11813696/latinos-around-the-bay-area-are-disproportionately-affected-by-covid-19\">\u003cspan class=\"s1\">show\u003c/span>\u003c/a> the disease disproportionately affects communities of color.\u003c/p>\n\u003cp>Now, researchers with the \u003ca href=\"https://www.phi.org/\">\u003cspan class=\"s1\">Public Health Institute\u003c/span>\u003c/a>, an Oakland-based nonprofit health organization, and UCSF are launching a joint study funded by the California Air Resources Board to examine the link between dirty air and disparate health outcomes at the neighborhood level.\u003c/p>\n\u003cp>“It’s already evident that low-income communities of color in California are at disproportionate risk of getting COVID-19, and also at increased risk of hospitalization and death,” said \u003ca href=\"https://www.phi.org/experts/gina-solomon/\" target=\"_blank\" rel=\"noopener noreferrer\">Gina Solomon\u003c/a>, the lead researcher on the study.\u003cspan class=\"Apple-converted-space\"> \u003c/span>“That’s a stark and horrifying fact already from the data.”\u003c/p>\n\u003cp>An open question, she says, is the extent to which air pollution is contributing to these health impacts.\u003c/p>\n\u003cp>The Harvard study examined data at the county level, but research has shown that air quality can vary wildly among neighborhoods and even individual\u003ca href=\"https://www.kqed.org/science/1955755/a-fleet-of-cars-will-collect-bay-area-air-quality-data-block-by-block-24-7\">\u003cspan class=\"s1\"> city blocks\u003c/span>\u003c/a>.\u003c/p>\n\u003cp>Solomon says it’s important for researchers to examine the “differences in air quality and health vulnerabilities across the counties,” as well as to examine the impact of recent exposure to air pollution along with long-term exposure.\u003c/p>\n\u003cp class=\"p1\">Her team will be analyzing local air quality models and exposure to particulate matter, ozone, smog, nitrogen oxides from diesel trucks and other air pollutants.\u003c/p>\n\u003cp>“We’re already seeing higher rates of COVID in communities,” said Solomon. “For example, in the L.A. area, in Imperial County, Riverside County, where we see bad air locally.”\u003c/p>\n\u003cp class=\"p1\">The researchers will look closely at data in the neighborhoods of West Oakland, Bayview-Hunters Point, Richmond and other communities in the Bay Area with heavy diesel truck traffic and dirtier air.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>Solomon says the results of the study could be available as soon as the end of the year.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1967987/cracking-the-potentially-deadly-connection-between-air-quality-and-coronavirus",
"authors": [
"11608"
],
"categories": [
"science_35",
"science_39",
"science_3890",
"science_40",
"science_4450"
],
"tags": [
"science_505",
"science_4329",
"science_4414",
"science_5181"
],
"featImg": "science_1946768",
"label": "source_science_1967987"
},
"science_1967970": {
"type": "posts",
"id": "science_1967970",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1967970",
"score": null,
"sort": [
1596482216000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1596482216,
"format": "aside",
"title": "Listen to the Pop-Punk Coronavirus Banger From Cousin Greg of 'Succession'",
"headTitle": "Listen to the Pop-Punk Coronavirus Banger From Cousin Greg of ‘Succession’ | KQED",
"content": "\u003cp>https://www.youtube.com/watch?v=wU_Fom02PIw\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">When shelter-in-place orders began in March, memes about how “\u003ca href=\"https://www.theguardian.com/stage/2020/mar/22/shakespeare-in-lockdown-did-he-write-king-lear-in-plague-quarantine\" target=\"_blank\" rel=\"noopener noreferrer\">Shakespeare wrote King Lear in quarantine\u003c/a>” were impossible to miss on the internet. It was a way for droves of suddenly homebound people to joke about how to use this unprecedented time to focus on creative projects.\u003c/span>\u003c/p>\n\u003cp>https://twitter.com/bobvulfov/status/1238896746689974280\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Since then, we’ve seen countless coronavirus-inspired \u003c/span>\u003ca href=\"https://www.kqed.org/arts/13876781/surprisingly-good-coronavirus-songs-to-stream-while-youre-sheltering-in-place\">\u003cspan style=\"font-weight: 400;\">songs\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\">. Add to the list a music video from Nicholas Braun called “\u003c/span>\u003cspan style=\"font-weight: 400;\">Antibodies (Do You Have The),”\u003c/span>\u003cspan style=\"font-weight: 400;\"> a (very) of-the-moment hook-up song that’s as cautious as it is anthemic. \u003c/span>\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Braun, who may be better known to “Succession” fans as Greg Hirsh (or to “Sky High” fans as Zach Springer) has actually been \u003c/span>\u003ca href=\"https://soundcloud.com/nicholasbraun\">\u003cspan style=\"font-weight: 400;\">making music for years\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> alongside his acting career. This latest single is a collaboration with PLUS1, and a portion of the proceeds from the \u003c/span>\u003ca href=\"https://www.doyouhavetheantibodies.com/\">\u003cspan style=\"font-weight: 400;\">single and merch\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> sales will go toward Partners In Health and the COPE Program. \u003c/span>\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">From the video’s website, “\u003c/span>\u003cspan style=\"font-weight: 400;\">This partnership will empower \u003c/span>\u003ca href=\"https://www.pih.org/\">\u003cspan style=\"font-weight: 400;\">Partners In Health\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> to control the spread of COVID-19 and ensure the most vulnerable people around the world receive access to dignified healthcare. The \u003c/span>\u003ca href=\"https://www.copeprogram.org/\">\u003cspan style=\"font-weight: 400;\">COPE Program\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> will work to bring equity of care and essential supplies and goods to the people of the Navajo Nation, the area that currently has the highest death rate from COVID-19 in the U.S.”\u003c/span>\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Check out the video for yourself, and watch for B-roll footage of Gov. Gavin Newsom with the lyrics, “I’ve been waiting patiently, I obeyed the rules / Now I’m ready to break them on you, no more sending nudes.” \u003c/span>\u003c/p>\n\n",
"stats": {
"hasVideo": true,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 298,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 7
},
"modified": 1704847127,
"excerpt": "To the countless coronavirus-inspired songs, add a music video from Nicholas Braun called \"Antibodies (Do You Have The)\", a (very) of-the-moment hook-up song that’s as cautious as it is anthemic. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "To the countless coronavirus-inspired songs, add a music video from Nicholas Braun called "Antibodies (Do You Have The)", a (very) of-the-moment hook-up song that’s as cautious as it is anthemic. ",
"title": "Listen to the Pop-Punk Coronavirus Banger From Cousin Greg of 'Succession' | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Listen to the Pop-Punk Coronavirus Banger From Cousin Greg of 'Succession'",
"datePublished": "2020-08-03T12:16:56-07:00",
"dateModified": "2024-01-09T16:38:47-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "listen-to-the-pop-punk-coronavirus-banger-from-successions-cousin-greg",
"status": "publish",
"sticky": false,
"source": "Coronavirus",
"path": "/science/1967970/listen-to-the-pop-punk-coronavirus-banger-from-successions-cousin-greg",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\u003cp>\u003cspan class='utils-parseShortcode-shortcodes-__youtubeShortcode__embedYoutube'>\n \u003cspan class='utils-parseShortcode-shortcodes-__youtubeShortcode__embedYoutubeInside'>\n \u003ciframe\n loading='lazy'\n class='utils-parseShortcode-shortcodes-__youtubeShortcode__youtubePlayer'\n type='text/html'\n src='//www.youtube.com/embed/wU_Fom02PIw'\n title='//www.youtube.com/embed/wU_Fom02PIw'\n allowfullscreen='true'\n style='border:0;'>\u003c/iframe>\n \u003c/span>\n \u003c/span>\u003c/p>\u003cp>\u003cp>\u003cspan style=\"font-weight: 400;\">When shelter-in-place orders began in March, memes about how “\u003ca href=\"https://www.theguardian.com/stage/2020/mar/22/shakespeare-in-lockdown-did-he-write-king-lear-in-plague-quarantine\" target=\"_blank\" rel=\"noopener noreferrer\">Shakespeare wrote King Lear in quarantine\u003c/a>” were impossible to miss on the internet. It was a way for droves of suddenly homebound people to joke about how to use this unprecedented time to focus on creative projects.\u003c/span>\u003c/p>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "singleTwitterStatus",
"attributes": {
"named": {
"id": "1238896746689974280"
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Since then, we’ve seen countless coronavirus-inspired \u003c/span>\u003ca href=\"https://www.kqed.org/arts/13876781/surprisingly-good-coronavirus-songs-to-stream-while-youre-sheltering-in-place\">\u003cspan style=\"font-weight: 400;\">songs\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\">. Add to the list a music video from Nicholas Braun called “\u003c/span>\u003cspan style=\"font-weight: 400;\">Antibodies (Do You Have The),”\u003c/span>\u003cspan style=\"font-weight: 400;\"> a (very) of-the-moment hook-up song that’s as cautious as it is anthemic. \u003c/span>\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Braun, who may be better known to “Succession” fans as Greg Hirsh (or to “Sky High” fans as Zach Springer) has actually been \u003c/span>\u003ca href=\"https://soundcloud.com/nicholasbraun\">\u003cspan style=\"font-weight: 400;\">making music for years\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> alongside his acting career. This latest single is a collaboration with PLUS1, and a portion of the proceeds from the \u003c/span>\u003ca href=\"https://www.doyouhavetheantibodies.com/\">\u003cspan style=\"font-weight: 400;\">single and merch\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> sales will go toward Partners In Health and the COPE Program. \u003c/span>\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">From the video’s website, “\u003c/span>\u003cspan style=\"font-weight: 400;\">This partnership will empower \u003c/span>\u003ca href=\"https://www.pih.org/\">\u003cspan style=\"font-weight: 400;\">Partners In Health\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> to control the spread of COVID-19 and ensure the most vulnerable people around the world receive access to dignified healthcare. The \u003c/span>\u003ca href=\"https://www.copeprogram.org/\">\u003cspan style=\"font-weight: 400;\">COPE Program\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> will work to bring equity of care and essential supplies and goods to the people of the Navajo Nation, the area that currently has the highest death rate from COVID-19 in the U.S.”\u003c/span>\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Check out the video for yourself, and watch for B-roll footage of Gov. Gavin Newsom with the lyrics, “I’ve been waiting patiently, I obeyed the rules / Now I’m ready to break them on you, no more sending nudes.” \u003c/span>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1967970/listen-to-the-pop-punk-coronavirus-banger-from-successions-cousin-greg",
"authors": [
"11530"
],
"categories": [
"science_39",
"science_40",
"science_4450"
],
"tags": [
"science_5197",
"science_4329",
"science_5181"
],
"featImg": "science_1967975",
"label": "source_science_1967970"
},
"science_1967921": {
"type": "posts",
"id": "science_1967921",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1967921",
"score": null,
"sort": [
1596243205000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1596243205,
"format": "standard",
"title": "Inside the ‘Huge Experiment’ to Rapidly Develop a COVID-19 Vaccine",
"headTitle": "Inside the ‘Huge Experiment’ to Rapidly Develop a COVID-19 Vaccine | KQED",
"content": "\u003cp>\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">N\u003c/span>\u003c/span>ever before have prospective vaccines for a pathogen entered final-stage clinical trials as rapidly as candidates for COVID-19.\u003c/p>\n\u003cp>Just six months ago, when the death toll from the coronavirus \u003ca href=\"https://www.statnews.com/2020/01/11/first-death-from-wuhan-pneumonia-outbreak-reported-as-scientists-release-dna-sequence-of-virus/\" target=\"_blank\" rel=\"noopener noreferrer\">stood at one,\u003c/a> and neither it nor the disease it caused \u003ca href=\"https://www.statnews.com/2020/02/11/disease-caused-by-the-novel-coronavirus-has-name-covid-19/\" target=\"_blank\" rel=\"noopener noreferrer\">had a name\u003c/a>, a team of Chinese scientists uploaded its genetic sequence to a \u003ca href=\"https://virological.org/t/novel-2019-coronavirus-genome/319\" target=\"_blank\" rel=\"noopener noreferrer\">public site\u003c/a>. That kicked off the record-breaking rush to develop vaccines — the salve that experts say could ultimately quell the pandemic.\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400\">[pullquote align='right' citation='Barney Graham, NIH']‘We were more prepared for a coronavirus than for any other family. To me, this is a wake-up call that we need to have a more systematic universal approach to developing vaccines and other countermeasures for virus families ahead of time.’[/pullquote]\u003c/span>\u003c/p>\n\u003cp>The colossal impact of the coronavirus is motivating the speed, opening a spigot of funding and inspiring research teams around the world to join the hunt. But the astonishing pace of the progress is also a consequence of the virus itself: It is, scientifically speaking, an easier target for potential vaccines than other pathogens, and a prime candidate for cutting-edge vaccine platforms new to scientists’ toolkits.\u003c/p>\n\u003cp>“Once we got the sequence, we pulled the trigger to ask how fast we could go,” said Barney Graham, the deputy director of the National Institutes of Health’s Vaccine Research Center. “And because it was a coronavirus, we could get into a Phase 3 trial in six months instead of two years.”\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Of course, progress so far remains just that. The vaccines are now facing their real tests: the monthslong, Phase 3 trials that will demonstrate whether or not they protect people from the virus.”\u003c/p>\n\u003cp>“This is a huge experiment and no one knows how it’s going to turn out,” said James Le Duc, the director of the University of Texas Medical Branch’s Galveston National Laboratory.\u003c/p>\n\u003cp>Vaccines typically take years, if not decades, to reach people; the record now is four years for the mumps vaccine. Here’s what has propelled the COVID-19 endeavor to eclipse prior efforts so far.\u003c/p>\n\u003cp>\u003cstrong>A Familiar Family\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">I\u003c/span>\u003c/span>\u003c/span>t’s difficult to associate anything with this pandemic with good fortune, but the fact that the culprit was a coronavirus — one that was strikingly similar to others that had previously leapt from animals to people — meant scientists could quickly rejigger vaccine projects in the works for those. It was almost like swapping a blue Lego for a red one in their assemblies.\u003c/p>\n\u003cp>Many of the teams pursuing vaccines for SARS-CoV-2 (the scientific name of the new coronavirus) have previously worked on vaccines for the original SARS virus, which caused a 2003 outbreak that killed some 800 people, and MERS, which has caused 2,500 cases since it started spreading in 2012.\u003c/p>\n\u003cp>The earlier projects had pointed to a component of the coronaviruses called the spike protein as a ripe target for a vaccine, which gave scientists a head start for crafting their candidates. Work on SARS also illuminated stumbling blocks in designing coronavirus vaccines that COVID-19 immunizations have so far avoided.\u003c/p>\n\u003cp>“What really helped was the knowledge gained from the SARS-1 infection,” said Rama Rao Amara, an immunologist and vaccine researcher at Emory University. “SARS-2 is quite similar to SARS-1, especially in that spike protein. People could take a very educated guess that this is the protein that we need to be going after.”\u003c/p>\n\u003cp>\u003cstrong>An Acute, Not Chronic Infection\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">S\u003c/span>\u003c/span>\u003c/span>ARS-CoV-2 causes an acute disease, COVID-19. It’s an infection that most people will clear on their own, which means there’s a vanquishing immune response that a vaccine can aim to induce in order to protect people.\u003c/p>\n\u003cp>That’s not true for something like HIV, a virus for which there is no vaccine despite decades of research. HIV causes a chronic infection and integrates itself into people’s genomes; there’s no natural immune response that eliminates the virus that a vaccine can mimic. HIV also mutates much faster than coronaviruses do, meaning it’s more difficult to rally a lasting defense.\u003c/p>\n\u003cp>It’s possible, then, that a pathogen that’s harder to design a vaccine for than the coronavirus could ignite the next pandemic.\u003c/p>\n\u003cp>“We were more prepared for a coronavirus than for any other family,” NIH’s Graham said. “To me, this is a wake-up call that we need to have a more systematic universal approach to developing vaccines and other countermeasures for virus families ahead of time.”\u003c/p>\n\u003cp>\u003cstrong>Cutting-Edge Approaches\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">V\u003c/span>\u003c/span>\u003c/span>accines train the immune system to recognize a pathogen it hasn’t yet encountered.\u003c/p>\n\u003cp>Normally, our immune system builds that memory by battling an infection, so that it can halt a virus in its tracks should it try to invade a second time. A vaccine acts like that first exposure, but without making people sick.\u003c/p>\n\u003cp>With SARS-CoV-2, researchers are working with new ways of providing that first look, building vaccines on adaptable platforms engineered to easily pivot from pathogen to pathogen.\u003c/p>\n\u003cp>Older strategies for developing vaccines, such as obtaining the virus and weakening or inactivating it, are lengthy processes. But the cutting-edge approaches require scientists only to know the virus’ genetic sequence. With that, they can string together the right pieces of code to synthesize vaccines.\u003c/p>\n\u003cp>That’s allowed scientists to move with record speed. Less than 10 weeks after the Chinese scientists published the SARS-CoV-2 sequence, a team from the National Institute of Allergy and Infectious Diseases and the biotech company Moderna had a candidate ready for a Phase 1 trial.\u003c/p>\n\u003cp>The Moderna/NIAID vaccine was built with mRNA, a piece of genetic code containing the instructions for the coronavirus’ spike protein. The vaccine shuttles the mRNA into cells, which “read” those instructions and churn out the protein — providing the immune system with that first peek to the spike, like giving a hound a scent.\u003c/p>\n\u003cp>A team from Pfizer and the German company BioNTech is \u003ca href=\"https://www.statnews.com/2020/07/01/covid-19-vaccine-from-pfizer-and-biontech-shows-positive-results/\" target=\"_blank\" rel=\"noopener noreferrer\">also working\u003c/a> on an mRNA vaccine, while a company called Inovio is \u003ca href=\"https://www.statnews.com/2020/06/30/inovio-claims-positive-results-on-covid-19-vaccine-but-critical-data-are-missing/\" target=\"_blank\" rel=\"noopener noreferrer\">pursuing a vaccine\u003c/a> based on a different genetic material, DNA. Neither an mRNA nor a DNA vaccine has been approved before.\u003c/p>\n\u003cp>Knowing the sequence of the coronavirus has also spurred other approaches. Some groups — including Johnson & Johnson, the \u003ca href=\"https://www.statnews.com/2020/05/22/early-study-of-covid-19-vaccine-developed-in-china-sees-mixed-results/\" target=\"_blank\" rel=\"noopener noreferrer\">Chinese firm CanSino\u003c/a>, and \u003ca href=\"https://www.statnews.com/2020/07/20/study-provides-first-glimpse-of-efficacy-of-oxford-astrazeneca-covid-19-vaccine/\" target=\"_blank\" rel=\"noopener noreferrer\">a collaboration between Oxford University and AstraZeneca\u003c/a> — are attaching the gene for the spike protein to another, harmless virus that ferries it into cells. There, it gets expressed into the spike, allowing the immune system to mount its forces. Another company, Novavax, is producing versions of the spike from the gene and using them directly in its vaccine.\u003c/p>\n\u003cp>The spike protein is a strategic choice. The proteins, which give SARS-CoV-2 the crown-like appearance that’s characteristic of coronaviruses, attach to receptors on people’s cells, allowing the virus to enter and replicate. By blocking spike proteins, then, vaccines could prevent infection. The spikes are also the “immunodominant” piece of the virus, meaning they elicit the strongest immune response. (Some vaccines are based on the whole spike, while some include select portions.)\u003c/p>\n\u003cp>Researchers are not only relying on advances in vaccine platforms. Innovations in basic genetics, immunology, and structural biology have also fueled the pace at which COVID-19 vaccines are moving. One way scientists have discovered so much about the spike protein, for example, is by applying methods honed over years to research the proteins on HIV.\u003c/p>\n\u003cp>\u003cstrong>Money, Money, Money\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">G\u003c/span>\u003c/span>\u003c/span>etting a vaccine approved is not just a scientific expedition. It’s also about money.\u003c/p>\n\u003cp>One reason vaccine development is so slow normally is because companies want to see candidates successfully pass through each sequence in the development process before sinking funding into the next phase.\u003c/p>\n\u003cp>But that playbook doesn’t fly in a pandemic.\u003c/p>\n\u003cp>“This is the biggest emergency we’ve had in our lifetime,” said Kawsar Talaat, a Johns Hopkins infectious disease physician and vaccine researcher. “Money is kind of no object. We don’t have time to wait.”\u003c/p>\n\u003cp>To rally companies, funding agencies, including governments and foundations like the Coalition for Epidemic Preparedness Innovations, or CEPI, are throwing millions — and in some cases, billions — into the hunt for vaccines. On Sunday, for example, Moderna said it had received $472 million from the U.S. Biomedical Advanced Research and Development Authority, on top of the $483 million it got in April.\u003c/p>\n\u003cp>The money isn’t just to cover the research and trials; it’s also to get companies to start manufacturing their products — even though their vaccines might not prove to be effective. It’s a strategy called manufacturing “at risk,” and public health experts say it’s necessary to ensure that any authorized vaccine can be rolled out to as many people as quickly as possible.\u003c/p>\n\u003cp>The U.S. government is also striking deals with companies to purchase their vaccines even before clinical trials are completed, including \u003ca href=\"https://www.statnews.com/2020/07/07/novavax-maker-of-a-covid-19-vaccine-is-backed-by-operation-warp-speed/\" target=\"_blank\" rel=\"noopener noreferrer\">a $1.6 billion agreement\u003c/a> with Novavax that includes 100 million doses and a $1.95 billion compact with Pfizer and BioNTech, also for 100 million doses.\u003c/p>\n\u003cp>“The fact that industry is able to hedge their bets like this and to make these investments is because the government has put up the money,” said UTMB’s Le Duc, who formerly led the Centers for Disease Control and Prevention’s viral diseases division. “The government has recognized that this is an incredibly important issue and we need to be going full blast knowing full well that not all these vaccines will work. Some are going to be duds, and will lose money.”\u003c/p>\n\u003cp>\u003cstrong>Regulatory Nimbleness\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">I\u003c/span>\u003c/span>\u003c/span>n-the-weeds regulatory decisions don’t get much public attention, but they are helping expedite clinical trials and the ultimate evaluation of how effective a vaccine is.\u003c/p>\n\u003cp>Many of these lessons were first learned during the West African Ebola crisis, when regulators embraced a new dexterity in green-lighting vaccine trials and took a more proactive approach to communicating with companies about the efficacy thresholds products needed to meet. That’s continuing with COVID-19: the Food and Drug Administration, for example, has \u003ca href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-action-help-facilitate-timely-development-safe-effective-covid\" target=\"_blank\" rel=\"noopener noreferrer\">outlined\u003c/a> that vaccines need to prevent infections or reduce the severity of COVID-19 in 50% of recipients to be approved.\u003c/p>\n\u003cp>The Ebola crisis “really did give the regulators greater experience and more comfort with the idea that they could have greater flexibility than they normally would have,” said Mark Feinberg, the president of the International AIDS Vaccine Initiative and a former executive at Merck Vaccines. “They could make decisions more quickly and really be true partners in the development process.”\u003c/p>\n\u003cp>Textbook clinical trials include three increasingly large phases that establish how safe and effective a drug or vaccine is. But with the COVID-19 pandemic, some of the trials have been collapsed into Phase 1/2 or Phase 2/3 trials. It’s a wonky distinction, but it can shave weeks or months off the process by saving research teams from having to write new protocols or get additional clearances.\u003c/p>\n\u003cp>The speed of vaccine development can also have an adverse effect. Some people have questioned how such a fast-moving process can ensure safety and might abstain from a vaccine. An \u003ca href=\"https://apnews.com/dacdc8bc428dd4df6511bfa259cfec44\" target=\"_blank\" rel=\"noopener noreferrer\">Associated Press poll\u003c/a> in May found that Black and Latinx Americans, who have been disproportionately harmed by the pandemic and have a history of mistreatment by the medical field, are more skeptical about COVID-19 vaccines than white Americans — showing the importance of outreach campaigns that public health experts say are required to increase the uptake of immunizations.\u003c/p>\n\u003cp>Others have raised suspicions that President Donald Trump — whose vaccine initiative is dubbed \u003ca href=\"https://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.html\" target=\"_blank\" rel=\"noopener noreferrer\">Operation Warp Speed\u003c/a> — might force an emergency authorization of a vaccine before the election, even if it hasn’t cleared efficacy and safety standards. Presumptive Democratic presidential nominee Joe Biden on Monday \u003ca href=\"https://medium.com/@JoeBiden/my-statement-on-vaccines-2133deed94ee\" target=\"_blank\" rel=\"noopener noreferrer\">raised the specter\u003c/a> of politics interfering in the quest for a vaccine.\u003c/p>\n\u003cp>Scientists and regulators are already stressing that safeguards aren’t being jettisoned. Public health experts say vaccine makers need to be transparent that while manufacturing and regulatory steps are being streamlined, safety checks aren’t being sacrificed.\u003c/p>\n\u003cp>In a call with reporters Monday, NIH Director Francis Collins, whom former President Barack Obama first tapped for the position, defended the integrity of the decisions regulators will make. “Nothing is being done here to compromise the safety” of COVID-19 vaccine trials, he said, “nor will we compromise on an ultimate conclusion about whether the vaccine is effective. Those issues are going to be tested in the most rigorous way.”\u003c/p>\n\u003cp>\u003cstrong>The Challenges Ahead\u003c/strong>\u003c/p>\n\u003cp>Exactly what all this speed will translate into remains to be seen. The monthslong, final-stage clinical trials starting now will settle that.\u003c/p>\n\u003cp>The Moderna and Pfizer/BioNTech candidates \u003ca href=\"https://www.statnews.com/2020/07/27/pfizer-biontech-pick-covid19-vaccine-begin-pivotal-study/\" target=\"_blank\" rel=\"noopener noreferrer\">respectively launched\u003c/a> Phase 3 and Phase 2/3 trials this week, and the Oxford/AstraZeneca vaccine is in a Phase 2/3 trial. Others are entering pivotal studies soon. These involve enrolling thousands of people, injecting half with the candidate and half with a placebo or control, and then comparing whether people who received the vaccine are less likely to be infected than their counterparts.\u003c/p>\n\u003cp>Some vaccine candidates could very well fail — a normal part of the scientific pursuit, experts say. “I hope that doesn’t happen, but people need to accept when things don’t pan out the way they hope,” said Maria Elena Bottazzi, the co-director of Texas Children’s Hospital Center for Vaccine Development at Baylor.\u003c/p>\n\u003cp>It’s also not clear yet what a vaccine “working” will look like. A COVID-19 vaccine might \u003ca href=\"https://www.statnews.com/2020/05/22/the-world-needs-covid-19-vaccines-it-may-also-be-overestimating-their-power/\" target=\"_blank\" rel=\"noopener noreferrer\">be like the flu vaccine\u003c/a> — only preventing infections in some people, or staving off serious disease but still leaving people contagious.\u003c/p>\n\u003cp>A vaccine that prevents even 50% of infections would be a massive lifeline. But experts worry there’s a disconnect between a public expecting vaccines to instantly reset their lives and what the first vaccines may actually allow. Successful vaccines \u003ca href=\"https://www.statnews.com/2020/07/22/confusion-spreads-over-system-to-determine-priority-access-to-covid-19-vaccines/\" target=\"_blank\" rel=\"noopener noreferrer\">will likely be restricted\u003c/a> to front-line workers and vulnerable populations at first. It could take some time for enough vaccine to be made for everyone who wants a shot. Some vaccines might require two doses to confer protection.\u003c/p>\n\u003cp>“It might not be some magic bullet that’s going to stop the pandemic in its tracks, and people need to be prepared for that possibility,” said Columbia University virologist Angela Rasmussen about the first vaccines that reach people. “I really hate the term vaccine race. Because that implies there’s going to be a medal ceremony, and the pandemic is over.”\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>\u003cem>This story was originally published by \u003ca href=\"https://www.statnews.com/\" target=\"_blank\" rel=\"noopener noreferrer\">STAT\u003c/a>, an online publication of Boston Globe Media that covers health, medicine, and scientific discovery.\u003c/em>\u003c/p>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 2572,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 52
},
"modified": 1704847130,
"excerpt": "Never before have prospective vaccines for a pathogen entered final-stage clinical trials as rapidly as candidates for COVID-19.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Never before have prospective vaccines for a pathogen entered final-stage clinical trials as rapidly as candidates for COVID-19.",
"title": "Inside the ‘Huge Experiment’ to Rapidly Develop a COVID-19 Vaccine | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Inside the ‘Huge Experiment’ to Rapidly Develop a COVID-19 Vaccine",
"datePublished": "2020-07-31T17:53:25-07:00",
"dateModified": "2024-01-09T16:38:50-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "inside-the-huge-experiment-to-rapidly-develop-a-covid-19-vaccine",
"status": "publish",
"nprByline": "Andrew Joseph \u003cbr />STAT\u003cbr>",
"sticky": false,
"source": "STAT",
"path": "/science/1967921/inside-the-huge-experiment-to-rapidly-develop-a-covid-19-vaccine",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">N\u003c/span>\u003c/span>ever before have prospective vaccines for a pathogen entered final-stage clinical trials as rapidly as candidates for COVID-19.\u003c/p>\n\u003cp>Just six months ago, when the death toll from the coronavirus \u003ca href=\"https://www.statnews.com/2020/01/11/first-death-from-wuhan-pneumonia-outbreak-reported-as-scientists-release-dna-sequence-of-virus/\" target=\"_blank\" rel=\"noopener noreferrer\">stood at one,\u003c/a> and neither it nor the disease it caused \u003ca href=\"https://www.statnews.com/2020/02/11/disease-caused-by-the-novel-coronavirus-has-name-covid-19/\" target=\"_blank\" rel=\"noopener noreferrer\">had a name\u003c/a>, a team of Chinese scientists uploaded its genetic sequence to a \u003ca href=\"https://virological.org/t/novel-2019-coronavirus-genome/319\" target=\"_blank\" rel=\"noopener noreferrer\">public site\u003c/a>. That kicked off the record-breaking rush to develop vaccines — the salve that experts say could ultimately quell the pandemic.\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400\">\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "‘We were more prepared for a coronavirus than for any other family. To me, this is a wake-up call that we need to have a more systematic universal approach to developing vaccines and other countermeasures for virus families ahead of time.’",
"name": "pullquote",
"attributes": {
"named": {
"align": "right",
"citation": "Barney Graham, NIH",
"label": ""
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/span>\u003c/p>\n\u003cp>The colossal impact of the coronavirus is motivating the speed, opening a spigot of funding and inspiring research teams around the world to join the hunt. But the astonishing pace of the progress is also a consequence of the virus itself: It is, scientifically speaking, an easier target for potential vaccines than other pathogens, and a prime candidate for cutting-edge vaccine platforms new to scientists’ toolkits.\u003c/p>\n\u003cp>“Once we got the sequence, we pulled the trigger to ask how fast we could go,” said Barney Graham, the deputy director of the National Institutes of Health’s Vaccine Research Center. “And because it was a coronavirus, we could get into a Phase 3 trial in six months instead of two years.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Of course, progress so far remains just that. The vaccines are now facing their real tests: the monthslong, Phase 3 trials that will demonstrate whether or not they protect people from the virus.”\u003c/p>\n\u003cp>“This is a huge experiment and no one knows how it’s going to turn out,” said James Le Duc, the director of the University of Texas Medical Branch’s Galveston National Laboratory.\u003c/p>\n\u003cp>Vaccines typically take years, if not decades, to reach people; the record now is four years for the mumps vaccine. Here’s what has propelled the COVID-19 endeavor to eclipse prior efforts so far.\u003c/p>\n\u003cp>\u003cstrong>A Familiar Family\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">I\u003c/span>\u003c/span>\u003c/span>t’s difficult to associate anything with this pandemic with good fortune, but the fact that the culprit was a coronavirus — one that was strikingly similar to others that had previously leapt from animals to people — meant scientists could quickly rejigger vaccine projects in the works for those. It was almost like swapping a blue Lego for a red one in their assemblies.\u003c/p>\n\u003cp>Many of the teams pursuing vaccines for SARS-CoV-2 (the scientific name of the new coronavirus) have previously worked on vaccines for the original SARS virus, which caused a 2003 outbreak that killed some 800 people, and MERS, which has caused 2,500 cases since it started spreading in 2012.\u003c/p>\n\u003cp>The earlier projects had pointed to a component of the coronaviruses called the spike protein as a ripe target for a vaccine, which gave scientists a head start for crafting their candidates. Work on SARS also illuminated stumbling blocks in designing coronavirus vaccines that COVID-19 immunizations have so far avoided.\u003c/p>\n\u003cp>“What really helped was the knowledge gained from the SARS-1 infection,” said Rama Rao Amara, an immunologist and vaccine researcher at Emory University. “SARS-2 is quite similar to SARS-1, especially in that spike protein. People could take a very educated guess that this is the protein that we need to be going after.”\u003c/p>\n\u003cp>\u003cstrong>An Acute, Not Chronic Infection\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">S\u003c/span>\u003c/span>\u003c/span>ARS-CoV-2 causes an acute disease, COVID-19. It’s an infection that most people will clear on their own, which means there’s a vanquishing immune response that a vaccine can aim to induce in order to protect people.\u003c/p>\n\u003cp>That’s not true for something like HIV, a virus for which there is no vaccine despite decades of research. HIV causes a chronic infection and integrates itself into people’s genomes; there’s no natural immune response that eliminates the virus that a vaccine can mimic. HIV also mutates much faster than coronaviruses do, meaning it’s more difficult to rally a lasting defense.\u003c/p>\n\u003cp>It’s possible, then, that a pathogen that’s harder to design a vaccine for than the coronavirus could ignite the next pandemic.\u003c/p>\n\u003cp>“We were more prepared for a coronavirus than for any other family,” NIH’s Graham said. “To me, this is a wake-up call that we need to have a more systematic universal approach to developing vaccines and other countermeasures for virus families ahead of time.”\u003c/p>\n\u003cp>\u003cstrong>Cutting-Edge Approaches\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">V\u003c/span>\u003c/span>\u003c/span>accines train the immune system to recognize a pathogen it hasn’t yet encountered.\u003c/p>\n\u003cp>Normally, our immune system builds that memory by battling an infection, so that it can halt a virus in its tracks should it try to invade a second time. A vaccine acts like that first exposure, but without making people sick.\u003c/p>\n\u003cp>With SARS-CoV-2, researchers are working with new ways of providing that first look, building vaccines on adaptable platforms engineered to easily pivot from pathogen to pathogen.\u003c/p>\n\u003cp>Older strategies for developing vaccines, such as obtaining the virus and weakening or inactivating it, are lengthy processes. But the cutting-edge approaches require scientists only to know the virus’ genetic sequence. With that, they can string together the right pieces of code to synthesize vaccines.\u003c/p>\n\u003cp>That’s allowed scientists to move with record speed. Less than 10 weeks after the Chinese scientists published the SARS-CoV-2 sequence, a team from the National Institute of Allergy and Infectious Diseases and the biotech company Moderna had a candidate ready for a Phase 1 trial.\u003c/p>\n\u003cp>The Moderna/NIAID vaccine was built with mRNA, a piece of genetic code containing the instructions for the coronavirus’ spike protein. The vaccine shuttles the mRNA into cells, which “read” those instructions and churn out the protein — providing the immune system with that first peek to the spike, like giving a hound a scent.\u003c/p>\n\u003cp>A team from Pfizer and the German company BioNTech is \u003ca href=\"https://www.statnews.com/2020/07/01/covid-19-vaccine-from-pfizer-and-biontech-shows-positive-results/\" target=\"_blank\" rel=\"noopener noreferrer\">also working\u003c/a> on an mRNA vaccine, while a company called Inovio is \u003ca href=\"https://www.statnews.com/2020/06/30/inovio-claims-positive-results-on-covid-19-vaccine-but-critical-data-are-missing/\" target=\"_blank\" rel=\"noopener noreferrer\">pursuing a vaccine\u003c/a> based on a different genetic material, DNA. Neither an mRNA nor a DNA vaccine has been approved before.\u003c/p>\n\u003cp>Knowing the sequence of the coronavirus has also spurred other approaches. Some groups — including Johnson & Johnson, the \u003ca href=\"https://www.statnews.com/2020/05/22/early-study-of-covid-19-vaccine-developed-in-china-sees-mixed-results/\" target=\"_blank\" rel=\"noopener noreferrer\">Chinese firm CanSino\u003c/a>, and \u003ca href=\"https://www.statnews.com/2020/07/20/study-provides-first-glimpse-of-efficacy-of-oxford-astrazeneca-covid-19-vaccine/\" target=\"_blank\" rel=\"noopener noreferrer\">a collaboration between Oxford University and AstraZeneca\u003c/a> — are attaching the gene for the spike protein to another, harmless virus that ferries it into cells. There, it gets expressed into the spike, allowing the immune system to mount its forces. Another company, Novavax, is producing versions of the spike from the gene and using them directly in its vaccine.\u003c/p>\n\u003cp>The spike protein is a strategic choice. The proteins, which give SARS-CoV-2 the crown-like appearance that’s characteristic of coronaviruses, attach to receptors on people’s cells, allowing the virus to enter and replicate. By blocking spike proteins, then, vaccines could prevent infection. The spikes are also the “immunodominant” piece of the virus, meaning they elicit the strongest immune response. (Some vaccines are based on the whole spike, while some include select portions.)\u003c/p>\n\u003cp>Researchers are not only relying on advances in vaccine platforms. Innovations in basic genetics, immunology, and structural biology have also fueled the pace at which COVID-19 vaccines are moving. One way scientists have discovered so much about the spike protein, for example, is by applying methods honed over years to research the proteins on HIV.\u003c/p>\n\u003cp>\u003cstrong>Money, Money, Money\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">G\u003c/span>\u003c/span>\u003c/span>etting a vaccine approved is not just a scientific expedition. It’s also about money.\u003c/p>\n\u003cp>One reason vaccine development is so slow normally is because companies want to see candidates successfully pass through each sequence in the development process before sinking funding into the next phase.\u003c/p>\n\u003cp>But that playbook doesn’t fly in a pandemic.\u003c/p>\n\u003cp>“This is the biggest emergency we’ve had in our lifetime,” said Kawsar Talaat, a Johns Hopkins infectious disease physician and vaccine researcher. “Money is kind of no object. We don’t have time to wait.”\u003c/p>\n\u003cp>To rally companies, funding agencies, including governments and foundations like the Coalition for Epidemic Preparedness Innovations, or CEPI, are throwing millions — and in some cases, billions — into the hunt for vaccines. On Sunday, for example, Moderna said it had received $472 million from the U.S. Biomedical Advanced Research and Development Authority, on top of the $483 million it got in April.\u003c/p>\n\u003cp>The money isn’t just to cover the research and trials; it’s also to get companies to start manufacturing their products — even though their vaccines might not prove to be effective. It’s a strategy called manufacturing “at risk,” and public health experts say it’s necessary to ensure that any authorized vaccine can be rolled out to as many people as quickly as possible.\u003c/p>\n\u003cp>The U.S. government is also striking deals with companies to purchase their vaccines even before clinical trials are completed, including \u003ca href=\"https://www.statnews.com/2020/07/07/novavax-maker-of-a-covid-19-vaccine-is-backed-by-operation-warp-speed/\" target=\"_blank\" rel=\"noopener noreferrer\">a $1.6 billion agreement\u003c/a> with Novavax that includes 100 million doses and a $1.95 billion compact with Pfizer and BioNTech, also for 100 million doses.\u003c/p>\n\u003cp>“The fact that industry is able to hedge their bets like this and to make these investments is because the government has put up the money,” said UTMB’s Le Duc, who formerly led the Centers for Disease Control and Prevention’s viral diseases division. “The government has recognized that this is an incredibly important issue and we need to be going full blast knowing full well that not all these vaccines will work. Some are going to be duds, and will lose money.”\u003c/p>\n\u003cp>\u003cstrong>Regulatory Nimbleness\u003c/strong>\u003c/p>\n\u003cp class=\"p1\">\u003cspan class=\"s1\">\u003cspan class=\"big-cap-wrap\">\u003cspan class=\"big-cap\">I\u003c/span>\u003c/span>\u003c/span>n-the-weeds regulatory decisions don’t get much public attention, but they are helping expedite clinical trials and the ultimate evaluation of how effective a vaccine is.\u003c/p>\n\u003cp>Many of these lessons were first learned during the West African Ebola crisis, when regulators embraced a new dexterity in green-lighting vaccine trials and took a more proactive approach to communicating with companies about the efficacy thresholds products needed to meet. That’s continuing with COVID-19: the Food and Drug Administration, for example, has \u003ca href=\"https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-takes-action-help-facilitate-timely-development-safe-effective-covid\" target=\"_blank\" rel=\"noopener noreferrer\">outlined\u003c/a> that vaccines need to prevent infections or reduce the severity of COVID-19 in 50% of recipients to be approved.\u003c/p>\n\u003cp>The Ebola crisis “really did give the regulators greater experience and more comfort with the idea that they could have greater flexibility than they normally would have,” said Mark Feinberg, the president of the International AIDS Vaccine Initiative and a former executive at Merck Vaccines. “They could make decisions more quickly and really be true partners in the development process.”\u003c/p>\n\u003cp>Textbook clinical trials include three increasingly large phases that establish how safe and effective a drug or vaccine is. But with the COVID-19 pandemic, some of the trials have been collapsed into Phase 1/2 or Phase 2/3 trials. It’s a wonky distinction, but it can shave weeks or months off the process by saving research teams from having to write new protocols or get additional clearances.\u003c/p>\n\u003cp>The speed of vaccine development can also have an adverse effect. Some people have questioned how such a fast-moving process can ensure safety and might abstain from a vaccine. An \u003ca href=\"https://apnews.com/dacdc8bc428dd4df6511bfa259cfec44\" target=\"_blank\" rel=\"noopener noreferrer\">Associated Press poll\u003c/a> in May found that Black and Latinx Americans, who have been disproportionately harmed by the pandemic and have a history of mistreatment by the medical field, are more skeptical about COVID-19 vaccines than white Americans — showing the importance of outreach campaigns that public health experts say are required to increase the uptake of immunizations.\u003c/p>\n\u003cp>Others have raised suspicions that President Donald Trump — whose vaccine initiative is dubbed \u003ca href=\"https://www.hhs.gov/about/news/2020/06/16/fact-sheet-explaining-operation-warp-speed.html\" target=\"_blank\" rel=\"noopener noreferrer\">Operation Warp Speed\u003c/a> — might force an emergency authorization of a vaccine before the election, even if it hasn’t cleared efficacy and safety standards. Presumptive Democratic presidential nominee Joe Biden on Monday \u003ca href=\"https://medium.com/@JoeBiden/my-statement-on-vaccines-2133deed94ee\" target=\"_blank\" rel=\"noopener noreferrer\">raised the specter\u003c/a> of politics interfering in the quest for a vaccine.\u003c/p>\n\u003cp>Scientists and regulators are already stressing that safeguards aren’t being jettisoned. Public health experts say vaccine makers need to be transparent that while manufacturing and regulatory steps are being streamlined, safety checks aren’t being sacrificed.\u003c/p>\n\u003cp>In a call with reporters Monday, NIH Director Francis Collins, whom former President Barack Obama first tapped for the position, defended the integrity of the decisions regulators will make. “Nothing is being done here to compromise the safety” of COVID-19 vaccine trials, he said, “nor will we compromise on an ultimate conclusion about whether the vaccine is effective. Those issues are going to be tested in the most rigorous way.”\u003c/p>\n\u003cp>\u003cstrong>The Challenges Ahead\u003c/strong>\u003c/p>\n\u003cp>Exactly what all this speed will translate into remains to be seen. The monthslong, final-stage clinical trials starting now will settle that.\u003c/p>\n\u003cp>The Moderna and Pfizer/BioNTech candidates \u003ca href=\"https://www.statnews.com/2020/07/27/pfizer-biontech-pick-covid19-vaccine-begin-pivotal-study/\" target=\"_blank\" rel=\"noopener noreferrer\">respectively launched\u003c/a> Phase 3 and Phase 2/3 trials this week, and the Oxford/AstraZeneca vaccine is in a Phase 2/3 trial. Others are entering pivotal studies soon. These involve enrolling thousands of people, injecting half with the candidate and half with a placebo or control, and then comparing whether people who received the vaccine are less likely to be infected than their counterparts.\u003c/p>\n\u003cp>Some vaccine candidates could very well fail — a normal part of the scientific pursuit, experts say. “I hope that doesn’t happen, but people need to accept when things don’t pan out the way they hope,” said Maria Elena Bottazzi, the co-director of Texas Children’s Hospital Center for Vaccine Development at Baylor.\u003c/p>\n\u003cp>It’s also not clear yet what a vaccine “working” will look like. A COVID-19 vaccine might \u003ca href=\"https://www.statnews.com/2020/05/22/the-world-needs-covid-19-vaccines-it-may-also-be-overestimating-their-power/\" target=\"_blank\" rel=\"noopener noreferrer\">be like the flu vaccine\u003c/a> — only preventing infections in some people, or staving off serious disease but still leaving people contagious.\u003c/p>\n\u003cp>A vaccine that prevents even 50% of infections would be a massive lifeline. But experts worry there’s a disconnect between a public expecting vaccines to instantly reset their lives and what the first vaccines may actually allow. Successful vaccines \u003ca href=\"https://www.statnews.com/2020/07/22/confusion-spreads-over-system-to-determine-priority-access-to-covid-19-vaccines/\" target=\"_blank\" rel=\"noopener noreferrer\">will likely be restricted\u003c/a> to front-line workers and vulnerable populations at first. It could take some time for enough vaccine to be made for everyone who wants a shot. Some vaccines might require two doses to confer protection.\u003c/p>\n\u003cp>“It might not be some magic bullet that’s going to stop the pandemic in its tracks, and people need to be prepared for that possibility,” said Columbia University virologist Angela Rasmussen about the first vaccines that reach people. “I really hate the term vaccine race. Because that implies there’s going to be a medal ceremony, and the pandemic is over.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cem>This story was originally published by \u003ca href=\"https://www.statnews.com/\" target=\"_blank\" rel=\"noopener noreferrer\">STAT\u003c/a>, an online publication of Boston Globe Media that covers health, medicine, and scientific discovery.\u003c/em>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1967921/inside-the-huge-experiment-to-rapidly-develop-a-covid-19-vaccine",
"authors": [
"byline_science_1967921"
],
"categories": [
"science_39",
"science_3890",
"science_40",
"science_4450"
],
"tags": [
"science_4329",
"science_3977"
],
"featImg": "science_1967932",
"label": "source_science_1967921"
},
"science_1967925": {
"type": "posts",
"id": "science_1967925",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1967925",
"score": null,
"sort": [
1596220199000
]
},
"guestAuthors": [],
"slug": "evs-are-coming-to-the-farm-in-californias-central-coast",
"title": "EVs Are Coming to the Farm in California's Central Coast",
"publishDate": 1596220199,
"format": "standard",
"headTitle": "EVs Are Coming to the Farm in California’s Central Coast | KQED",
"labelTerm": {},
"content": "\u003cp>\u003cem>\u003ca href=\"https://protect-us.mimecast.com/s/Neq_CwpkPvsGmMG7hVOy7A?domain=insideclimatenews.org\" target=\"_blank\" rel=\"noopener noreferrer\">InsideClimate News\u003c/a> is a nonprofit, independent news organization that covers climate, energy and the environment. Sign up for the ICN newsletter \u003ca href=\"https://protect-us.mimecast.com/s/pD-rCxklQwf1V61yTviMEq?domain=insideclimatenews.org\" target=\"_blank\" rel=\"noopener noreferrer\">here\u003c/a>.\u003c/em>\u003c/p>\n\u003cp style=\"font-weight: 400\">Monterey Bay Community Power is entering the world of agricultural electrification.\u003c/p>\n\u003cp style=\"font-weight: 400\">The community-owned electricity provider launched its first \u003ca href=\"https://www.mbcommunitypower.org/ag-electrification-grant-program/\">agriculture-specific grant program\u003c/a> this week, an initiative that will fund the replacement of fossil fuel-powered farm equipment, like tractors and forklifts, with electric alternatives.\u003c/p>\n\u003cp style=\"font-weight: 400\">Funding will be allocated based on the number of customers that the electricity provider serves in each county. Of the $160,000 available — enough to fund at least eight grants of up to $20,000 each — half the money is earmarked for agricultural customers in Monterey County and a quarter for Santa Cruz County, with the remainder split between San Benito County and the cities of San Luis Obispo and Morro Bay.\u003c/p>\n\u003cp style=\"font-weight: 400\">“The hope is to learn, establish ourselves as a trusted resource for the Ag sector, and then just build upon the success of this program,” said J.R. Killigrew, director of communications and outreach for Monterey Bay Community Power.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp style=\"font-weight: 400\">The electricity provider’s leaders have said their goal is to electrify the Central Coast, and they want to ensure that agricultural customers are included in that transition.\u003c/p>\n\u003cp style=\"font-weight: 400\">The grant program would mean new customers for the small but growing array of companies that make electric farm equipment. One of those companies is \u003ca href=\"https://www.solectrac.com/\">Solectrac\u003c/a>, a startup based in Mendocino County, California, that makes compact electric tractors. Its eUtility model provides the equivalent of 40 horsepower for a base price of $45,000, which is roughly 50% more than an equivalent diesel tractor.\u003c/p>\n\u003cp style=\"font-weight: 400\">“I became converted that this is going to work, and this is coming,” said Roger Hoy, director of the University of Nebraska Tractor Test Laboratory, who has tested the Solectac model.\u003c/p>\n\u003cp style=\"font-weight: 400\">He said he expects that the electric tractor market will start with small models and build from that niche, adding that there is not yet a viable electric alternative to the large tractors used for row crops.\u003c/p>\n\u003cp style=\"font-weight: 400\">The grants from Monterey Bay Community Power would reduce or eliminate the cost difference between an electric model and a diesel one, which should make the EVs an attractive option.\u003c/p>\n\u003cp style=\"font-weight: 400\">“At the end of the day, they’re trying to make a buck,” Killigrew said about the farmers that may apply. “They’re trying to make sure that they stay in business. So any way they could find means that could help support their operations, and if we can do it in a clean and sustainable way, then we’re meeting their goals and we’re also meeting our goals.”\u003c/p>\n\u003cp style=\"font-weight: 400\">Applications for the grant close at the end of August. The electricity provider plans to announce recipients by late September.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp style=\"font-weight: 400\">\u003ci>\u003cem>Reporter Nicole Pollack contributed to this story.\u003c/em>\u003c/i>\u003c/p>\n\n",
"blocks": [],
"excerpt": "Monterey Bay Community Power launched a grant program to pay for replacing gas-powered farm equipment with electric ones. ",
"status": "publish",
"parent": 0,
"modified": 1725577888,
"stats": {
"hasAudio": false,
"hasVideo": false,
"hasChartOrMap": false,
"iframeSrcs": [],
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"hasPolis": false,
"paragraphCount": 3,
"wordCount": 488
},
"headData": {
"title": "EVs Are Coming to the Farm in California's Central Coast | KQED",
"description": "Monterey Bay Community Power launched a grant program to pay for replacing gas-powered farm equipment with electric ones. ",
"ogTitle": "",
"ogDescription": "",
"ogImgId": "",
"twTitle": "",
"twDescription": "",
"twImgId": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "EVs Are Coming to the Farm in California's Central Coast",
"datePublished": "2020-07-31T11:29:59-07:00",
"dateModified": "2024-09-05T16:11:28-07:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"source": "InsideClimate News",
"sticky": false,
"nprByline": "Dan Gearino \u003cbr />InsideClimate News\u003cbr>",
"path": "/science/1967925/evs-are-coming-to-the-farm-in-californias-central-coast",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>\u003cem>\u003ca href=\"https://protect-us.mimecast.com/s/Neq_CwpkPvsGmMG7hVOy7A?domain=insideclimatenews.org\" target=\"_blank\" rel=\"noopener noreferrer\">InsideClimate News\u003c/a> is a nonprofit, independent news organization that covers climate, energy and the environment. Sign up for the ICN newsletter \u003ca href=\"https://protect-us.mimecast.com/s/pD-rCxklQwf1V61yTviMEq?domain=insideclimatenews.org\" target=\"_blank\" rel=\"noopener noreferrer\">here\u003c/a>.\u003c/em>\u003c/p>\n\u003cp style=\"font-weight: 400\">Monterey Bay Community Power is entering the world of agricultural electrification.\u003c/p>\n\u003cp style=\"font-weight: 400\">The community-owned electricity provider launched its first \u003ca href=\"https://www.mbcommunitypower.org/ag-electrification-grant-program/\">agriculture-specific grant program\u003c/a> this week, an initiative that will fund the replacement of fossil fuel-powered farm equipment, like tractors and forklifts, with electric alternatives.\u003c/p>\n\u003cp style=\"font-weight: 400\">Funding will be allocated based on the number of customers that the electricity provider serves in each county. Of the $160,000 available — enough to fund at least eight grants of up to $20,000 each — half the money is earmarked for agricultural customers in Monterey County and a quarter for Santa Cruz County, with the remainder split between San Benito County and the cities of San Luis Obispo and Morro Bay.\u003c/p>\n\u003cp style=\"font-weight: 400\">“The hope is to learn, establish ourselves as a trusted resource for the Ag sector, and then just build upon the success of this program,” said J.R. Killigrew, director of communications and outreach for Monterey Bay Community Power.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp style=\"font-weight: 400\">The electricity provider’s leaders have said their goal is to electrify the Central Coast, and they want to ensure that agricultural customers are included in that transition.\u003c/p>\n\u003cp style=\"font-weight: 400\">The grant program would mean new customers for the small but growing array of companies that make electric farm equipment. One of those companies is \u003ca href=\"https://www.solectrac.com/\">Solectrac\u003c/a>, a startup based in Mendocino County, California, that makes compact electric tractors. Its eUtility model provides the equivalent of 40 horsepower for a base price of $45,000, which is roughly 50% more than an equivalent diesel tractor.\u003c/p>\n\u003cp style=\"font-weight: 400\">“I became converted that this is going to work, and this is coming,” said Roger Hoy, director of the University of Nebraska Tractor Test Laboratory, who has tested the Solectac model.\u003c/p>\n\u003cp style=\"font-weight: 400\">He said he expects that the electric tractor market will start with small models and build from that niche, adding that there is not yet a viable electric alternative to the large tractors used for row crops.\u003c/p>\n\u003cp style=\"font-weight: 400\">The grants from Monterey Bay Community Power would reduce or eliminate the cost difference between an electric model and a diesel one, which should make the EVs an attractive option.\u003c/p>\n\u003cp style=\"font-weight: 400\">“At the end of the day, they’re trying to make a buck,” Killigrew said about the farmers that may apply. “They’re trying to make sure that they stay in business. So any way they could find means that could help support their operations, and if we can do it in a clean and sustainable way, then we’re meeting their goals and we’re also meeting our goals.”\u003c/p>\n\u003cp style=\"font-weight: 400\">Applications for the grant close at the end of August. The electricity provider plans to announce recipients by late September.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp style=\"font-weight: 400\">\u003ci>\u003cem>Reporter Nicole Pollack contributed to this story.\u003c/em>\u003c/i>\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1967925/evs-are-coming-to-the-farm-in-californias-central-coast",
"authors": [
"byline_science_1967925"
],
"categories": [
"science_31",
"science_33",
"science_36",
"science_39",
"science_40",
"science_4450"
],
"tags": [
"science_392",
"science_194",
"science_4122"
],
"featImg": "science_1967927",
"label": "source_science_1967925"
},
"science_1967579": {
"type": "posts",
"id": "science_1967579",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1967579",
"score": null,
"sort": [
1596059856000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1596059856,
"format": "standard",
"title": "San Mateo County Says More Closures Likely After Addition to COVID Monitoring List",
"headTitle": "San Mateo County Says More Closures Likely After Addition to COVID Monitoring List | KQED",
"content": "\u003cp>After weeks of indecision, California health officials Wednesday added San Mateo to a \u003ca href=\"https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/CountyMonitoringDataStep2.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">\u003cspan style=\"font-weight: 400;\">watchlist\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> of counties experiencing troubling coronavirus transmission.\u003c/span>\u003c/p>\n\u003cp>If a county is on the watchlist for three days or longer, the state can order the shuttering of businesses while the county works with health officials to lower the numbers below watchlist thresholds.\u003c/p>\n\u003cp>The county “will be in involved in active engagement with the state while the case rate is closely monitored” over the next three days, the county said in an \u003ca href=\"https://cmo.smcgov.org/press-release/san-mateo-county-added-state%E2%80%99s-covid-19-monitoring-list-preparing-potential-additional\" target=\"_blank\" rel=\"noopener noreferrer\">update\u003c/a>.\u003c/p>\n\u003cp>But it acknowledged that health officials believe the case rate will not decrease in time to prevent more business closures and disruptions. The county advised gyms, salons, malls, places of worship and other businesses to prepare to operate outside or through customer pickup by Saturday morning.\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Businesses like tattoo parlors that are not allowed to operate outside must temporarily close. \u003c/span>\u003c/p>\n\u003cp>Schools in counties on the state’s monitoring list are not allowed to hold in-class instruction, though elementary schools can request a waiver from the county.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>\u003cstrong>More Coronavirus Cases\u003c/strong>\u003c/p>\n\u003cp>The state will add a county to the watchlist if it detects a surge in coronavirus cases or hospitalizations; if ICU bed and ventilator capacity are stretched too thin; or if not enough tests are given.\u003c/p>\n\u003cp>Currently, county data shows an average case rate of 110.4 per 100,000 people — higher than the state benchmark of 100.\u003c/p>\n\u003cp>“San Mateo County is experiencing an elevated case rate that exceeds the State threshold,” the California Department of Public Health explains on its \u003ca href=\"https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/CountyMonitoringDataStep2.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">County Data Monitoring\u003c/a> webpage. “The County sees roots of community transmission related to social gatherings without sufficient physical distancing and wearing of facial coverings, as well as higher exposure for residents performing work that involves person-to-person contact and crowded housing conditions that make home isolation difficult.”\u003c/p>\n\u003cp>The state is asking the county to expand testing and contact tracing, find more places for those infected with the coronavirus to quarantine away from their families, and prepare its hospital systems for a potential surge in COVID-19 patients.\u003c/p>\n\u003cp>San Mateo County, the last of nine Bay Area counties to escape monitoring status, has teetered on the edge of getting listed since mid-July, when monitoring of its coronavirus data registered a spike in cases.\u003c/p>\n\u003cp>https://twitter.com/davidcanepa/status/1288575595425628161?s=20\u003c/p>\n\u003cp> \u003c/p>\n\u003cp>\u003cstrong> Open … For Now\u003c/strong>\u003c/p>\n\u003cp>Staying off the list has meant businesses like Physique Magnifique Fitness Training Academy can keep their doors open while those in watchlist counties have been forced to mostly shut down after a brief period of activity.\u003c/p>\n\u003cp>Physique Magnifique is operating with modifications. Staffers take the temperatures of members at the door, sanitize shoe bottoms, and wipe down the equipment once an hour, said Futaba Takashima, co-owner of the bodybuilding gym with her husband.\u003c/p>\n\u003cp>Over the past weeks, as the county’s numbers crossed over into the red zone, her anticipation mounted that the state would drop the hammer.\u003c/p>\n\u003cp>“We expect it,” Takashima said last week. “The first time we got shut down, we didn’t think it would go on for so long. But we were shut down for three-and-a-half-months, which was not good.”\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Mike Callagy, county manager, said in a statement it’s clear that COVID-19 is spreading in the Bay Area.\u003c/span>\u003c/p>\n\u003cp>“It’s vital that we all do everything we can — wearing face coverings, washing our hands, and avoiding gatherings — to slow and eventually stop the spread,” he said. “These individual actions can make a huge difference.”\u003c/p>\n\u003cp>\u003cem>Jon Brooks contributed to this report.\u003c/em>\u003c/p>\n\u003cp>\u003c/p>\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 619,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 22
},
"modified": 1704847143,
"excerpt": "The county was pessimistic about its chances of decreasing its case count in time to prevent the forced closure of indoor operations at gyms, salons, malls, places of worship and other businesses starting Saturday morning.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "The county was pessimistic about its chances of decreasing its case count in time to prevent the forced closure of indoor operations at gyms, salons, malls, places of worship and other businesses starting Saturday morning.",
"title": "San Mateo County Says More Closures Likely After Addition to COVID Monitoring List | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "San Mateo County Says More Closures Likely After Addition to COVID Monitoring List",
"datePublished": "2020-07-29T14:57:36-07:00",
"dateModified": "2024-01-09T16:39:03-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "san-mateo-is-the-only-bay-area-county-to-escape-californias-covid-19-watchlist-but-how-long-can-that-last",
"status": "publish",
"sticky": false,
"source": "Coronavirus",
"path": "/science/1967579/san-mateo-is-the-only-bay-area-county-to-escape-californias-covid-19-watchlist-but-how-long-can-that-last",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>After weeks of indecision, California health officials Wednesday added San Mateo to a \u003ca href=\"https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/CountyMonitoringDataStep2.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">\u003cspan style=\"font-weight: 400;\">watchlist\u003c/span>\u003c/a>\u003cspan style=\"font-weight: 400;\"> of counties experiencing troubling coronavirus transmission.\u003c/span>\u003c/p>\n\u003cp>If a county is on the watchlist for three days or longer, the state can order the shuttering of businesses while the county works with health officials to lower the numbers below watchlist thresholds.\u003c/p>\n\u003cp>The county “will be in involved in active engagement with the state while the case rate is closely monitored” over the next three days, the county said in an \u003ca href=\"https://cmo.smcgov.org/press-release/san-mateo-county-added-state%E2%80%99s-covid-19-monitoring-list-preparing-potential-additional\" target=\"_blank\" rel=\"noopener noreferrer\">update\u003c/a>.\u003c/p>\n\u003cp>But it acknowledged that health officials believe the case rate will not decrease in time to prevent more business closures and disruptions. The county advised gyms, salons, malls, places of worship and other businesses to prepare to operate outside or through customer pickup by Saturday morning.\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Businesses like tattoo parlors that are not allowed to operate outside must temporarily close. \u003c/span>\u003c/p>\n\u003cp>Schools in counties on the state’s monitoring list are not allowed to hold in-class instruction, though elementary schools can request a waiver from the county.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cstrong>More Coronavirus Cases\u003c/strong>\u003c/p>\n\u003cp>The state will add a county to the watchlist if it detects a surge in coronavirus cases or hospitalizations; if ICU bed and ventilator capacity are stretched too thin; or if not enough tests are given.\u003c/p>\n\u003cp>Currently, county data shows an average case rate of 110.4 per 100,000 people — higher than the state benchmark of 100.\u003c/p>\n\u003cp>“San Mateo County is experiencing an elevated case rate that exceeds the State threshold,” the California Department of Public Health explains on its \u003ca href=\"https://www.cdph.ca.gov/Programs/CID/DCDC/Pages/COVID-19/CountyMonitoringDataStep2.aspx\" target=\"_blank\" rel=\"noopener noreferrer\">County Data Monitoring\u003c/a> webpage. “The County sees roots of community transmission related to social gatherings without sufficient physical distancing and wearing of facial coverings, as well as higher exposure for residents performing work that involves person-to-person contact and crowded housing conditions that make home isolation difficult.”\u003c/p>\n\u003cp>The state is asking the county to expand testing and contact tracing, find more places for those infected with the coronavirus to quarantine away from their families, and prepare its hospital systems for a potential surge in COVID-19 patients.\u003c/p>\n\u003cp>San Mateo County, the last of nine Bay Area counties to escape monitoring status, has teetered on the edge of getting listed since mid-July, when monitoring of its coronavirus data registered a spike in cases.\u003c/p>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "singleTwitterStatus",
"attributes": {
"named": {
"id": "1288575595425628161"
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\n\u003cp> \u003c/p>\n\u003cp>\u003cstrong> Open … For Now\u003c/strong>\u003c/p>\n\u003cp>Staying off the list has meant businesses like Physique Magnifique Fitness Training Academy can keep their doors open while those in watchlist counties have been forced to mostly shut down after a brief period of activity.\u003c/p>\n\u003cp>Physique Magnifique is operating with modifications. Staffers take the temperatures of members at the door, sanitize shoe bottoms, and wipe down the equipment once an hour, said Futaba Takashima, co-owner of the bodybuilding gym with her husband.\u003c/p>\n\u003cp>Over the past weeks, as the county’s numbers crossed over into the red zone, her anticipation mounted that the state would drop the hammer.\u003c/p>\n\u003cp>“We expect it,” Takashima said last week. “The first time we got shut down, we didn’t think it would go on for so long. But we were shut down for three-and-a-half-months, which was not good.”\u003c/p>\n\u003cp>\u003cspan style=\"font-weight: 400;\">Mike Callagy, county manager, said in a statement it’s clear that COVID-19 is spreading in the Bay Area.\u003c/span>\u003c/p>\n\u003cp>“It’s vital that we all do everything we can — wearing face coverings, washing our hands, and avoiding gatherings — to slow and eventually stop the spread,” he said. “These individual actions can make a huge difference.”\u003c/p>\n\u003cp>\u003cem>Jon Brooks contributed to this report.\u003c/em>\u003c/p>\n\u003cp>\u003c/p>\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1967579/san-mateo-is-the-only-bay-area-county-to-escape-californias-covid-19-watchlist-but-how-long-can-that-last",
"authors": [
"11608"
],
"categories": [
"science_39",
"science_40",
"science_4450"
],
"tags": [
"science_4329",
"science_5181"
],
"featImg": "science_1967585",
"label": "source_science_1967579"
},
"science_1967769": {
"type": "posts",
"id": "science_1967769",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1967769",
"score": null,
"sort": [
1596047360000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1596047360,
"format": "standard",
"title": "Researchers Testing if Harvested Antibodies Can Prevent COVID-19 Infection",
"headTitle": "Researchers Testing if Harvested Antibodies Can Prevent COVID-19 Infection | KQED",
"content": "\u003cp>If you’re bitten or scratched by an animal with rabies, your doctor can \u003ca href=\"https://www.cdc.gov/vaccines/hcp/vis/vis-statements/rabies.pdf\">give you a shot\u003c/a> to prevent the virus from taking hold in you and causing an infection. The same concept is now being put to the test for the coronavirus.\u003c/p>\n\u003cp>Most people who get sick with COVID-19 produce antibodies in their blood that seem to protect them from reinfection. A \u003ca href=\"https://clinicaltrials.gov/ct2/show/NCT04323800?term=NCT04323800&draw=2&rank=1\">study is now underway\u003c/a> to see whether an infusion of those antibodies can protect someone who has been exposed to the virus and is at high risk of infection.\u003c/p>\n\u003cp>One of the first volunteers for this study is a physician who treats transplant patients at the Johns Hopkins University School of Medicine. \u003ca href=\"https://www.hopkinsmedicine.org/profiles/results/directory/profile/0013314/jonathan-orens\">Jonathan Orens \u003c/a>had a close brush with the coronavirus involving not his work, but his family.\u003c/p>\n\u003cp>His daughter from Los Angeles wanted to come home to be near her sister, who was about to give birth to her first baby. Orens says the traveling daughter was careful about protecting her health in Los Angeles and did everything she could think of to stay safe on her flight to Baltimore.\u003c/p>\n\u003cp>“She wore a mask, she wore gloves, she had sanitizer, she had wipes,” he said. “The load on the plane was relatively small.” They chose the Fourth of July as a travel day, knowing that even fewer people were likely to be traveling that day. “We actually bought the two seats in the row to keep her away from everybody else.”\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>She wore masks through the airports and in the car ride back to her parents’ house. Once there, she kept her distance from them.\u003c/p>\n\u003cp>Just to be sure, about a week after she arrived, she and her parents went for coronavirus testing.\u003c/p>\n\u003cp>Though she had no symptoms, “she was positive,” Orens said. “And fortunately my wife and I were negative.” But they were still at high risk of contracting the disease, given the close contact with their daughter.\u003c/p>\n\u003cp>As luck would have it, one of Orens’ colleagues at Johns Hopkins was just starting a study to see if purified blood serum from people who have recovered from COVID-19 — called convalescent plasma — could prevent the disease in someone else. Orens and his wife, who are in their early 60s, are entering an age group at higher risk of serious disease if infected with the coronavirus. They signed up for the experimental treatment.\u003c/p>\n\u003cp>Half the people in this clinical trial get an intravenous infusion of convalescent plasma, while the other half get an infusion of blood serum that had been donated before the pandemic emerged (so it lacked protective antibodies). Neither the participants nor the doctors treating them know who’s getting what.\u003c/p>\n\u003cp>The infusion took about an hour, Orens says. “I didn’t feel anything except for the pinprick from the IV, and we went on our merry way.”\u003c/p>\n\u003cp>He now returns to the clinic for regular blood tests.\u003c/p>\n\u003cp>“We’ll follow him along to see if he develops symptoms and if he turns positive,” said \u003ca href=\"https://www.hopkinsmedicine.org/profiles/results/directory/profile/4090026/shmuel-shoham\">Dr. Shmuel Shoham\u003c/a>, who is directing the study. Shoham says he plans to enroll up to 500 patients — though, in the best-case scenario, if the treatment is highly effective he won’t need to study that many people.\u003c/p>\n\u003cp>In addition to recruiting patients in Baltimore, “right now we have sites in Houston, sites in Alabama,” Shoham said. “We’re opening up additional sites in Dallas and Arizona. We have sites all over Southern California.”\u003c/p>\n\u003cp>He’s also involved in a second study that looks at whether plasma will prevent serious illness in people who are infected but not sick. He says if both of these strategies work, they could help a lot of people, even in the absence of a vaccine.\u003c/p>\n\u003cp>“That would give people a lot of confidence, I think, to go back to school, go back to work,” he says, “because if somebody gets sick it’s not a tragedy — because we can protect them and protect those around them.”\u003c/p>\n\u003cp>These studies are among \u003ca href=\"https://ccpp19.org/healthcare_providers/component_3/index.html\">a growing number of experiments\u003c/a> involving convalescent plasma, both as preventive measures and as treatments for COVID-19.\u003c/p>\n\u003cp>\u003ca href=\"https://www.publichealth.columbia.edu/people/our-faculty/jj2158\">Dr. Jessica Justman\u003c/a> at Columbia University’s Mailman School of Public Health in New York tried to launch a similar study this spring. Good news for New York — but a complication for her study — was that the disease had largely abated in the city, and she didn’t have luck recruiting people to participate.\u003c/p>\n\u003cp>“Compared to March and April, people have become less worried, less scared of COVID and perhaps a little bit less inclined to go for a preventive treatment,” Justman said.\u003c/p>\n\u003cp>That situation could turn around if the disease roars back in her area. And Justman says the idea is well worth pursuing. A similar strategy works against other diseases — not just rabies, but hepatitis B, botulism and a potentially serious viral infection in babies called \u003ca href=\"https://www.cdc.gov/mmwr/volumes/67/wr/mm6702a4.htm\">respiratory syncytial virus\u003c/a>. In fact, this general strategy dates back more than a century. Shoham was involved in a study that attempted to use convalescent serum to treat the flu, and it was not successful — so it isn’t a cure-all.\u003c/p>\n\u003cp>Piggybacking on this strategy, drug companies are gearing up to manufacture antibodies, instead of collecting blood from recovered patients. But those products — monoclonal antibodies — wouldn’t be cheap.\u003c/p>\n\u003cp>“What I like about the convalescent plasma idea is that if it worked, I see it as something that could really be scalable in resource-limited settings,” Justman says, referring to developing countries where expensive pharmaceuticals are frequently out of reach. “And I think that’s where convalescent plasma has this really great potential.”\u003c/p>\n\u003cp>As for the Orens family, nobody fell ill — whether that was due to in part to treatment or luck, nobody knows. Their quarantine period ended just in time for a quick trip to New York after the baby’s birth to see the new mom.\u003c/p>\n\u003cp>“The plan is to drive up after she is out of the hospital. Hopefully, everything will go well, and we will all be outside,” Orens said. “We will see the baby from a distance. I’ve already been informed by my daughter that I am not allowed to get anywhere near the baby. And then we will turn around and come back to Baltimore.”\u003c/p>\n\u003cp>It’s hardly the way he was hoping to greet his first grandchild, he says, “however it’s the price we have to pay to bring this pandemic under control.”\u003c/p>\n\u003cp>The researchers in Baltimore hope to know by mid-September whether the convalescent plasma will in fact inoculate people from COVID-19.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>\u003cem>You can contact NPR science correspondent Richard Harris at \u003c/em>\u003ca href=\"mailto:rharris@npr.org\">\u003cem>rharris@npr.org\u003c/em>\u003c/a>\u003cem>.\u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2020 NPR. To see more, visit https://www.npr.org.\u003cimg decoding=\"async\" src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Harvested+Antibodies+Now+Being+Tested+As+A+Prevention+Tool+Against+COVID-19&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1193,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 29
},
"modified": 1704847144,
"excerpt": "Scientists are now checking to see if purified blood serum from people who have recovered from COVID-19 might be more than a useful treatment. ",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Scientists are now checking to see if purified blood serum from people who have recovered from COVID-19 might be more than a useful treatment. ",
"title": "Researchers Testing if Harvested Antibodies Can Prevent COVID-19 Infection | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Researchers Testing if Harvested Antibodies Can Prevent COVID-19 Infection",
"datePublished": "2020-07-29T11:29:20-07:00",
"dateModified": "2024-01-09T16:39:04-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "researchers-testing-if-harvested-antibodies-can-prevent-covid-19-infection",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=895996309&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Richard Harris \u003cbr />NPR\u003cbr>",
"nprStoryDate": "Wed, 29 Jul 2020 05:00:03 -0400",
"nprLastModifiedDate": "Wed, 29 Jul 2020 08:03:46 -0400",
"sticky": false,
"nprHtmlLink": "https://www.npr.org/sections/health-shots/2020/07/29/895996309/harvested-antibodies-now-being-tested-as-a-prevention-tool-against-covid-19?ft=nprml&f=895996309",
"nprImageAgency": "Reuters",
"nprImageCredit": "Lindsey Wasson",
"source": "NPR",
"nprStoryId": "895996309",
"nprRetrievedStory": "1",
"nprPubDate": "Wed, 29 Jul 2020 08:03:00 -0400",
"path": "/science/1967769/researchers-testing-if-harvested-antibodies-can-prevent-covid-19-infection",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>If you’re bitten or scratched by an animal with rabies, your doctor can \u003ca href=\"https://www.cdc.gov/vaccines/hcp/vis/vis-statements/rabies.pdf\">give you a shot\u003c/a> to prevent the virus from taking hold in you and causing an infection. The same concept is now being put to the test for the coronavirus.\u003c/p>\n\u003cp>Most people who get sick with COVID-19 produce antibodies in their blood that seem to protect them from reinfection. A \u003ca href=\"https://clinicaltrials.gov/ct2/show/NCT04323800?term=NCT04323800&draw=2&rank=1\">study is now underway\u003c/a> to see whether an infusion of those antibodies can protect someone who has been exposed to the virus and is at high risk of infection.\u003c/p>\n\u003cp>One of the first volunteers for this study is a physician who treats transplant patients at the Johns Hopkins University School of Medicine. \u003ca href=\"https://www.hopkinsmedicine.org/profiles/results/directory/profile/0013314/jonathan-orens\">Jonathan Orens \u003c/a>had a close brush with the coronavirus involving not his work, but his family.\u003c/p>\n\u003cp>His daughter from Los Angeles wanted to come home to be near her sister, who was about to give birth to her first baby. Orens says the traveling daughter was careful about protecting her health in Los Angeles and did everything she could think of to stay safe on her flight to Baltimore.\u003c/p>\n\u003cp>“She wore a mask, she wore gloves, she had sanitizer, she had wipes,” he said. “The load on the plane was relatively small.” They chose the Fourth of July as a travel day, knowing that even fewer people were likely to be traveling that day. “We actually bought the two seats in the row to keep her away from everybody else.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>She wore masks through the airports and in the car ride back to her parents’ house. Once there, she kept her distance from them.\u003c/p>\n\u003cp>Just to be sure, about a week after she arrived, she and her parents went for coronavirus testing.\u003c/p>\n\u003cp>Though she had no symptoms, “she was positive,” Orens said. “And fortunately my wife and I were negative.” But they were still at high risk of contracting the disease, given the close contact with their daughter.\u003c/p>\n\u003cp>As luck would have it, one of Orens’ colleagues at Johns Hopkins was just starting a study to see if purified blood serum from people who have recovered from COVID-19 — called convalescent plasma — could prevent the disease in someone else. Orens and his wife, who are in their early 60s, are entering an age group at higher risk of serious disease if infected with the coronavirus. They signed up for the experimental treatment.\u003c/p>\n\u003cp>Half the people in this clinical trial get an intravenous infusion of convalescent plasma, while the other half get an infusion of blood serum that had been donated before the pandemic emerged (so it lacked protective antibodies). Neither the participants nor the doctors treating them know who’s getting what.\u003c/p>\n\u003cp>The infusion took about an hour, Orens says. “I didn’t feel anything except for the pinprick from the IV, and we went on our merry way.”\u003c/p>\n\u003cp>He now returns to the clinic for regular blood tests.\u003c/p>\n\u003cp>“We’ll follow him along to see if he develops symptoms and if he turns positive,” said \u003ca href=\"https://www.hopkinsmedicine.org/profiles/results/directory/profile/4090026/shmuel-shoham\">Dr. Shmuel Shoham\u003c/a>, who is directing the study. Shoham says he plans to enroll up to 500 patients — though, in the best-case scenario, if the treatment is highly effective he won’t need to study that many people.\u003c/p>\n\u003cp>In addition to recruiting patients in Baltimore, “right now we have sites in Houston, sites in Alabama,” Shoham said. “We’re opening up additional sites in Dallas and Arizona. We have sites all over Southern California.”\u003c/p>\n\u003cp>He’s also involved in a second study that looks at whether plasma will prevent serious illness in people who are infected but not sick. He says if both of these strategies work, they could help a lot of people, even in the absence of a vaccine.\u003c/p>\n\u003cp>“That would give people a lot of confidence, I think, to go back to school, go back to work,” he says, “because if somebody gets sick it’s not a tragedy — because we can protect them and protect those around them.”\u003c/p>\n\u003cp>These studies are among \u003ca href=\"https://ccpp19.org/healthcare_providers/component_3/index.html\">a growing number of experiments\u003c/a> involving convalescent plasma, both as preventive measures and as treatments for COVID-19.\u003c/p>\n\u003cp>\u003ca href=\"https://www.publichealth.columbia.edu/people/our-faculty/jj2158\">Dr. Jessica Justman\u003c/a> at Columbia University’s Mailman School of Public Health in New York tried to launch a similar study this spring. Good news for New York — but a complication for her study — was that the disease had largely abated in the city, and she didn’t have luck recruiting people to participate.\u003c/p>\n\u003cp>“Compared to March and April, people have become less worried, less scared of COVID and perhaps a little bit less inclined to go for a preventive treatment,” Justman said.\u003c/p>\n\u003cp>That situation could turn around if the disease roars back in her area. And Justman says the idea is well worth pursuing. A similar strategy works against other diseases — not just rabies, but hepatitis B, botulism and a potentially serious viral infection in babies called \u003ca href=\"https://www.cdc.gov/mmwr/volumes/67/wr/mm6702a4.htm\">respiratory syncytial virus\u003c/a>. In fact, this general strategy dates back more than a century. Shoham was involved in a study that attempted to use convalescent serum to treat the flu, and it was not successful — so it isn’t a cure-all.\u003c/p>\n\u003cp>Piggybacking on this strategy, drug companies are gearing up to manufacture antibodies, instead of collecting blood from recovered patients. But those products — monoclonal antibodies — wouldn’t be cheap.\u003c/p>\n\u003cp>“What I like about the convalescent plasma idea is that if it worked, I see it as something that could really be scalable in resource-limited settings,” Justman says, referring to developing countries where expensive pharmaceuticals are frequently out of reach. “And I think that’s where convalescent plasma has this really great potential.”\u003c/p>\n\u003cp>As for the Orens family, nobody fell ill — whether that was due to in part to treatment or luck, nobody knows. Their quarantine period ended just in time for a quick trip to New York after the baby’s birth to see the new mom.\u003c/p>\n\u003cp>“The plan is to drive up after she is out of the hospital. Hopefully, everything will go well, and we will all be outside,” Orens said. “We will see the baby from a distance. I’ve already been informed by my daughter that I am not allowed to get anywhere near the baby. And then we will turn around and come back to Baltimore.”\u003c/p>\n\u003cp>It’s hardly the way he was hoping to greet his first grandchild, he says, “however it’s the price we have to pay to bring this pandemic under control.”\u003c/p>\n\u003cp>The researchers in Baltimore hope to know by mid-September whether the convalescent plasma will in fact inoculate people from COVID-19.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>\u003cem>You can contact NPR science correspondent Richard Harris at \u003c/em>\u003ca href=\"mailto:rharris@npr.org\">\u003cem>rharris@npr.org\u003c/em>\u003c/a>\u003cem>.\u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2020 NPR. To see more, visit https://www.npr.org.\u003cimg decoding=\"async\" src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=Harvested+Antibodies+Now+Being+Tested+As+A+Prevention+Tool+Against+COVID-19&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1967769/researchers-testing-if-harvested-antibodies-can-prevent-covid-19-infection",
"authors": [
"byline_science_1967769"
],
"categories": [
"science_39",
"science_3890",
"science_40",
"science_4450"
],
"tags": [
"science_4329",
"science_5181",
"science_2936"
],
"featImg": "science_1967770",
"label": "source_science_1967769"
},
"science_1967728": {
"type": "posts",
"id": "science_1967728",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1967728",
"score": null,
"sort": [
1595984533000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1595984533,
"format": "audio",
"title": "San Francisco Child Care Providers Are Hurting During Coronavirus Pandemic",
"headTitle": "San Francisco Child Care Providers Are Hurting During Coronavirus Pandemic | KQED",
"content": "\u003cp>\u003cem>Updated July 30\u003c/em>\u003c/p>\n\u003cp>Child care looks very different at Baby Steps Nature School in San Francisco since the start of the coronavirus pandemic. And it’s not just because staff are taking temperatures, greeting families at the curb, and everyone over three is wearing a face mask.\u003c/p>\n\u003cp>The games the children and staff play are different too, said owner Patricia Sullivan.\u003c/p>\n\u003cp>“One of their big games right now is ‘The Floor Is Lava,'” Sullivan said. “We do obstacle courses, things that they still get to have fun together, but they don’t have to necessarily touch each other all the time.”\u003c/p>\n\u003cp>She said the songs that staff sing with kids are more calming, as are the books that the group reads. Sullivan said that’s because her young pupils know something is off these days, even if they can’t articulate it. Instead of focusing on activity after activity, she said, the whole group is slowing down.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>“The most important thing to do this is to really spend more time talking to each other, listening to what the kids are saying,” said Sullivan.\u003c/p>\n\u003cp>Outside the daily routine at Baby Steps, the entire child care industry has absorbed a seismic jolt. Parents are grappling with the decision of whether to send their kids back to day care, and persistent low enrollment endangers the long-term health of the field.\u003c/p>\n\u003cp>[pullquote align='right' citation='Gina Fromer']‘If you’re a family day care home and you were supporting 24 kids pre-COVID and now you can have six, what does that do for your business?’[/pullquote]Sullivan represents hundreds of other home-based providers through the \u003ca href=\"https://www.fccasf.com/en-us\" target=\"_blank\" rel=\"noopener noreferrer\">Family Child Care Association of San Francisco.\u003c/a> She said the group is made up largely of women of color, and they’re facing a challenging loss of income.\u003c/p>\n\u003cp>“If the parents chose not to return, we were no longer getting paid,” she said, reflecting on the time since June 1, when day care centers serving the general public were allowed to reopen. Those serving the children of essential workers have been allowed to stay open throughout the pandemic.\u003c/p>\n\u003cp>Sullivan said there were already shortages in available child care spots for infants and toddlers in San Francisco, and if providers close permanently, people with very young children “are going to have a hard time finding care.” She also said providers who offer “off-hours care,” anything outside of the hours of 7 a.m. to 6 p.m., are less likely to stay open, since many are primarily essential workers in other sectors, like grocery stores, and caring for children would be too risky in terms of coronavirus transmission.\u003c/p>\n\u003cp>Gina Fromer, CEO of the nonprofit \u003ca href=\"https://www.childrenscouncil.org/\" target=\"_blank\" rel=\"noopener noreferrer\">Children’s Council of San Francisco\u003c/a>, an advocacy group for child care, said providers “are hurting right now.”\u003c/p>\n\u003cp>While San Francisco and the state have extended some financial relief, Fromer said strict COVID guidelines mean “the majority of the sites in San Francisco are operating at half capacity,” as they must adhere to social distancing, smaller group sizes, and fewer children returning out of family choice.\u003c/p>\n\u003cp>“If you’re a family day care home and you were supporting 24 kids pre-COVID and now you can have six, what does that do for your business?” she asked.\u003c/p>\n\u003cp>In fact, just over 40% of San Francisco’s roughly 1,100 child care providers are currently closed, according to the \u003ca href=\"https://sfoece.org/\" target=\"_blank\" rel=\"noopener noreferrer\">San Francisco Office of Early Care & Education\u003c/a>. This includes larger centers, often run by companies out of a specific site, and family day cares, which are smaller and typically based in a provider’s home.\u003c/p>\n\u003cp>Fromer said some of these providers won’t open back up again, which is not just a problem for children, families, and the child care industry.\u003c/p>\n\u003cp>“There is no road to recovery in San Francisco without child care,” she said, noting that businesses will suffer if their employees can’t find proper care for their kids. She estimates that 40% of child care providers shut down after the 2007-8 economic recession.\u003c/p>\n\u003cp>“We need local, state and federal investment in child care infrastructure in order for the economy to bounce back,” said Fromer.\u003c/p>\n\u003cp>Some families are choosing not to send their children back to day care due to the expense and fear of their children getting or passing the coronavirus.\u003c/p>\n\u003cp>Dr. Naomi Bardach, associate professor of pediatrics and health policy at UCSF, said there are risks of children getting COVID-19 and transmitting the virus to adults, but those dangers are low.\u003c/p>\n\u003cp>“Most younger kids get very mild illness if they get ill at all, and they are much less likely to get it compared to adults,” she said.\u003c/p>\n\u003cp>Throughout all of California, the number of child care staff, children and their parents \u003ca href=\"https://www.cdss.ca.gov/\" target=\"_blank\" rel=\"noopener noreferrer\">who’ve tested positive\u003c/a> for the virus is roughly 1,518 as of July 29. Of that number, 313 were children, 562 were staff, 489 were parents, and 154 were in none of those categories, such as people who live in the home of a family day care worker but are not on staff.\u003c/p>\n\u003cp>Compared to the total number of preschool children in California, which she estimated “in the hundreds of thousands at least,” the number of children at day care who’ve tested positive is relatively low, she said.\u003c/p>\n\u003cp>Bardach said of the positive coronavirus cases associated with child care, “We’re not totally sure if it came from the community or the preschools. And then the other thing is we have to just put it in the context of [how] we take some risks normally in our lives when we drive in a car or cross the street.”\u003c/p>\n\u003cp>She added that when parents make their decisions, it’s important to consider how prevalent the virus is in their community, and what the safety practices are at their specific child care setting.\u003c/p>\n\u003cp>Back at Baby Steps Nature School, Sullivan understands that parents are fearful. Even if they do send their kids to day care, she sees that fear pop up in other ways — through the kids. She said her young charges are afraid to separate from their parents because they worry their mom or dad may get the virus.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>Sullivan is calming these fears with another change to her day care: pasting pictures of parents in the children’s cubbies.\u003c/p>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1109,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 28
},
"modified": 1704847147,
"excerpt": "Roughly 40% of child care providers are closed in San Francisco, and child care advocates fear this will lead to a long-term shortage.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Roughly 40% of child care providers are closed in San Francisco, and child care advocates fear this will lead to a long-term shortage.",
"title": "San Francisco Child Care Providers Are Hurting During Coronavirus Pandemic | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "San Francisco Child Care Providers Are Hurting During Coronavirus Pandemic",
"datePublished": "2020-07-28T18:02:13-07:00",
"dateModified": "2024-01-09T16:39:07-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "how-the-coronavirus-could-shrink-the-number-of-child-care-providers",
"status": "publish",
"audioUrl": "https://traffic.omny.fm/d/clips/0af137ef-751e-4b19-a055-aaef00d2d578/ffca7e9f-6831-41c5-bcaf-aaef00f5a073/6d21c967-f44c-4882-b3f4-ac060123c698/audio.mp3",
"sticky": false,
"source": "Coronavirus",
"path": "/science/1967728/how-the-coronavirus-could-shrink-the-number-of-child-care-providers",
"audioDuration": 190000,
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>\u003cem>Updated July 30\u003c/em>\u003c/p>\n\u003cp>Child care looks very different at Baby Steps Nature School in San Francisco since the start of the coronavirus pandemic. And it’s not just because staff are taking temperatures, greeting families at the curb, and everyone over three is wearing a face mask.\u003c/p>\n\u003cp>The games the children and staff play are different too, said owner Patricia Sullivan.\u003c/p>\n\u003cp>“One of their big games right now is ‘The Floor Is Lava,'” Sullivan said. “We do obstacle courses, things that they still get to have fun together, but they don’t have to necessarily touch each other all the time.”\u003c/p>\n\u003cp>She said the songs that staff sing with kids are more calming, as are the books that the group reads. Sullivan said that’s because her young pupils know something is off these days, even if they can’t articulate it. Instead of focusing on activity after activity, she said, the whole group is slowing down.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>“The most important thing to do this is to really spend more time talking to each other, listening to what the kids are saying,” said Sullivan.\u003c/p>\n\u003cp>Outside the daily routine at Baby Steps, the entire child care industry has absorbed a seismic jolt. Parents are grappling with the decision of whether to send their kids back to day care, and persistent low enrollment endangers the long-term health of the field.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "‘If you’re a family day care home and you were supporting 24 kids pre-COVID and now you can have six, what does that do for your business?’",
"name": "pullquote",
"attributes": {
"named": {
"align": "right",
"citation": "Gina Fromer",
"label": ""
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>Sullivan represents hundreds of other home-based providers through the \u003ca href=\"https://www.fccasf.com/en-us\" target=\"_blank\" rel=\"noopener noreferrer\">Family Child Care Association of San Francisco.\u003c/a> She said the group is made up largely of women of color, and they’re facing a challenging loss of income.\u003c/p>\n\u003cp>“If the parents chose not to return, we were no longer getting paid,” she said, reflecting on the time since June 1, when day care centers serving the general public were allowed to reopen. Those serving the children of essential workers have been allowed to stay open throughout the pandemic.\u003c/p>\n\u003cp>Sullivan said there were already shortages in available child care spots for infants and toddlers in San Francisco, and if providers close permanently, people with very young children “are going to have a hard time finding care.” She also said providers who offer “off-hours care,” anything outside of the hours of 7 a.m. to 6 p.m., are less likely to stay open, since many are primarily essential workers in other sectors, like grocery stores, and caring for children would be too risky in terms of coronavirus transmission.\u003c/p>\n\u003cp>Gina Fromer, CEO of the nonprofit \u003ca href=\"https://www.childrenscouncil.org/\" target=\"_blank\" rel=\"noopener noreferrer\">Children’s Council of San Francisco\u003c/a>, an advocacy group for child care, said providers “are hurting right now.”\u003c/p>\n\u003cp>While San Francisco and the state have extended some financial relief, Fromer said strict COVID guidelines mean “the majority of the sites in San Francisco are operating at half capacity,” as they must adhere to social distancing, smaller group sizes, and fewer children returning out of family choice.\u003c/p>\n\u003cp>“If you’re a family day care home and you were supporting 24 kids pre-COVID and now you can have six, what does that do for your business?” she asked.\u003c/p>\n\u003cp>In fact, just over 40% of San Francisco’s roughly 1,100 child care providers are currently closed, according to the \u003ca href=\"https://sfoece.org/\" target=\"_blank\" rel=\"noopener noreferrer\">San Francisco Office of Early Care & Education\u003c/a>. This includes larger centers, often run by companies out of a specific site, and family day cares, which are smaller and typically based in a provider’s home.\u003c/p>\n\u003cp>Fromer said some of these providers won’t open back up again, which is not just a problem for children, families, and the child care industry.\u003c/p>\n\u003cp>“There is no road to recovery in San Francisco without child care,” she said, noting that businesses will suffer if their employees can’t find proper care for their kids. She estimates that 40% of child care providers shut down after the 2007-8 economic recession.\u003c/p>\n\u003cp>“We need local, state and federal investment in child care infrastructure in order for the economy to bounce back,” said Fromer.\u003c/p>\n\u003cp>Some families are choosing not to send their children back to day care due to the expense and fear of their children getting or passing the coronavirus.\u003c/p>\n\u003cp>Dr. Naomi Bardach, associate professor of pediatrics and health policy at UCSF, said there are risks of children getting COVID-19 and transmitting the virus to adults, but those dangers are low.\u003c/p>\n\u003cp>“Most younger kids get very mild illness if they get ill at all, and they are much less likely to get it compared to adults,” she said.\u003c/p>\n\u003cp>Throughout all of California, the number of child care staff, children and their parents \u003ca href=\"https://www.cdss.ca.gov/\" target=\"_blank\" rel=\"noopener noreferrer\">who’ve tested positive\u003c/a> for the virus is roughly 1,518 as of July 29. Of that number, 313 were children, 562 were staff, 489 were parents, and 154 were in none of those categories, such as people who live in the home of a family day care worker but are not on staff.\u003c/p>\n\u003cp>Compared to the total number of preschool children in California, which she estimated “in the hundreds of thousands at least,” the number of children at day care who’ve tested positive is relatively low, she said.\u003c/p>\n\u003cp>Bardach said of the positive coronavirus cases associated with child care, “We’re not totally sure if it came from the community or the preschools. And then the other thing is we have to just put it in the context of [how] we take some risks normally in our lives when we drive in a car or cross the street.”\u003c/p>\n\u003cp>She added that when parents make their decisions, it’s important to consider how prevalent the virus is in their community, and what the safety practices are at their specific child care setting.\u003c/p>\n\u003cp>Back at Baby Steps Nature School, Sullivan understands that parents are fearful. Even if they do send their kids to day care, she sees that fear pop up in other ways — through the kids. She said her young charges are afraid to separate from their parents because they worry their mom or dad may get the virus.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Sullivan is calming these fears with another change to her day care: pasting pictures of parents in the children’s cubbies.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1967728/how-the-coronavirus-could-shrink-the-number-of-child-care-providers",
"authors": [
"8648"
],
"categories": [
"science_39",
"science_40",
"science_4450"
],
"tags": [
"science_512",
"science_4329"
],
"featImg": "science_1967733",
"label": "source_science_1967728"
},
"science_1967695": {
"type": "posts",
"id": "science_1967695",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1967695",
"score": null,
"sort": [
1595965518000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1595965518,
"format": "standard",
"title": "Anti-Vaccine Misinformation on Facebook Has Gained a Lot of Traction During Pandemic",
"headTitle": "Anti-Vaccine Misinformation on Facebook Has Gained a Lot of Traction During Pandemic | KQED",
"content": "\u003cp>As scientists begin to clear a path to a potential coronavirus vaccine, researchers and advocates are increasingly sounding the alarm over what they see as a looming threat: Facebook’s apparent inability to police dangerous falsehoods about vaccines.\u003c/p>\n\u003cp>Since the outset of the pandemic, vaccine-related falsehoods have ballooned on the platform — and recent research suggests some of those inaccurate posts are gaining traction among people who weren’t previously opposed to vaccinations. Part of the problem appears to be the way Facebook’s algorithms \u003ca href=\"https://www.wsj.com/articles/facebook-knows-it-encourages-division-top-executives-nixed-solutions-11590507499\" target=\"_blank\" rel=\"noopener noreferrer\">capitalize on divisive or extremist content\u003c/a>.\u003c/p>\n\u003cp>Compounding the issue is Facebook’s history of hesitating to address misinformation until a particular subject has snowballed into an urgent problem. In the middle of a global measles outbreak last year spurred by low vaccination rates, Facebook rolled out a series of policies to curb vaccine misinformation. But the changes did little to prevent the problem from resurfacing again amid the COVID-19 pandemic.\u003c/p>\n\u003cp>Concerned that Facebook’s failure to crack down on vaccine falsehoods will backfire at the worst possible time, advocates and scientists have called on Facebook co-founder Mark Zuckerberg to take action.\u003c/p>\n\u003cp>“COVID-19 misinformation is the equivalent of an ideological dirty bomb: It has the capacity to hurt tens of thousands of people when it detonates in the moment that vaccines are available,” said Imran Ahmed, founder and chief executive officer of the U.K.-based nonprofit Center for Countering Digital Hate, which recently assessed the growing influence of anti-vaccination content on social media platforms including Facebook since the outset of the pandemic.\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Facebook did not respond to a request for comment about its efforts to combat COVID-19 vaccine information. But in a July \u003ca href=\"https://252f2edd-1c8b-49f5-9bb2-cb57bb47e4ba.filesusr.com/ugd/f4d9b9_7aa1bf9819904295a0493a013b285a6b.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">report\u003c/a>, Ahmed’s organization assessed the influence of 409 English-language social media accounts sharing anti-vaccination content between May and June of 2020, just after the pandemic began. The report found that falsehoods about a COVID-19 vaccine have been prevalent on Facebook and other social media sites for months.\u003c/p>\n\u003cp>It’s a dire situation — and one that has only worsened with time.\u003c/p>\n\u003cp>“The first thing that came back from our researchers was, ‘Oh no. They’ve grown a lot,’” Ahmed said. In their sample, Facebook groups and pages spreading vaccination falsehoods had over 31 million followers, representing more than half of the combined following of all the social media accounts they studied.\u003c/p>\n\u003cp>Among the pages spreading falsehoods, the researchers identified one prominent category: people who sell or profit off of vaccine misinformation. These “anti-vaccination entrepreneurs” — who collectively garnered a total following of 28 million people — saw their followers grow by 854,000 between May and June. Zeroing in on groups, the researchers identified 64 that regularly shared vaccine misinformation, with a collective following of 1 million that has also kept growing.\u003c/p>\n\u003cp>Based on the research findings, Ahmed is deeply concerned that the growth in vaccine-related falsehoods will sow distrust in an eventual vaccine before one even arrives.\u003c/p>\n\u003cp>“Personally, I’m scared,” he said.\u003c/p>\n\u003cp>Since people have been asked to stay at home, more conversations have moved online — giving misinformation a chance to gain even more of a foothold on social media sites. Anti-vaccination content, in particular, has thrived.\u003c/p>\n\u003cp>“It’s basically like if you injected adrenaline into them,” said Neil Johnson, a professor of physics and researcher at the Institute for Data, Democracy, & Politics at George Washington University.\u003c/p>\n\u003cp>In May, Johnson and his colleagues \u003ca href=\"https://www.nature.com/articles/s41586-020-2281-1\" target=\"_blank\" rel=\"noopener noreferrer\">published a study in Nature\u003c/a> that showed a sizable uptick in the followers of pages promoting anti-vaccine rhetoric on Facebook between February and October of 2019. While pages spreading falsehoods about vaccines had fewer followers than pages that shared factual vaccine content, the researchers found that there were more pages spreading falsehoods, and those pages were faster-growing and increasingly more connected to neutral pages where people did not yet have a clear leaning one way or the other. If the trend continues, Johnson predicted that anti-vaccination rhetoric will dominate online discussion by 2030.\u003c/p>\n\u003cp>He and his team have been studying the change on a rolling basis in the months since their study ended — and from their view, the problem is growing more pressing.\u003c/p>\n\u003cp>Based on what we’re seeing now, “it would only take something to go wrong with one of the vaccines and then that [change] would happen in a year,” Johnson said.\u003c/p>\n\u003cp>Critics say another possible factor in the social media giant’s failure to get rid of vaccine misinformation is Zuckerberg’s own approach to moderation. Zuckerberg has, in the past, presented the social network \u003ca href=\"https://www.wsj.com/articles/facebooks-mark-zuckerberg-defends-free-speech-amid-calls-for-tighter-controls-11571335528?mod=article_inline\" target=\"_blank\" rel=\"noopener noreferrer\">as a stalwart of free speech\u003c/a>, even if that speech is potentially harmful — one of the reasons the company has \u003ca href=\"https://www.nytimes.com/2020/01/09/technology/facebook-political-ads-lies.html\" target=\"_blank\" rel=\"noopener noreferrer\">repeatedly opted to permit lies in political ads\u003c/a>.\u003c/p>\n\u003cp>In recent months, some of Zuckerberg’s dissenters have appealed to his more philanthropic intentions. In a June letter, hundreds of scientists affiliated with the Chan Zuckerberg Initiative — the research organization he and his wife, pediatrician Priscilla Chan, founded in 2015 — \u003ca href=\"https://www.statnews.com/2020/06/06/in-unusual-revolt-scientists-funded-by-mark-zuckerberg-criticize-facebooks-inaction-on-president-trumps-posts/\">called the social network’s practices “antithetical”\u003c/a> to their benefactor’s mission.\u003c/p>\n\u003cp>“The spread of news that is not vetted for factual accuracy leads to confusion and a mistrust of experts,” they wrote.\u003c/p>\n\u003cp>Facebook’s failure to eradicate scientific falsehoods is difficult to reconcile with the research efforts spearheaded by the Chan Zuckerberg Initiative. While Facebook has avoided public calls to uniformly crack down on misinformation, Zuckerberg and Chan have continued to funnel millions into CZI, including funding for several research efforts aimed at better understanding the spread of the coronavirus.\u003c/p>\n\u003cp>In April, Zuckerberg and Chan invested \u003ca href=\"https://www.statnews.com/2020/04/29/chan-zuckerberg-initiative-funds-bay-area-coronavirus-tracking/\" target=\"_blank\" rel=\"noopener noreferrer\">$13.6 million into a pair of coronavirus studies\u003c/a>, led by CZI, to flag new infections and better understand how immunity to the virus develops.\u003c/p>\n\u003cp>“From my vantage point, we’re all just trying to figure out how to do our part to answer these questions and rebuild,” Chan said in an interview with STAT in April. At the same time, though, rampant falsehoods about the virus — including the dangerous notion that an eventual vaccine will be deadly — were spreading quickly across Facebook.\u003c/p>\n\u003cp>It’s not that Facebook is doing nothing about the issue; rather, its piecemeal approaches are simply too little too late, according to researchers.\u003c/p>\n\u003cp>Last March, amid worldwide measles outbreaks, for example, the company instituted its first policy to combat vaccine misinformation, which involved using its algorithms to demote groups and pages that spread vaccine-related falsehoods and to exclude them from recommendations and predictions when users search within the platform. But as researchers pointed out at the time, demoting certain pages doesn’t stop anti-vaccination conversations from cropping up in others.\u003c/p>\n\u003cp>Among the pages where Johnson found anti-vaccine falsehoods, most were dedicated to things like hobbies and mutual interests. There were pages tailored to parents of kids who played soccer, people who like cats, and aficionados of organic produce, for example. But every so often, a strand of a conversation about something like the best way to treat a leg sprain would devolve into an inaccurate — and dangerous — diatribe against vaccines.\u003c/p>\n\u003cp>“Often in these communities, the number of what I’d call ‘bad’ posts is small — they’re mostly talking about cats or their favorite sports team or whatever, and then all of a sudden there’s a post stuck in there about vaccines,” Johnson said.\u003c/p>\n\u003cp>More recently in response to the coronavirus, Facebook began targeting people who had interacted with certain COVID-19 falsehoods with generic messages that read, “Help friends and family avoid false information about COVID-19.” Those messages point users to the World Health Organization’s myth-busting page about the coronavirus.\u003c/p>\n\u003cp>While Facebook \u003ca href=\"https://www.statnews.com/2020/05/01/facebooks-covid-19-misinformation-campaign-is-based-on-research-the-authors-worry-facebook-missed-the-message/\" target=\"_blank\" rel=\"noopener noreferrer\">said the strategy was based on psychological research\u003c/a>, the authors of the studies the platform cited as justification for their policies told STAT in May that Facebook seemed to have misinterpreted their findings. Rather than placing a generic message in people’s news feeds, Facebook should be correcting falsehoods by providing the facts, the researchers said.\u003c/p>\n\u003cp>Experts said that if Facebook is to combat misinformation in time for the arrival of an eventual coronavirus vaccine, there’s a significant amount of work that needs to happen quickly.\u003c/p>\n\u003cp>“It’s going to be a heavy lift,” Johnson said.\u003c/p>\n\u003cp>[ad floatright]\u003c/p>\n\u003cp>This story was originally published by \u003ca href=\"https://www.statnews.com/\" target=\"_blank\" rel=\"noopener noreferrer\">STAT\u003c/a>, an online publication of Boston Globe Media that covers health, medicine, and scientific discovery.\u003c/p>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 1476,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 33
},
"modified": 1704847149,
"excerpt": "Since the outset of the pandemic, vaccine-related falsehoods have ballooned on the platform — and recent research suggests some of those inaccurate posts are gaining traction among people who weren’t previously opposed to vaccinations.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Since the outset of the pandemic, vaccine-related falsehoods have ballooned on the platform — and recent research suggests some of those inaccurate posts are gaining traction among people who weren’t previously opposed to vaccinations.",
"title": "Anti-Vaccine Misinformation on Facebook Has Gained a Lot of Traction During Pandemic | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Anti-Vaccine Misinformation on Facebook Has Gained a Lot of Traction During Pandemic",
"datePublished": "2020-07-28T12:45:18-07:00",
"dateModified": "2024-01-09T16:39:09-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "anti-vaccine-misinformation-on-facebook-has-gained-a-lot-of-traction-during-pandemic",
"status": "publish",
"nprByline": " Erin Brodwin \u003cbr />STAT\u003cbr>",
"sticky": false,
"source": "STAT",
"path": "/science/1967695/anti-vaccine-misinformation-on-facebook-has-gained-a-lot-of-traction-during-pandemic",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>As scientists begin to clear a path to a potential coronavirus vaccine, researchers and advocates are increasingly sounding the alarm over what they see as a looming threat: Facebook’s apparent inability to police dangerous falsehoods about vaccines.\u003c/p>\n\u003cp>Since the outset of the pandemic, vaccine-related falsehoods have ballooned on the platform — and recent research suggests some of those inaccurate posts are gaining traction among people who weren’t previously opposed to vaccinations. Part of the problem appears to be the way Facebook’s algorithms \u003ca href=\"https://www.wsj.com/articles/facebook-knows-it-encourages-division-top-executives-nixed-solutions-11590507499\" target=\"_blank\" rel=\"noopener noreferrer\">capitalize on divisive or extremist content\u003c/a>.\u003c/p>\n\u003cp>Compounding the issue is Facebook’s history of hesitating to address misinformation until a particular subject has snowballed into an urgent problem. In the middle of a global measles outbreak last year spurred by low vaccination rates, Facebook rolled out a series of policies to curb vaccine misinformation. But the changes did little to prevent the problem from resurfacing again amid the COVID-19 pandemic.\u003c/p>\n\u003cp>Concerned that Facebook’s failure to crack down on vaccine falsehoods will backfire at the worst possible time, advocates and scientists have called on Facebook co-founder Mark Zuckerberg to take action.\u003c/p>\n\u003cp>“COVID-19 misinformation is the equivalent of an ideological dirty bomb: It has the capacity to hurt tens of thousands of people when it detonates in the moment that vaccines are available,” said Imran Ahmed, founder and chief executive officer of the U.K.-based nonprofit Center for Countering Digital Hate, which recently assessed the growing influence of anti-vaccination content on social media platforms including Facebook since the outset of the pandemic.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Facebook did not respond to a request for comment about its efforts to combat COVID-19 vaccine information. But in a July \u003ca href=\"https://252f2edd-1c8b-49f5-9bb2-cb57bb47e4ba.filesusr.com/ugd/f4d9b9_7aa1bf9819904295a0493a013b285a6b.pdf\" target=\"_blank\" rel=\"noopener noreferrer\">report\u003c/a>, Ahmed’s organization assessed the influence of 409 English-language social media accounts sharing anti-vaccination content between May and June of 2020, just after the pandemic began. The report found that falsehoods about a COVID-19 vaccine have been prevalent on Facebook and other social media sites for months.\u003c/p>\n\u003cp>It’s a dire situation — and one that has only worsened with time.\u003c/p>\n\u003cp>“The first thing that came back from our researchers was, ‘Oh no. They’ve grown a lot,’” Ahmed said. In their sample, Facebook groups and pages spreading vaccination falsehoods had over 31 million followers, representing more than half of the combined following of all the social media accounts they studied.\u003c/p>\n\u003cp>Among the pages spreading falsehoods, the researchers identified one prominent category: people who sell or profit off of vaccine misinformation. These “anti-vaccination entrepreneurs” — who collectively garnered a total following of 28 million people — saw their followers grow by 854,000 between May and June. Zeroing in on groups, the researchers identified 64 that regularly shared vaccine misinformation, with a collective following of 1 million that has also kept growing.\u003c/p>\n\u003cp>Based on the research findings, Ahmed is deeply concerned that the growth in vaccine-related falsehoods will sow distrust in an eventual vaccine before one even arrives.\u003c/p>\n\u003cp>“Personally, I’m scared,” he said.\u003c/p>\n\u003cp>Since people have been asked to stay at home, more conversations have moved online — giving misinformation a chance to gain even more of a foothold on social media sites. Anti-vaccination content, in particular, has thrived.\u003c/p>\n\u003cp>“It’s basically like if you injected adrenaline into them,” said Neil Johnson, a professor of physics and researcher at the Institute for Data, Democracy, & Politics at George Washington University.\u003c/p>\n\u003cp>In May, Johnson and his colleagues \u003ca href=\"https://www.nature.com/articles/s41586-020-2281-1\" target=\"_blank\" rel=\"noopener noreferrer\">published a study in Nature\u003c/a> that showed a sizable uptick in the followers of pages promoting anti-vaccine rhetoric on Facebook between February and October of 2019. While pages spreading falsehoods about vaccines had fewer followers than pages that shared factual vaccine content, the researchers found that there were more pages spreading falsehoods, and those pages were faster-growing and increasingly more connected to neutral pages where people did not yet have a clear leaning one way or the other. If the trend continues, Johnson predicted that anti-vaccination rhetoric will dominate online discussion by 2030.\u003c/p>\n\u003cp>He and his team have been studying the change on a rolling basis in the months since their study ended — and from their view, the problem is growing more pressing.\u003c/p>\n\u003cp>Based on what we’re seeing now, “it would only take something to go wrong with one of the vaccines and then that [change] would happen in a year,” Johnson said.\u003c/p>\n\u003cp>Critics say another possible factor in the social media giant’s failure to get rid of vaccine misinformation is Zuckerberg’s own approach to moderation. Zuckerberg has, in the past, presented the social network \u003ca href=\"https://www.wsj.com/articles/facebooks-mark-zuckerberg-defends-free-speech-amid-calls-for-tighter-controls-11571335528?mod=article_inline\" target=\"_blank\" rel=\"noopener noreferrer\">as a stalwart of free speech\u003c/a>, even if that speech is potentially harmful — one of the reasons the company has \u003ca href=\"https://www.nytimes.com/2020/01/09/technology/facebook-political-ads-lies.html\" target=\"_blank\" rel=\"noopener noreferrer\">repeatedly opted to permit lies in political ads\u003c/a>.\u003c/p>\n\u003cp>In recent months, some of Zuckerberg’s dissenters have appealed to his more philanthropic intentions. In a June letter, hundreds of scientists affiliated with the Chan Zuckerberg Initiative — the research organization he and his wife, pediatrician Priscilla Chan, founded in 2015 — \u003ca href=\"https://www.statnews.com/2020/06/06/in-unusual-revolt-scientists-funded-by-mark-zuckerberg-criticize-facebooks-inaction-on-president-trumps-posts/\">called the social network’s practices “antithetical”\u003c/a> to their benefactor’s mission.\u003c/p>\n\u003cp>“The spread of news that is not vetted for factual accuracy leads to confusion and a mistrust of experts,” they wrote.\u003c/p>\n\u003cp>Facebook’s failure to eradicate scientific falsehoods is difficult to reconcile with the research efforts spearheaded by the Chan Zuckerberg Initiative. While Facebook has avoided public calls to uniformly crack down on misinformation, Zuckerberg and Chan have continued to funnel millions into CZI, including funding for several research efforts aimed at better understanding the spread of the coronavirus.\u003c/p>\n\u003cp>In April, Zuckerberg and Chan invested \u003ca href=\"https://www.statnews.com/2020/04/29/chan-zuckerberg-initiative-funds-bay-area-coronavirus-tracking/\" target=\"_blank\" rel=\"noopener noreferrer\">$13.6 million into a pair of coronavirus studies\u003c/a>, led by CZI, to flag new infections and better understand how immunity to the virus develops.\u003c/p>\n\u003cp>“From my vantage point, we’re all just trying to figure out how to do our part to answer these questions and rebuild,” Chan said in an interview with STAT in April. At the same time, though, rampant falsehoods about the virus — including the dangerous notion that an eventual vaccine will be deadly — were spreading quickly across Facebook.\u003c/p>\n\u003cp>It’s not that Facebook is doing nothing about the issue; rather, its piecemeal approaches are simply too little too late, according to researchers.\u003c/p>\n\u003cp>Last March, amid worldwide measles outbreaks, for example, the company instituted its first policy to combat vaccine misinformation, which involved using its algorithms to demote groups and pages that spread vaccine-related falsehoods and to exclude them from recommendations and predictions when users search within the platform. But as researchers pointed out at the time, demoting certain pages doesn’t stop anti-vaccination conversations from cropping up in others.\u003c/p>\n\u003cp>Among the pages where Johnson found anti-vaccine falsehoods, most were dedicated to things like hobbies and mutual interests. There were pages tailored to parents of kids who played soccer, people who like cats, and aficionados of organic produce, for example. But every so often, a strand of a conversation about something like the best way to treat a leg sprain would devolve into an inaccurate — and dangerous — diatribe against vaccines.\u003c/p>\n\u003cp>“Often in these communities, the number of what I’d call ‘bad’ posts is small — they’re mostly talking about cats or their favorite sports team or whatever, and then all of a sudden there’s a post stuck in there about vaccines,” Johnson said.\u003c/p>\n\u003cp>More recently in response to the coronavirus, Facebook began targeting people who had interacted with certain COVID-19 falsehoods with generic messages that read, “Help friends and family avoid false information about COVID-19.” Those messages point users to the World Health Organization’s myth-busting page about the coronavirus.\u003c/p>\n\u003cp>While Facebook \u003ca href=\"https://www.statnews.com/2020/05/01/facebooks-covid-19-misinformation-campaign-is-based-on-research-the-authors-worry-facebook-missed-the-message/\" target=\"_blank\" rel=\"noopener noreferrer\">said the strategy was based on psychological research\u003c/a>, the authors of the studies the platform cited as justification for their policies told STAT in May that Facebook seemed to have misinterpreted their findings. Rather than placing a generic message in people’s news feeds, Facebook should be correcting falsehoods by providing the facts, the researchers said.\u003c/p>\n\u003cp>Experts said that if Facebook is to combat misinformation in time for the arrival of an eventual coronavirus vaccine, there’s a significant amount of work that needs to happen quickly.\u003c/p>\n\u003cp>“It’s going to be a heavy lift,” Johnson said.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "floatright"
},
"numeric": [
"floatright"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>This story was originally published by \u003ca href=\"https://www.statnews.com/\" target=\"_blank\" rel=\"noopener noreferrer\">STAT\u003c/a>, an online publication of Boston Globe Media that covers health, medicine, and scientific discovery.\u003c/p>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1967695/anti-vaccine-misinformation-on-facebook-has-gained-a-lot-of-traction-during-pandemic",
"authors": [
"byline_science_1967695"
],
"categories": [
"science_39",
"science_40",
"science_4450"
],
"tags": [
"science_4329",
"science_5181",
"science_3977"
],
"featImg": "science_1967705",
"label": "source_science_1967695"
},
"science_1967710": {
"type": "posts",
"id": "science_1967710",
"meta": {
"index": "posts_1716263798",
"site": "science",
"id": "1967710",
"score": null,
"sort": [
1595961185000
]
},
"parent": 0,
"labelTerm": {},
"blocks": [],
"publishDate": 1595961185,
"format": "standard",
"title": "Recent Headlines Suggest Coronavirus Immunity Doesn't Last. The Science is More Reassuring",
"headTitle": "Recent Headlines Suggest Coronavirus Immunity Doesn’t Last. The Science is More Reassuring | KQED",
"content": "\u003cp>So many people are counting on a vaccine to help end the coronavirus pandemic that any hint of bad news gets a lot of attention. That’s proving to be the case for a series of studies examining how long antibodies persist in people who have been infected with the coronavirus.\u003c/p>\n\u003cp>[pullquote]Three recent studies — from China, Britain and the U.S. — have called into question how long people carry antibodies after infection. But the reality may be less dire than recent headlines suggest.[/pullquote]Antibodies help ward off infections. In some diseases, they can prevent reinfection, though scientists can’t say for sure if that’s true for the coronavirus. And it’s also not clear how long antibodies linger.\u003c/p>\n\u003cp>Three recent studies — from \u003ca href=\"https://www.nature.com/articles/s41591-020-0965-6\" target=\"_blank\" rel=\"noopener noreferrer\">China\u003c/a>, \u003ca href=\"https://www.medrxiv.org/content/10.1101/2020.07.09.20148429v1\" target=\"_blank\" rel=\"noopener noreferrer\">Britain\u003c/a> and now the United States — have called into question how long people carry antibodies after infection. But the reality may be less dire than \u003ca href=\"https://www.forbes.com/sites/tommybeer/2020/07/13/study-immunity-to-coronavirus-may-fade-away-within-weeks/\" target=\"_blank\" rel=\"noopener noreferrer\">recent headlines\u003c/a> suggest.\u003c/p>\n\u003cp>The latest of these papers is from a research group at UCLA. It tracked antibodies in 34 people with the coronavirus and found that the average antibody levels dropped to half of where they started over a period of about 2 1/2 months.\u003c/p>\n\u003cp>“The big caveat is of course that this is just one snapshot for a relatively short period of time,” said \u003ca href=\"https://bioscience.ucla.edu/faculty/otto-yang\" target=\"_blank\" rel=\"noopener noreferrer\">Dr. Otto Yang at UCLA,\u003c/a> “so we don’t know that it will continue that same rate of drop over time.”\u003c/p>\n\u003cp>[ad fullwidth]\u003c/p>\n\u003cp>Scientists have noticed that people with milder symptoms — or no symptoms at all — tend to have a weaker immune response to the coronavirus. And \u003ca href=\"https://www.nejm.org/doi/full/10.1056/NEJMc2025179\" target=\"_blank\" rel=\"noopener noreferrer\">Yang’s letter,\u003c/a> published online in \u003cem>The\u003c/em> \u003cem>New England Journal of Medicine,\u003c/em> focused on people with mild illness.\u003c/p>\n\u003cp>“The majority just recovered at home with no hospital care, so their antibody titers [levels] weren’t extremely high,” Yang said. “Indeed, we have seen other people that have very, very high antibody titers, on the order of 10 to 100 times higher than these.”\u003c/p>\n\u003cp>A research group based at the Icahn School of Medicine at Mount Sinai in New York looked at nearly 20,000 people with mild to moderate illness. The group tells a more reassuring story in an \u003ca href=\"https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1\" target=\"_blank\" rel=\"noopener noreferrer\">unpublished research report\u003c/a>.\u003c/p>\n\u003cp>It finds that 90% of those people had antibody responses that lasted at least three months. And these antibodies neutralized the virus, at least in the lab.\u003c/p>\n\u003cp>“It’s reasonable to assume that there will be protection for a time frame of one to three years,” said \u003ca href=\"https://icahn.mssm.edu/profiles/florian-krammer\" target=\"_blank\" rel=\"noopener noreferrer\">Florian Krammer\u003c/a>, one of the scientists on that study. “But of course, we are scientists. We have to prove that, right? That’s why everyone’s cautious about it. But I think that’s a pretty fair assumption.”\u003c/p>\n\u003cp>Scientists focus a lot on antibodies as markers of immunity in part because they are easy to measure. Antibodies do tend to wane over time in many instances, but when that happens, the immune system doesn’t necessarily have to start again from scratch. Memory of a past infection can be stored in a cell called a memory B cell.\u003c/p>\n\u003cp>“Those are cells that don’t actually make any antibodies unless the virus comes back, and then they see that virus again,” Krammer said. “But then they react very, very quickly and make antibodies quickly. So, there are many arms that the immune system has to tackle this virus.”\u003c/p>\n\u003cp>Yet another line of defense is a kind of immune cell called a T cell.\u003c/p>\n\u003cp>“T cells are very important in fighting viruses,” said \u003ca href=\"https://profiles.stanford.edu/kari-nadeau\" target=\"_blank\" rel=\"noopener noreferrer\">Dr. Kari Nadeau\u003c/a> at Stanford. They can kill viruses. “And so, one thing we’re looking at [is] as the antibodies wane, do the T-cell responses also wane?”\u003c/p>\n\u003cp>Scientists developing some of the coronavirus vaccines have noticed that their experimental products spark a strong T-cell response. That includes \u003ca href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">the vaccine from the University of Oxford\u003c/a>, which is in an advanced stage of testing.\u003c/p>\n\u003cp>“We know from many other infections, the vaccine response can be much more durable than the natural infection response,” said Adrian Hill, who is the principal investigator for this vaccine study.\u003c/p>\n\u003cp>That’s partly because people get a strong dose with a vaccine, which stimulates strong immunity.\u003c/p>\n\u003cp>“I’m pretty confident that in COVID we’re going to see the vaccines are more durable than a natural COVID infection,” Hill said. “But again, we don’t know yet. We need to wait and see.”\u003c/p>\n\u003cp>And, for now, people who have already been infected with the coronavirus will also have to wait and see whether they remain immune, and if so for how long.\u003c/p>\n\u003cp>Immunity to four milder coronaviruses, which circulate widely and cause common colds, doesn’t persist for years on end. So, the duration of an antibody response may depend at least in part on whether an infection led to a significant illness — and a significant immune reaction.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>You can contact NPR science correspondent Richard Harris at \u003c/em>\u003ca href=\"mailto:rharris@npr.org\">\u003cem>rharris@npr.org\u003c/em>\u003c/a>\u003cem>.\u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2020 NPR. To see more, visit https://www.npr.org.\u003cimg decoding=\"async\" src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=How+Long+Will+Immunity+To+The+Coronavirus+Last%3F+&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n",
"stats": {
"hasVideo": false,
"hasChartOrMap": false,
"hasAudio": false,
"hasPolis": false,
"wordCount": 887,
"hasGoogleForm": false,
"hasGallery": false,
"hasHearkenModule": false,
"iframeSrcs": [],
"paragraphCount": 23
},
"modified": 1704847151,
"excerpt": "Recent studies have raised fears that immunity to the coronavirus might be fleeting, thus making potential vaccines ineffective. The reality of the science is more complex — and more reassuring.",
"headData": {
"twImgId": "",
"twTitle": "",
"ogTitle": "",
"ogImgId": "",
"twDescription": "",
"description": "Recent studies have raised fears that immunity to the coronavirus might be fleeting, thus making potential vaccines ineffective. The reality of the science is more complex — and more reassuring.",
"title": "Recent Headlines Suggest Coronavirus Immunity Doesn't Last. The Science is More Reassuring | KQED",
"ogDescription": "",
"schema": {
"@context": "https://schema.org",
"@type": "Article",
"headline": "Recent Headlines Suggest Coronavirus Immunity Doesn't Last. The Science is More Reassuring",
"datePublished": "2020-07-28T11:33:05-07:00",
"dateModified": "2024-01-09T16:39:11-08:00",
"image": "https://cdn.kqed.org/wp-content/uploads/2020/02/KQED-OG-Image@1x.png"
}
},
"guestAuthors": [],
"slug": "recent-headlines-suggest-coronavirus-immunity-doesnt-last-the-science-is-more-reassuring",
"status": "publish",
"nprApiLink": "http://api.npr.org/query?id=894670842&apiKey=MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004",
"nprByline": "Richard Harris \u003cbr />NPR\u003cbr>",
"nprStoryDate": "Thu, 23 Jul 2020 13:49:25 -0400",
"nprLastModifiedDate": "Thu, 23 Jul 2020 16:06:58 -0400",
"sticky": false,
"nprHtmlLink": "https://www.npr.org/sections/health-shots/2020/07/23/894670842/how-long-will-immunity-to-the-coronavirus-last?ft=nprml&f=894670842",
"nprImageAgency": "Pool via AP",
"nprImageCredit": "Simon Dawson",
"source": "NPR",
"nprStoryId": "894670842",
"nprRetrievedStory": "1",
"nprPubDate": "Thu, 23 Jul 2020 16:06:00 -0400",
"path": "/science/1967710/recent-headlines-suggest-coronavirus-immunity-doesnt-last-the-science-is-more-reassuring",
"audioTrackLength": null,
"parsedContent": [
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003cp>So many people are counting on a vaccine to help end the coronavirus pandemic that any hint of bad news gets a lot of attention. That’s proving to be the case for a series of studies examining how long antibodies persist in people who have been infected with the coronavirus.\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "Three recent studies — from China, Britain and the U.S. — have called into question how long people carry antibodies after infection. But the reality may be less dire than recent headlines suggest.",
"name": "pullquote",
"attributes": {
"named": {
"label": ""
},
"numeric": []
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>Antibodies help ward off infections. In some diseases, they can prevent reinfection, though scientists can’t say for sure if that’s true for the coronavirus. And it’s also not clear how long antibodies linger.\u003c/p>\n\u003cp>Three recent studies — from \u003ca href=\"https://www.nature.com/articles/s41591-020-0965-6\" target=\"_blank\" rel=\"noopener noreferrer\">China\u003c/a>, \u003ca href=\"https://www.medrxiv.org/content/10.1101/2020.07.09.20148429v1\" target=\"_blank\" rel=\"noopener noreferrer\">Britain\u003c/a> and now the United States — have called into question how long people carry antibodies after infection. But the reality may be less dire than \u003ca href=\"https://www.forbes.com/sites/tommybeer/2020/07/13/study-immunity-to-coronavirus-may-fade-away-within-weeks/\" target=\"_blank\" rel=\"noopener noreferrer\">recent headlines\u003c/a> suggest.\u003c/p>\n\u003cp>The latest of these papers is from a research group at UCLA. It tracked antibodies in 34 people with the coronavirus and found that the average antibody levels dropped to half of where they started over a period of about 2 1/2 months.\u003c/p>\n\u003cp>“The big caveat is of course that this is just one snapshot for a relatively short period of time,” said \u003ca href=\"https://bioscience.ucla.edu/faculty/otto-yang\" target=\"_blank\" rel=\"noopener noreferrer\">Dr. Otto Yang at UCLA,\u003c/a> “so we don’t know that it will continue that same rate of drop over time.”\u003c/p>\n\u003cp>\u003c/p>\u003c/div>",
"attributes": {
"named": {},
"numeric": []
}
},
{
"type": "component",
"content": "",
"name": "ad",
"attributes": {
"named": {
"label": "fullwidth"
},
"numeric": [
"fullwidth"
]
}
},
{
"type": "contentString",
"content": "\u003cdiv class=\"post-body\">\u003cp>\u003c/p>\n\u003cp>Scientists have noticed that people with milder symptoms — or no symptoms at all — tend to have a weaker immune response to the coronavirus. And \u003ca href=\"https://www.nejm.org/doi/full/10.1056/NEJMc2025179\" target=\"_blank\" rel=\"noopener noreferrer\">Yang’s letter,\u003c/a> published online in \u003cem>The\u003c/em> \u003cem>New England Journal of Medicine,\u003c/em> focused on people with mild illness.\u003c/p>\n\u003cp>“The majority just recovered at home with no hospital care, so their antibody titers [levels] weren’t extremely high,” Yang said. “Indeed, we have seen other people that have very, very high antibody titers, on the order of 10 to 100 times higher than these.”\u003c/p>\n\u003cp>A research group based at the Icahn School of Medicine at Mount Sinai in New York looked at nearly 20,000 people with mild to moderate illness. The group tells a more reassuring story in an \u003ca href=\"https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1\" target=\"_blank\" rel=\"noopener noreferrer\">unpublished research report\u003c/a>.\u003c/p>\n\u003cp>It finds that 90% of those people had antibody responses that lasted at least three months. And these antibodies neutralized the virus, at least in the lab.\u003c/p>\n\u003cp>“It’s reasonable to assume that there will be protection for a time frame of one to three years,” said \u003ca href=\"https://icahn.mssm.edu/profiles/florian-krammer\" target=\"_blank\" rel=\"noopener noreferrer\">Florian Krammer\u003c/a>, one of the scientists on that study. “But of course, we are scientists. We have to prove that, right? That’s why everyone’s cautious about it. But I think that’s a pretty fair assumption.”\u003c/p>\n\u003cp>Scientists focus a lot on antibodies as markers of immunity in part because they are easy to measure. Antibodies do tend to wane over time in many instances, but when that happens, the immune system doesn’t necessarily have to start again from scratch. Memory of a past infection can be stored in a cell called a memory B cell.\u003c/p>\n\u003cp>“Those are cells that don’t actually make any antibodies unless the virus comes back, and then they see that virus again,” Krammer said. “But then they react very, very quickly and make antibodies quickly. So, there are many arms that the immune system has to tackle this virus.”\u003c/p>\n\u003cp>Yet another line of defense is a kind of immune cell called a T cell.\u003c/p>\n\u003cp>“T cells are very important in fighting viruses,” said \u003ca href=\"https://profiles.stanford.edu/kari-nadeau\" target=\"_blank\" rel=\"noopener noreferrer\">Dr. Kari Nadeau\u003c/a> at Stanford. They can kill viruses. “And so, one thing we’re looking at [is] as the antibodies wane, do the T-cell responses also wane?”\u003c/p>\n\u003cp>Scientists developing some of the coronavirus vaccines have noticed that their experimental products spark a strong T-cell response. That includes \u003ca href=\"https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31604-4/fulltext\" target=\"_blank\" rel=\"noopener noreferrer\">the vaccine from the University of Oxford\u003c/a>, which is in an advanced stage of testing.\u003c/p>\n\u003cp>“We know from many other infections, the vaccine response can be much more durable than the natural infection response,” said Adrian Hill, who is the principal investigator for this vaccine study.\u003c/p>\n\u003cp>That’s partly because people get a strong dose with a vaccine, which stimulates strong immunity.\u003c/p>\n\u003cp>“I’m pretty confident that in COVID we’re going to see the vaccines are more durable than a natural COVID infection,” Hill said. “But again, we don’t know yet. We need to wait and see.”\u003c/p>\n\u003cp>And, for now, people who have already been infected with the coronavirus will also have to wait and see whether they remain immune, and if so for how long.\u003c/p>\n\u003cp>Immunity to four milder coronaviruses, which circulate widely and cause common colds, doesn’t persist for years on end. So, the duration of an antibody response may depend at least in part on whether an infection led to a significant illness — and a significant immune reaction.\u003c/p>\n\u003cp>\u003c/p>\n\u003cp>\u003cem>You can contact NPR science correspondent Richard Harris at \u003c/em>\u003ca href=\"mailto:rharris@npr.org\">\u003cem>rharris@npr.org\u003c/em>\u003c/a>\u003cem>.\u003c/em>\u003c/p>\n\u003cdiv class=\"fullattribution\">Copyright 2020 NPR. To see more, visit https://www.npr.org.\u003cimg decoding=\"async\" src=\"https://www.google-analytics.com/__utm.gif?utmac=UA-5828686-4&utmdt=How+Long+Will+Immunity+To+The+Coronavirus+Last%3F+&utme=8(APIKey)9(MDAxOTAwOTE4MDEyMTkxMDAzNjczZDljZA004)\">\u003c/div>\n\n\u003c/div>\u003c/p>",
"attributes": {
"named": {},
"numeric": []
}
}
],
"link": "/science/1967710/recent-headlines-suggest-coronavirus-immunity-doesnt-last-the-science-is-more-reassuring",
"authors": [
"byline_science_1967710"
],
"categories": [
"science_39",
"science_3890",
"science_40",
"science_4450"
],
"featImg": "science_1967711",
"label": "source_science_1967710"
}
},
"podcastsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"podcasts": {}
},
"radioProgramsReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"radioPrograms": {}
},
"radioSearchSegmentsReducer": {},
"programsReducer": {
"all-things-considered": {
"id": "all-things-considered",
"title": "All Things Considered",
"info": "Every weekday, \u003cem>All Things Considered\u003c/em> hosts Robert Siegel, Audie Cornish, Ari Shapiro, and Kelly McEvers present the program's trademark mix of news, interviews, commentaries, reviews, and offbeat features. Michel Martin hosts on the weekends.",
"airtime": "MON-FRI 1pm-2pm, 4:30pm-6:30pm\u003cbr />SAT-SUN 5pm-6pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/All-Things-Considered-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/all-things-considered/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/all-things-considered"
},
"american-suburb-podcast": {
"id": "american-suburb-podcast",
"title": "American Suburb: The Podcast",
"tagline": "The flip side of gentrification, told through one town",
"info": "Gentrification is changing cities across America, forcing people from neighborhoods they have long called home. Call them the displaced. Now those priced out of the Bay Area are looking for a better life in an unlikely place. American Suburb follows this migration to one California town along the Delta, 45 miles from San Francisco. But is this once sleepy suburb ready for them?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/American-Suburb-Podcast-Tile-703x703-1.jpg",
"officialWebsiteLink": "/news/series/american-suburb-podcast",
"meta": {
"site": "news",
"source": "kqed",
"order": 19
},
"link": "/news/series/american-suburb-podcast/",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/RBrW",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=1287748328",
"tuneIn": "https://tunein.com/radio/American-Suburb-p1086805/",
"rss": "https://ww2.kqed.org/news/series/american-suburb-podcast/feed/podcast",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMzMDExODgxNjA5"
}
},
"baycurious": {
"id": "baycurious",
"title": "Bay Curious",
"tagline": "Exploring the Bay Area, one question at a time",
"info": "KQED’s new podcast, Bay Curious, gets to the bottom of the mysteries — both profound and peculiar — that give the Bay Area its unique identity. And we’ll do it with your help! You ask the questions. You decide what Bay Curious investigates. And you join us on the journey to find the answers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Bay-Curious-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Bay Curious",
"officialWebsiteLink": "/news/series/baycurious",
"meta": {
"site": "news",
"source": "kqed",
"order": 3
},
"link": "/podcasts/baycurious",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/bay-curious/id1172473406",
"npr": "https://www.npr.org/podcasts/500557090/bay-curious",
"rss": "https://ww2.kqed.org/news/category/bay-curious-podcast/feed/podcast",
"amazon": "https://music.amazon.com/podcasts/9a90d476-aa04-455d-9a4c-0871ed6216d4/bay-curious",
"stitcher": "https://www.stitcher.com/podcast/kqed/bay-curious",
"spotify": "https://open.spotify.com/show/6O76IdmhixfijmhTZLIJ8k"
}
},
"bbc-world-service": {
"id": "bbc-world-service",
"title": "BBC World Service",
"info": "The day's top stories from BBC News compiled twice daily in the week, once at weekends.",
"airtime": "MON-FRI 9pm-10pm, TUE-FRI 1am-2am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/BBC-World-Service-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.bbc.co.uk/sounds/play/live:bbc_world_service",
"meta": {
"site": "news",
"source": "BBC World Service"
},
"link": "/radio/program/bbc-world-service",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/global-news-podcast/id135067274?mt=2",
"tuneIn": "https://tunein.com/radio/BBC-World-Service-p455581/",
"rss": "https://podcasts.files.bbci.co.uk/p02nq0gn.rss"
}
},
"californiareport": {
"id": "californiareport",
"title": "The California Report",
"tagline": "California, day by day",
"info": "KQED’s statewide radio news program providing daily coverage of issues, trends and public policy decisions.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report",
"officialWebsiteLink": "/californiareport",
"meta": {
"site": "news",
"source": "kqed",
"order": 8
},
"link": "/californiareport",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-the-california-report/id79681292",
"amazon": "https://music.amazon.com/podcasts/26099305-72af-4542-9dde-ac1807fe36d5/kqed-s-the-california-report",
"npr": "https://www.npr.org/podcasts/432285393/the-california-report",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-the-california-report-podcast-8838",
"rss": "https://ww2.kqed.org/news/tag/tcram/feed/podcast"
}
},
"californiareportmagazine": {
"id": "californiareportmagazine",
"title": "The California Report Magazine",
"tagline": "Your state, your stories",
"info": "Every week, The California Report Magazine takes you on a road trip for the ears: to visit the places and meet the people who make California unique. The in-depth storytelling podcast from the California Report.",
"airtime": "FRI 4:30pm-5pm, 6:30pm-7pm, 11pm-11:30pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-California-Report-Magazine-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The California Report Magazine",
"officialWebsiteLink": "/californiareportmagazine",
"meta": {
"site": "news",
"source": "kqed",
"order": 10
},
"link": "/californiareportmagazine",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-california-report-magazine/id1314750545",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM3NjkwNjk1OTAz",
"npr": "https://www.npr.org/podcasts/564733126/the-california-report-magazine",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-california-report-magazine",
"rss": "https://ww2.kqed.org/news/tag/tcrmag/feed/podcast"
}
},
"city-arts": {
"id": "city-arts",
"title": "City Arts & Lectures",
"info": "A one-hour radio program to hear celebrated writers, artists and thinkers address contemporary ideas and values, often discussing the creative process. Please note: tapes or transcripts are not available",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/cityartsandlecture-300x300.jpg",
"officialWebsiteLink": "https://www.cityarts.net/",
"airtime": "SUN 1pm-2pm, TUE 10pm, WED 1am",
"meta": {
"site": "news",
"source": "City Arts & Lectures"
},
"link": "https://www.cityarts.net",
"subscribe": {
"tuneIn": "https://tunein.com/radio/City-Arts-and-Lectures-p692/",
"rss": "https://www.cityarts.net/feed/"
}
},
"closealltabs": {
"id": "closealltabs",
"title": "Close All Tabs",
"tagline": "Your irreverent guide to the trends redefining our world",
"info": "Close All Tabs breaks down how digital culture shapes our world through thoughtful insights and irreverent humor.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/02/CAT_2_Tile-scaled.jpg",
"imageAlt": "KQED Close All Tabs",
"officialWebsiteLink": "/podcasts/closealltabs",
"meta": {
"site": "news",
"source": "kqed",
"order": 1
},
"link": "/podcasts/closealltabs",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/close-all-tabs/id214663465",
"rss": "https://feeds.megaphone.fm/KQINC6993880386",
"amazon": "https://music.amazon.com/podcasts/92d9d4ac-67a3-4eed-b10a-fb45d45b1ef2/close-all-tabs",
"spotify": "https://open.spotify.com/show/6LAJFHnGK1pYXYzv6SIol6?si=deb0cae19813417c"
}
},
"code-switch-life-kit": {
"id": "code-switch-life-kit",
"title": "Code Switch / Life Kit",
"info": "\u003cem>Code Switch\u003c/em>, which listeners will hear in the first part of the hour, has fearless and much-needed conversations about race. Hosted by journalists of color, the show tackles the subject of race head-on, exploring how it impacts every part of society — from politics and pop culture to history, sports and more.\u003cbr />\u003cbr />\u003cem>Life Kit\u003c/em>, which will be in the second part of the hour, guides you through spaces and feelings no one prepares you for — from finances to mental health, from workplace microaggressions to imposter syndrome, from relationships to parenting. The show features experts with real world experience and shares their knowledge. Because everyone needs a little help being human.\u003cbr />\u003cbr />\u003ca href=\"https://www.npr.org/podcasts/510312/codeswitch\">\u003cem>Code Switch\u003c/em> offical site and podcast\u003c/a>\u003cbr />\u003ca href=\"https://www.npr.org/lifekit\">\u003cem>Life Kit\u003c/em> offical site and podcast\u003c/a>\u003cbr />",
"airtime": "SUN 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Code-Switch-Life-Kit-Podcast-Tile-360x360-1.jpg",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/code-switch-life-kit",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/1112190608?mt=2&at=11l79Y&ct=nprdirectory",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93d3cubnByLm9yZy9yc3MvcG9kY2FzdC5waHA_aWQ9NTEwMzEy",
"spotify": "https://open.spotify.com/show/3bExJ9JQpkwNhoHvaIIuyV",
"rss": "https://feeds.npr.org/510312/podcast.xml"
}
},
"commonwealth-club": {
"id": "commonwealth-club",
"title": "Commonwealth Club of California Podcast",
"info": "The Commonwealth Club of California is the nation's oldest and largest public affairs forum. As a non-partisan forum, The Club brings to the public airwaves diverse viewpoints on important topics. The Club's weekly radio broadcast - the oldest in the U.S., dating back to 1924 - is carried across the nation on public radio stations and is now podcasting. Our website archive features audio of our recent programs, as well as selected speeches from our long and distinguished history. This podcast feed is usually updated twice a week and is always un-edited.",
"airtime": "THU 10pm, FRI 1am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Commonwealth-Club-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.commonwealthclub.org/podcasts",
"meta": {
"site": "news",
"source": "Commonwealth Club of California"
},
"link": "/radio/program/commonwealth-club",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/commonwealth-club-of-california-podcast/id976334034?mt=2",
"google": "https://podcasts.google.com/feed/aHR0cDovL3d3dy5jb21tb253ZWFsdGhjbHViLm9yZy9hdWRpby9wb2RjYXN0L3dlZWtseS54bWw",
"tuneIn": "https://tunein.com/radio/Commonwealth-Club-of-California-p1060/"
}
},
"forum": {
"id": "forum",
"title": "Forum",
"tagline": "The conversation starts here",
"info": "KQED’s live call-in program discussing local, state, national and international issues, as well as in-depth interviews.",
"airtime": "MON-FRI 9am-11am, 10pm-11pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Forum-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Forum with Mina Kim and Alexis Madrigal",
"officialWebsiteLink": "/forum",
"meta": {
"site": "news",
"source": "kqed",
"order": 9
},
"link": "/forum",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/kqeds-forum/id73329719",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM5NTU3MzgxNjMz",
"npr": "https://www.npr.org/podcasts/432307980/forum",
"stitcher": "https://www.stitcher.com/podcast/kqedfm-kqeds-forum-podcast",
"rss": "https://feeds.megaphone.fm/KQINC9557381633"
}
},
"freakonomics-radio": {
"id": "freakonomics-radio",
"title": "Freakonomics Radio",
"info": "Freakonomics Radio is a one-hour award-winning podcast and public-radio project hosted by Stephen Dubner, with co-author Steve Levitt as a regular guest. It is produced in partnership with WNYC.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/freakonomicsRadio.png",
"officialWebsiteLink": "http://freakonomics.com/",
"airtime": "SUN 1am-2am, SAT 3pm-4pm",
"meta": {
"site": "radio",
"source": "WNYC"
},
"link": "/radio/program/freakonomics-radio",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/us/podcast/freakonomics-radio/id354668519",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/Freakonomics-Radio-p272293/",
"rss": "https://feeds.feedburner.com/freakonomicsradio"
}
},
"fresh-air": {
"id": "fresh-air",
"title": "Fresh Air",
"info": "Hosted by Terry Gross, \u003cem>Fresh Air from WHYY\u003c/em> is the Peabody Award-winning weekday magazine of contemporary arts and issues. One of public radio's most popular programs, Fresh Air features intimate conversations with today's biggest luminaries.",
"airtime": "MON-FRI 7pm-8pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Fresh-Air-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/fresh-air/",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/fresh-air",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/4s8b",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=214089682&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Fresh-Air-p17/",
"rss": "https://feeds.npr.org/381444908/podcast.xml"
}
},
"here-and-now": {
"id": "here-and-now",
"title": "Here & Now",
"info": "A live production of NPR and WBUR Boston, in collaboration with stations across the country, Here & Now reflects the fluid world of news as it's happening in the middle of the day, with timely, in-depth news, interviews and conversation. Hosted by Robin Young, Jeremy Hobson and Tonya Mosley.",
"airtime": "MON-THU 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Here-And-Now-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://www.wbur.org/hereandnow",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/here-and-now",
"subsdcribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?mt=2&id=426698661",
"tuneIn": "https://tunein.com/radio/Here--Now-p211/",
"rss": "https://feeds.npr.org/510051/podcast.xml"
}
},
"hidden-brain": {
"id": "hidden-brain",
"title": "Hidden Brain",
"info": "Shankar Vedantam uses science and storytelling to reveal the unconscious patterns that drive human behavior, shape our choices and direct our relationships.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/05/hiddenbrain.jpg",
"officialWebsiteLink": "https://www.npr.org/series/423302056/hidden-brain",
"airtime": "SUN 7pm-8pm",
"meta": {
"site": "news",
"source": "NPR"
},
"link": "/radio/program/hidden-brain",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/hidden-brain/id1028908750?mt=2",
"tuneIn": "https://tunein.com/podcasts/Science-Podcasts/Hidden-Brain-p787503/",
"rss": "https://feeds.npr.org/510308/podcast.xml"
}
},
"how-i-built-this": {
"id": "how-i-built-this",
"title": "How I Built This with Guy Raz",
"info": "Guy Raz dives into the stories behind some of the world's best known companies. How I Built This weaves a narrative journey about innovators, entrepreneurs and idealists—and the movements they built.",
"imageSrc": "https://ww2.kqed.org/news/wp-content/uploads/sites/10/2018/05/howIBuiltThis.png",
"officialWebsiteLink": "https://www.npr.org/podcasts/510313/how-i-built-this",
"airtime": "SUN 7:30pm-8pm",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/how-i-built-this",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/3zxy",
"apple": "https://itunes.apple.com/us/podcast/how-i-built-this-with-guy-raz/id1150510297?mt=2",
"tuneIn": "https://tunein.com/podcasts/Arts--Culture-Podcasts/How-I-Built-This-p910896/",
"rss": "https://feeds.npr.org/510313/podcast.xml"
}
},
"hyphenacion": {
"id": "hyphenacion",
"title": "Hyphenación",
"tagline": "Where conversation and cultura meet",
"info": "What kind of no sabo word is Hyphenación? For us, it’s about living within a hyphenation. Like being a third-gen Mexican-American from the Texas border now living that Bay Area Chicano life. Like Xorje! Each week we bring together a couple of hyphenated Latinos to talk all about personal life choices: family, careers, relationships, belonging … everything is on the table. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/03/Hyphenacion_FinalAssets_PodcastTile.png",
"imageAlt": "KQED Hyphenación",
"officialWebsiteLink": "/podcasts/hyphenacion",
"meta": {
"site": "news",
"source": "kqed",
"order": 15
},
"link": "/podcasts/hyphenacion",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/hyphenaci%C3%B3n/id1191591838",
"spotify": "https://open.spotify.com/show/2p3Fifq96nw9BPcmFdIq0o?si=39209f7b25774f38",
"youtube": "https://www.youtube.com/c/kqedarts",
"amazon": "https://music.amazon.com/podcasts/6c3dd23c-93fb-4aab-97ba-1725fa6315f1/hyphenaci%C3%B3n",
"rss": "https://feeds.megaphone.fm/KQINC2275451163"
}
},
"jerrybrown": {
"id": "jerrybrown",
"title": "The Political Mind of Jerry Brown",
"tagline": "Lessons from a lifetime in politics",
"info": "The Political Mind of Jerry Brown brings listeners the wisdom of the former Governor, Mayor, and presidential candidate. Scott Shafer interviewed Brown for more than 40 hours, covering the former governor's life and half-century in the political game – and Brown has some lessons he'd like to share. ",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Political-Mind-of-Jerry-Brown-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Political Mind of Jerry Brown",
"officialWebsiteLink": "/podcasts/jerrybrown",
"meta": {
"site": "news",
"source": "kqed",
"order": 18
},
"link": "/podcasts/jerrybrown",
"subscribe": {
"npr": "https://www.npr.org/podcasts/790253322/the-political-mind-of-jerry-brown",
"apple": "https://itunes.apple.com/us/podcast/id1492194549",
"rss": "https://ww2.kqed.org/news/series/jerrybrown/feed/podcast/",
"tuneIn": "http://tun.in/pjGcK",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-political-mind-of-jerry-brown",
"spotify": "https://open.spotify.com/show/54C1dmuyFyKMFttY6X2j6r?si=K8SgRCoISNK6ZbjpXrX5-w",
"amazon": "https://music.amazon.com/podcasts/44420f75-3b0e-4301-ab3b-16da6b09e543/the-political-mind-of-jerry-brown"
}
},
"latino-usa": {
"id": "latino-usa",
"title": "Latino USA",
"airtime": "MON 1am-2am, SUN 6pm-7pm",
"info": "Latino USA, the radio journal of news and culture, is the only national, English-language radio program produced from a Latino perspective.",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/latinoUsa.jpg",
"officialWebsiteLink": "http://latinousa.org/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/latino-usa",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/xtTd",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=79681317&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Latino-USA-p621/",
"rss": "https://feeds.npr.org/510016/podcast.xml"
}
},
"marketplace": {
"id": "marketplace",
"title": "Marketplace",
"info": "Our flagship program, helmed by Kai Ryssdal, examines what the day in money delivered, through stories, conversations, newsworthy numbers and more. Updated Monday through Friday at about 3:30 p.m. PT.",
"airtime": "MON-FRI 4pm-4:30pm, MON-WED 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Marketplace-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.marketplace.org/",
"meta": {
"site": "news",
"source": "American Public Media"
},
"link": "/radio/program/marketplace",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201853034&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/APM-Marketplace-p88/",
"rss": "https://feeds.publicradio.org/public_feeds/marketplace-pm/rss/rss"
}
},
"masters-of-scale": {
"id": "masters-of-scale",
"title": "Masters of Scale",
"info": "Masters of Scale is an original podcast in which LinkedIn co-founder and Greylock Partner Reid Hoffman sets out to describe and prove theories that explain how great entrepreneurs take their companies from zero to a gazillion in ingenious fashion.",
"airtime": "Every other Wednesday June 12 through October 16 at 8pm (repeats Thursdays at 2am)",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Masters-of-Scale-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://mastersofscale.com/",
"meta": {
"site": "radio",
"source": "WaitWhat"
},
"link": "/radio/program/masters-of-scale",
"subscribe": {
"apple": "http://mastersofscale.app.link/",
"rss": "https://rss.art19.com/masters-of-scale"
}
},
"mindshift": {
"id": "mindshift",
"title": "MindShift",
"tagline": "A podcast about the future of learning and how we raise our kids",
"info": "The MindShift podcast explores the innovations in education that are shaping how kids learn. Hosts Ki Sung and Katrina Schwartz introduce listeners to educators, researchers, parents and students who are developing effective ways to improve how kids learn. We cover topics like how fed-up administrators are developing surprising tactics to deal with classroom disruptions; how listening to podcasts are helping kids develop reading skills; the consequences of overparenting; and why interdisciplinary learning can engage students on all ends of the traditional achievement spectrum. This podcast is part of the MindShift education site, a division of KQED News. KQED is an NPR/PBS member station based in San Francisco. You can also visit the MindShift website for episodes and supplemental blog posts or tweet us \u003ca href=\"https://twitter.com/MindShiftKQED\">@MindShiftKQED\u003c/a> or visit us at \u003ca href=\"/mindshift\">MindShift.KQED.org\u003c/a>",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Mindshift-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED MindShift: How We Will Learn",
"officialWebsiteLink": "/mindshift/",
"meta": {
"site": "news",
"source": "kqed",
"order": 12
},
"link": "/podcasts/mindshift",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/mindshift-podcast/id1078765985",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkM1NzY0NjAwNDI5",
"npr": "https://www.npr.org/podcasts/464615685/mind-shift-podcast",
"stitcher": "https://www.stitcher.com/podcast/kqed/stories-teachers-share",
"spotify": "https://open.spotify.com/show/0MxSpNYZKNprFLCl7eEtyx"
}
},
"morning-edition": {
"id": "morning-edition",
"title": "Morning Edition",
"info": "\u003cem>Morning Edition\u003c/em> takes listeners around the country and the world with multi-faceted stories and commentaries every weekday. Hosts Steve Inskeep, David Greene and Rachel Martin bring you the latest breaking news and features to prepare you for the day.",
"airtime": "MON-FRI 3am-9am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Morning-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/morning-edition/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/morning-edition"
},
"onourwatch": {
"id": "onourwatch",
"title": "On Our Watch",
"tagline": "Deeply-reported investigative journalism",
"info": "For decades, the process for how police police themselves has been inconsistent – if not opaque. In some states, like California, these proceedings were completely hidden. After a new police transparency law unsealed scores of internal affairs files, our reporters set out to examine these cases and the shadow world of police discipline. On Our Watch brings listeners into the rooms where officers are questioned and witnesses are interrogated to find out who this system is really protecting. Is it the officers, or the public they've sworn to serve?",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/On-Our-Watch-Podcast-Tile-703x703-1.jpg",
"imageAlt": "On Our Watch from NPR and KQED",
"officialWebsiteLink": "/podcasts/onourwatch",
"meta": {
"site": "news",
"source": "kqed",
"order": 11
},
"link": "/podcasts/onourwatch",
"subscribe": {
"apple": "https://podcasts.apple.com/podcast/id1567098962",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5ucHIub3JnLzUxMDM2MC9wb2RjYXN0LnhtbD9zYz1nb29nbGVwb2RjYXN0cw",
"npr": "https://rpb3r.app.goo.gl/onourwatch",
"spotify": "https://open.spotify.com/show/0OLWoyizopu6tY1XiuX70x",
"tuneIn": "https://tunein.com/radio/On-Our-Watch-p1436229/",
"stitcher": "https://www.stitcher.com/show/on-our-watch",
"rss": "https://feeds.npr.org/510360/podcast.xml"
}
},
"on-the-media": {
"id": "on-the-media",
"title": "On The Media",
"info": "Our weekly podcast explores how the media 'sausage' is made, casts an incisive eye on fluctuations in the marketplace of ideas, and examines threats to the freedom of information and expression in America and abroad. For one hour a week, the show tries to lift the veil from the process of \"making media,\" especially news media, because it's through that lens that we see the world and the world sees us",
"airtime": "SUN 2pm-3pm, MON 12am-1am",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/onTheMedia.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/otm",
"meta": {
"site": "news",
"source": "wnyc"
},
"link": "/radio/program/on-the-media",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/on-the-media/id73330715?mt=2",
"tuneIn": "https://tunein.com/radio/On-the-Media-p69/",
"rss": "http://feeds.wnyc.org/onthemedia"
}
},
"pbs-newshour": {
"id": "pbs-newshour",
"title": "PBS NewsHour",
"info": "Analysis, background reports and updates from the PBS NewsHour putting today's news in context.",
"airtime": "MON-FRI 3pm-4pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/PBS-News-Hour-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pbs.org/newshour/",
"meta": {
"site": "news",
"source": "pbs"
},
"link": "/radio/program/pbs-newshour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pbs-newshour-full-show/id394432287?mt=2",
"tuneIn": "https://tunein.com/radio/PBS-NewsHour---Full-Show-p425698/",
"rss": "https://www.pbs.org/newshour/feeds/rss/podcasts/show"
}
},
"perspectives": {
"id": "perspectives",
"title": "Perspectives",
"tagline": "KQED's series of daily listener commentaries since 1991",
"info": "KQED's series of daily listener commentaries since 1991.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/01/Perspectives_Tile_Final.jpg",
"imageAlt": "KQED Perspectives",
"officialWebsiteLink": "/perspectives/",
"meta": {
"site": "radio",
"source": "kqed",
"order": 14
},
"link": "/perspectives",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/id73801135",
"npr": "https://www.npr.org/podcasts/432309616/perspectives",
"rss": "https://ww2.kqed.org/perspectives/category/perspectives/feed/",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly93dzIua3FlZC5vcmcvcGVyc3BlY3RpdmVzL2NhdGVnb3J5L3BlcnNwZWN0aXZlcy9mZWVkLw"
}
},
"planet-money": {
"id": "planet-money",
"title": "Planet Money",
"info": "The economy explained. Imagine you could call up a friend and say, Meet me at the bar and tell me what's going on with the economy. Now imagine that's actually a fun evening.",
"airtime": "SUN 3pm-4pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/planetmoney.jpg",
"officialWebsiteLink": "https://www.npr.org/sections/money/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/planet-money",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/M4f5",
"apple": "https://itunes.apple.com/us/podcast/planet-money/id290783428?mt=2",
"tuneIn": "https://tunein.com/podcasts/Business--Economics-Podcasts/Planet-Money-p164680/",
"rss": "https://feeds.npr.org/510289/podcast.xml"
}
},
"politicalbreakdown": {
"id": "politicalbreakdown",
"title": "Political Breakdown",
"tagline": "Politics from a personal perspective",
"info": "Political Breakdown is a new series that explores the political intersection of California and the nation. Each week hosts Scott Shafer and Marisa Lagos are joined with a new special guest to unpack politics -- with personality — and offer an insider’s glimpse at how politics happens.",
"airtime": "THU 6:30pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Political-Breakdown-2024-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Political Breakdown",
"officialWebsiteLink": "/podcasts/politicalbreakdown",
"meta": {
"site": "radio",
"source": "kqed",
"order": 5
},
"link": "/podcasts/politicalbreakdown",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/political-breakdown/id1327641087",
"amazon": "https://music.amazon.com/podcasts/e0c2d153-ad36-4c8d-901d-f1da6a724824/political-breakdown",
"npr": "https://www.npr.org/podcasts/572155894/political-breakdown",
"stitcher": "https://www.stitcher.com/podcast/kqed/political-breakdown",
"spotify": "https://open.spotify.com/show/07RVyIjIdk2WDuVehvBMoN",
"rss": "https://ww2.kqed.org/news/tag/political-breakdown/feed/podcast"
}
},
"possible": {
"id": "possible",
"title": "Possible",
"info": "Possible is hosted by entrepreneur Reid Hoffman and writer Aria Finger. Together in Possible, Hoffman and Finger lead enlightening discussions about building a brighter collective future. The show features interviews with visionary guests like Trevor Noah, Sam Altman and Janette Sadik-Khan. Possible paints an optimistic portrait of the world we can create through science, policy, business, art and our shared humanity. It asks: What if everything goes right for once? How can we get there? Each episode also includes a short fiction story generated by advanced AI GPT-4, serving as a thought-provoking springboard to speculate how humanity could leverage technology for good.",
"airtime": "SUN 2pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Possible-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.possible.fm/",
"meta": {
"site": "news",
"source": "Possible"
},
"link": "/radio/program/possible",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/possible/id1677184070",
"spotify": "https://open.spotify.com/show/730YpdUSNlMyPQwNnyjp4k"
}
},
"pri-the-world": {
"id": "pri-the-world",
"title": "PRI's The World: Latest Edition",
"info": "Each weekday, host Marco Werman and his team of producers bring you the world's most interesting stories in an hour of radio that reminds us just how small our planet really is.",
"airtime": "MON-FRI 2pm-3pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-World-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.pri.org/programs/the-world",
"meta": {
"site": "news",
"source": "PRI"
},
"link": "/radio/program/pri-the-world",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/pris-the-world-latest-edition/id278196007?mt=2",
"tuneIn": "https://tunein.com/podcasts/News--Politics-Podcasts/PRIs-The-World-p24/",
"rss": "http://feeds.feedburner.com/pri/theworld"
}
},
"radiolab": {
"id": "radiolab",
"title": "Radiolab",
"info": "A two-time Peabody Award-winner, Radiolab is an investigation told through sounds and stories, and centered around one big idea. In the Radiolab world, information sounds like music and science and culture collide. Hosted by Jad Abumrad and Robert Krulwich, the show is designed for listeners who demand skepticism, but appreciate wonder. WNYC Studios is the producer of other leading podcasts including Freakonomics Radio, Death, Sex & Money, On the Media and many more.",
"airtime": "SUN 12am-1am, SAT 2pm-3pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/radiolab1400.png",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/radiolab/",
"meta": {
"site": "science",
"source": "WNYC"
},
"link": "/radio/program/radiolab",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/radiolab/id152249110?mt=2",
"tuneIn": "https://tunein.com/radio/RadioLab-p68032/",
"rss": "https://feeds.wnyc.org/radiolab"
}
},
"reveal": {
"id": "reveal",
"title": "Reveal",
"info": "Created by The Center for Investigative Reporting and PRX, Reveal is public radios first one-hour weekly radio show and podcast dedicated to investigative reporting. Credible, fact based and without a partisan agenda, Reveal combines the power and artistry of driveway moment storytelling with data-rich reporting on critically important issues. The result is stories that inform and inspire, arming our listeners with information to right injustices, hold the powerful accountable and improve lives.Reveal is hosted by Al Letson and showcases the award-winning work of CIR and newsrooms large and small across the nation. In a radio and podcast market crowded with choices, Reveal focuses on important and often surprising stories that illuminate the world for our listeners.",
"airtime": "SAT 4pm-5pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/reveal300px.png",
"officialWebsiteLink": "https://www.revealnews.org/episodes/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/reveal",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/reveal/id886009669",
"tuneIn": "https://tunein.com/radio/Reveal-p679597/",
"rss": "http://feeds.revealradio.org/revealpodcast"
}
},
"rightnowish": {
"id": "rightnowish",
"title": "Rightnowish",
"tagline": "Art is where you find it",
"info": "Rightnowish digs into life in the Bay Area right now… ish. Journalist Pendarvis Harshaw takes us to galleries painted on the sides of liquor stores in West Oakland. We'll dance in warehouses in the Bayview, make smoothies with kids in South Berkeley, and listen to classical music in a 1984 Cutlass Supreme in Richmond. Every week, Pen talks to movers and shakers about how the Bay Area shapes what they create, and how they shape the place we call home.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Rightnowish-Podcast-Tile-500x500-1.jpg",
"imageAlt": "KQED Rightnowish with Pendarvis Harshaw",
"officialWebsiteLink": "/podcasts/rightnowish",
"meta": {
"site": "arts",
"source": "kqed",
"order": 16
},
"link": "/podcasts/rightnowish",
"subscribe": {
"npr": "https://www.npr.org/podcasts/721590300/rightnowish",
"rss": "https://ww2.kqed.org/arts/programs/rightnowish/feed/podcast",
"apple": "https://podcasts.apple.com/us/podcast/rightnowish/id1482187648",
"stitcher": "https://www.stitcher.com/podcast/kqed/rightnowish",
"google": "https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5tZWdhcGhvbmUuZm0vS1FJTkMxMjU5MTY3NDc4",
"spotify": "https://open.spotify.com/show/7kEJuafTzTVan7B78ttz1I"
}
},
"science-friday": {
"id": "science-friday",
"title": "Science Friday",
"info": "Science Friday is a weekly science talk show, broadcast live over public radio stations nationwide. Each week, the show focuses on science topics that are in the news and tries to bring an educated, balanced discussion to bear on the scientific issues at hand. Panels of expert guests join host Ira Flatow, a veteran science journalist, to discuss science and to take questions from listeners during the call-in portion of the program.",
"airtime": "FRI 11am-1pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Science-Friday-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/science-friday",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/science-friday",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=73329284&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Science-Friday-p394/",
"rss": "http://feeds.wnyc.org/science-friday"
}
},
"snap-judgment": {
"id": "snap-judgment",
"title": "Snap Judgment",
"tagline": "Real stories with killer beats",
"info": "The Snap Judgment radio show and podcast mixes real stories with killer beats to produce cinematic, dramatic radio. Snap's musical brand of storytelling dares listeners to see the world through the eyes of another. This is storytelling... with a BEAT!! Snap first aired on public radio stations nationwide in July 2010. Today, Snap Judgment airs on over 450 public radio stations and is brought to the airwaves by KQED & PRX.",
"airtime": "SAT 1pm-2pm, 9pm-10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/05/Snap-Judgment-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Snap Judgment",
"officialWebsiteLink": "https://snapjudgment.org",
"meta": {
"site": "arts",
"source": "kqed",
"order": 4
},
"link": "https://snapjudgment.org",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/snap-judgment/id283657561",
"npr": "https://www.npr.org/podcasts/449018144/snap-judgment",
"stitcher": "https://www.pandora.com/podcast/snap-judgment/PC:241?source=stitcher-sunset",
"spotify": "https://open.spotify.com/show/3Cct7ZWmxHNAtLgBTqjC5v",
"rss": "https://snap.feed.snapjudgment.org/"
}
},
"soldout": {
"id": "soldout",
"title": "SOLD OUT: Rethinking Housing in America",
"tagline": "A new future for housing",
"info": "Sold Out: Rethinking Housing in America",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Sold-Out-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Sold Out: Rethinking Housing in America",
"officialWebsiteLink": "/podcasts/soldout",
"meta": {
"site": "news",
"source": "kqed",
"order": 13
},
"link": "/podcasts/soldout",
"subscribe": {
"npr": "https://www.npr.org/podcasts/911586047/s-o-l-d-o-u-t-a-new-future-for-housing",
"apple": "https://podcasts.apple.com/us/podcast/introducing-sold-out-rethinking-housing-in-america/id1531354937",
"rss": "https://feeds.megaphone.fm/soldout",
"spotify": "https://open.spotify.com/show/38dTBSk2ISFoPiyYNoKn1X",
"stitcher": "https://www.stitcher.com/podcast/kqed/sold-out-rethinking-housing-in-america",
"tunein": "https://tunein.com/radio/SOLD-OUT-Rethinking-Housing-in-America-p1365871/"
}
},
"spooked": {
"id": "spooked",
"title": "Spooked",
"tagline": "True-life supernatural stories",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/10/Spooked-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED Spooked",
"officialWebsiteLink": "https://spookedpodcast.org/",
"meta": {
"site": "news",
"source": "kqed",
"order": 7
},
"link": "https://spookedpodcast.org/",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/spooked/id1279361017",
"npr": "https://www.npr.org/podcasts/549547848/snap-judgment-presents-spooked",
"spotify": "https://open.spotify.com/show/76571Rfl3m7PLJQZKQIGCT",
"rss": "https://feeds.simplecast.com/TBotaapn"
}
},
"tech-nation": {
"id": "tech-nation",
"title": "Tech Nation Radio Podcast",
"info": "Tech Nation is a weekly public radio program, hosted by Dr. Moira Gunn. Founded in 1993, it has grown from a simple interview show to a multi-faceted production, featuring conversations with noted technology and science leaders, and a weekly science and technology-related commentary.",
"airtime": "FRI 10pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Tech-Nation-Radio-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "http://technation.podomatic.com/",
"meta": {
"site": "science",
"source": "Tech Nation Media"
},
"link": "/radio/program/tech-nation",
"subscribe": {
"rss": "https://technation.podomatic.com/rss2.xml"
}
},
"ted-radio-hour": {
"id": "ted-radio-hour",
"title": "TED Radio Hour",
"info": "The TED Radio Hour is a journey through fascinating ideas, astonishing inventions, fresh approaches to old problems, and new ways to think and create.",
"airtime": "SUN 3pm-4pm, SAT 10pm-11pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/tedRadioHour.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/ted-radio-hour/?showDate=2018-06-22",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/ted-radio-hour",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/8vsS",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=523121474&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/TED-Radio-Hour-p418021/",
"rss": "https://feeds.npr.org/510298/podcast.xml"
}
},
"thebay": {
"id": "thebay",
"title": "The Bay",
"tagline": "Local news to keep you rooted",
"info": "Host Devin Katayama walks you through the biggest story of the day with reporters and newsmakers.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Bay-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Bay",
"officialWebsiteLink": "/podcasts/thebay",
"meta": {
"site": "radio",
"source": "kqed",
"order": 2
},
"link": "/podcasts/thebay",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-bay/id1350043452",
"amazon": "https://music.amazon.com/podcasts/d800ea4c-7a2c-42f2-b861-edaf78a5db0b/the-bay",
"npr": "https://www.npr.org/podcasts/586725995/the-bay",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-bay",
"spotify": "https://open.spotify.com/show/4BIKBKIujizLHlIlBNaAqQ",
"rss": "https://feeds.megaphone.fm/KQINC8259786327"
}
},
"thelatest": {
"id": "thelatest",
"title": "The Latest",
"tagline": "Trusted local news in real time",
"info": "",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/05/The-Latest-2025-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Latest",
"officialWebsiteLink": "/thelatest",
"meta": {
"site": "news",
"source": "kqed",
"order": 6
},
"link": "/thelatest",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-latest-from-kqed/id1197721799",
"npr": "https://www.npr.org/podcasts/1257949365/the-latest-from-k-q-e-d",
"spotify": "https://open.spotify.com/show/5KIIXMgM9GTi5AepwOYvIZ?si=bd3053fec7244dba",
"rss": "https://feeds.megaphone.fm/KQINC9137121918"
}
},
"theleap": {
"id": "theleap",
"title": "The Leap",
"tagline": "What if you closed your eyes, and jumped?",
"info": "Stories about people making dramatic, risky changes, told by award-winning public radio reporter Judy Campbell.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Leap-Podcast-Tile-703x703-1.jpg",
"imageAlt": "KQED The Leap",
"officialWebsiteLink": "/podcasts/theleap",
"meta": {
"site": "news",
"source": "kqed",
"order": 17
},
"link": "/podcasts/theleap",
"subscribe": {
"apple": "https://podcasts.apple.com/us/podcast/the-leap/id1046668171",
"npr": "https://www.npr.org/podcasts/447248267/the-leap",
"stitcher": "https://www.stitcher.com/podcast/kqed/the-leap",
"spotify": "https://open.spotify.com/show/3sSlVHHzU0ytLwuGs1SD1U",
"rss": "https://ww2.kqed.org/news/programs/the-leap/feed/podcast"
}
},
"the-moth-radio-hour": {
"id": "the-moth-radio-hour",
"title": "The Moth Radio Hour",
"info": "Since its launch in 1997, The Moth has presented thousands of true stories, told live and without notes, to standing-room-only crowds worldwide. Moth storytellers stand alone, under a spotlight, with only a microphone and a roomful of strangers. The storyteller and the audience embark on a high-wire act of shared experience which is both terrifying and exhilarating. Since 2008, The Moth podcast has featured many of our favorite stories told live on Moth stages around the country. For information on all of our programs and live events, visit themoth.org.",
"airtime": "SAT 8pm-9pm and SUN 11am-12pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/theMoth.jpg",
"officialWebsiteLink": "https://themoth.org/",
"meta": {
"site": "arts",
"source": "prx"
},
"link": "/radio/program/the-moth-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/the-moth-podcast/id275699983?mt=2",
"tuneIn": "https://tunein.com/radio/The-Moth-p273888/",
"rss": "http://feeds.themoth.org/themothpodcast"
}
},
"the-new-yorker-radio-hour": {
"id": "the-new-yorker-radio-hour",
"title": "The New Yorker Radio Hour",
"info": "The New Yorker Radio Hour is a weekly program presented by the magazine's editor, David Remnick, and produced by WNYC Studios and The New Yorker. Each episode features a diverse mix of interviews, profiles, storytelling, and an occasional burst of humor inspired by the magazine, and shaped by its writers, artists, and editors. This isn't a radio version of a magazine, but something all its own, reflecting the rich possibilities of audio storytelling and conversation. Theme music for the show was composed and performed by Merrill Garbus of tUnE-YArDs.",
"airtime": "SAT 10am-11am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-New-Yorker-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.wnycstudios.org/shows/tnyradiohour",
"meta": {
"site": "arts",
"source": "WNYC"
},
"link": "/radio/program/the-new-yorker-radio-hour",
"subscribe": {
"apple": "https://itunes.apple.com/us/podcast/id1050430296",
"tuneIn": "https://tunein.com/podcasts/WNYC-Podcasts/New-Yorker-Radio-Hour-p803804/",
"rss": "https://feeds.feedburner.com/newyorkerradiohour"
}
},
"the-sam-sanders-show": {
"id": "the-sam-sanders-show",
"title": "The Sam Sanders Show",
"info": "One of public radio's most dynamic voices, Sam Sanders helped launch The NPR Politics Podcast and hosted NPR's hit show It's Been A Minute. Now, the award-winning host returns with something brand new, The Sam Sanders Show. Every week, Sam Sanders and friends dig into the culture that shapes our lives: what's driving the biggest trends, how artists really think, and even the memes you can't stop scrolling past. Sam is beloved for his way of unpacking the world and bringing you up close to fresh currents and engaging conversations. The Sam Sanders Show is smart, funny and always a good time.",
"airtime": "FRI 12-1pm AND SAT 11am-12pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/11/The-Sam-Sanders-Show-Podcast-Tile-400x400-1.jpg",
"officialWebsiteLink": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"meta": {
"site": "arts",
"source": "KCRW"
},
"link": "https://www.kcrw.com/shows/the-sam-sanders-show/latest",
"subscribe": {
"rss": "https://feed.cdnstream1.com/zjb/feed/download/ac/28/59/ac28594c-e1d0-4231-8728-61865cdc80e8.xml"
}
},
"the-splendid-table": {
"id": "the-splendid-table",
"title": "The Splendid Table",
"info": "\u003cem>The Splendid Table\u003c/em> hosts our nation's conversations about cooking, sustainability and food culture.",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/The-Splendid-Table-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.splendidtable.org/",
"airtime": "SUN 10-11 pm",
"meta": {
"site": "radio",
"source": "npr"
},
"link": "/radio/program/the-splendid-table"
},
"this-american-life": {
"id": "this-american-life",
"title": "This American Life",
"info": "This American Life is a weekly public radio show, heard by 2.2 million people on more than 500 stations. Another 2.5 million people download the weekly podcast. It is hosted by Ira Glass, produced in collaboration with Chicago Public Media, delivered to stations by PRX The Public Radio Exchange, and has won all of the major broadcasting awards.",
"airtime": "SAT 12pm-1pm, 7pm-8pm",
"imageSrc": "https://ww2.kqed.org/radio/wp-content/uploads/sites/50/2018/04/thisAmericanLife.png",
"officialWebsiteLink": "https://www.thisamericanlife.org/",
"meta": {
"site": "news",
"source": "wbez"
},
"link": "/radio/program/this-american-life",
"subscribe": {
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=201671138&at=11l79Y&ct=nprdirectory",
"rss": "https://www.thisamericanlife.org/podcast/rss.xml"
}
},
"tinydeskradio": {
"id": "tinydeskradio",
"title": "Tiny Desk Radio",
"info": "We're bringing the best of Tiny Desk to the airwaves, only on public radio.",
"airtime": "SUN 8pm and SAT 9pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2025/04/300x300-For-Member-Station-Logo-Tiny-Desk-Radio-@2x.png",
"officialWebsiteLink": "https://www.npr.org/series/g-s1-52030/tiny-desk-radio",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/tinydeskradio",
"subscribe": {
"rss": "https://feeds.npr.org/g-s1-52030/rss.xml"
}
},
"wait-wait-dont-tell-me": {
"id": "wait-wait-dont-tell-me",
"title": "Wait Wait... Don't Tell Me!",
"info": "Peter Sagal and Bill Kurtis host the weekly NPR News quiz show alongside some of the best and brightest news and entertainment personalities.",
"airtime": "SUN 10am-11am, SAT 11am-12pm, SAT 6pm-7pm",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Wait-Wait-Podcast-Tile-300x300-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/wait-wait-dont-tell-me/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/wait-wait-dont-tell-me",
"subscribe": {
"npr": "https://rpb3r.app.goo.gl/Xogv",
"apple": "https://itunes.apple.com/WebObjects/MZStore.woa/wa/viewPodcast?s=143441&mt=2&id=121493804&at=11l79Y&ct=nprdirectory",
"tuneIn": "https://tunein.com/radio/Wait-Wait-Dont-Tell-Me-p46/",
"rss": "https://feeds.npr.org/344098539/podcast.xml"
}
},
"weekend-edition-saturday": {
"id": "weekend-edition-saturday",
"title": "Weekend Edition Saturday",
"info": "Weekend Edition Saturday wraps up the week's news and offers a mix of analysis and features on a wide range of topics, including arts, sports, entertainment, and human interest stories. The two-hour program is hosted by NPR's Peabody Award-winning Scott Simon.",
"airtime": "SAT 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-saturday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-saturday"
},
"weekend-edition-sunday": {
"id": "weekend-edition-sunday",
"title": "Weekend Edition Sunday",
"info": "Weekend Edition Sunday features interviews with newsmakers, artists, scientists, politicians, musicians, writers, theologians and historians. The program has covered news events from Nelson Mandela's 1990 release from a South African prison to the capture of Saddam Hussein.",
"airtime": "SUN 5am-10am",
"imageSrc": "https://cdn.kqed.org/wp-content/uploads/2024/04/Weekend-Edition-Podcast-Tile-360x360-1.jpg",
"officialWebsiteLink": "https://www.npr.org/programs/weekend-edition-sunday/",
"meta": {
"site": "news",
"source": "npr"
},
"link": "/radio/program/weekend-edition-sunday"
}
},
"racesReducer": {},
"racesGenElectionReducer": {},
"racesGenElection2026Reducer": {},
"radioSchedulesReducer": {},
"listsReducer": {
"posts/science?category=health": {
"isFetching": false,
"latestQuery": {
"from": 204,
"size": 12
},
"vitalsOnly": false,
"totalRequested": 12,
"isLoading": false,
"isLoadingMore": true,
"total": {
"value": 1299,
"relation": "eq"
},
"items": [
"science_1968259",
"science_1968038",
"science_1968013",
"science_1967987",
"science_1967970",
"science_1967921",
"science_1967925",
"science_1967579",
"science_1967769",
"science_1967728",
"science_1967695",
"science_1967710"
],
"complete": true
}
},
"recallGuideReducer": {
"intros": {},
"policy": {},
"candidates": {}
},
"savedArticleReducer": {
"articles": [],
"status": {}
},
"newslettersReducer": {
"isFetching": false,
"fetchFailed": false,
"hasFetched": false,
"newsletters": {},
"isSubscribing": false,
"isUnsubscribing": false,
"subscribedNewsletters": {}
},
"termsReducer": {
"about": {
"name": "About",
"type": "terms",
"id": "about",
"slug": "about",
"link": "/about",
"taxonomy": "site"
},
"arts": {
"name": "Arts & Culture",
"grouping": [
"arts",
"pop",
"trulyca"
],
"description": "KQED Arts provides daily in-depth coverage of the Bay Area's music, art, film, performing arts, literature and arts news, as well as cultural commentary and criticism.",
"type": "terms",
"id": "arts",
"slug": "arts",
"link": "/arts",
"taxonomy": "site"
},
"artschool": {
"name": "Art School",
"parent": "arts",
"type": "terms",
"id": "artschool",
"slug": "artschool",
"link": "/artschool",
"taxonomy": "site"
},
"bayareabites": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "bayareabites",
"slug": "bayareabites",
"link": "/food",
"taxonomy": "site"
},
"bayareahiphop": {
"name": "Bay Area Hiphop",
"type": "terms",
"id": "bayareahiphop",
"slug": "bayareahiphop",
"link": "/bayareahiphop",
"taxonomy": "site"
},
"campaign21": {
"name": "Campaign 21",
"type": "terms",
"id": "campaign21",
"slug": "campaign21",
"link": "/campaign21",
"taxonomy": "site"
},
"careers": {
"name": "Careers",
"type": "terms",
"id": "careers",
"slug": "careers",
"link": "/careers",
"taxonomy": "site"
},
"checkplease": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"parent": "food",
"type": "terms",
"id": "checkplease",
"slug": "checkplease",
"link": "/food",
"taxonomy": "site"
},
"education": {
"name": "Education",
"grouping": [
"education"
],
"type": "terms",
"id": "education",
"slug": "education",
"link": "/education",
"taxonomy": "site"
},
"elections": {
"name": "Elections",
"type": "terms",
"id": "elections",
"slug": "elections",
"link": "/elections",
"taxonomy": "site"
},
"events": {
"name": "Events",
"type": "terms",
"id": "events",
"slug": "events",
"link": "/events",
"taxonomy": "site"
},
"event": {
"name": "Event",
"alias": "events",
"type": "terms",
"id": "event",
"slug": "event",
"link": "/event",
"taxonomy": "site"
},
"filmschoolshorts": {
"name": "Film School Shorts",
"type": "terms",
"id": "filmschoolshorts",
"slug": "filmschoolshorts",
"link": "/filmschoolshorts",
"taxonomy": "site"
},
"food": {
"name": "KQED food",
"grouping": [
"food",
"bayareabites",
"checkplease"
],
"type": "terms",
"id": "food",
"slug": "food",
"link": "/food",
"taxonomy": "site"
},
"forum": {
"name": "Forum",
"relatedContentQuery": "posts/forum?",
"parent": "news",
"type": "terms",
"id": "forum",
"slug": "forum",
"link": "/forum",
"taxonomy": "site"
},
"futureofyou": {
"name": "Future of You",
"grouping": [
"science",
"futureofyou"
],
"parent": "science",
"type": "terms",
"id": "futureofyou",
"slug": "futureofyou",
"link": "/futureofyou",
"taxonomy": "site"
},
"jpepinheart": {
"name": "KQED food",
"relatedContentQuery": "posts/food,bayareabites,checkplease",
"parent": "food",
"type": "terms",
"id": "jpepinheart",
"slug": "jpepinheart",
"link": "/food",
"taxonomy": "site"
},
"liveblog": {
"name": "Live Blog",
"type": "terms",
"id": "liveblog",
"slug": "liveblog",
"link": "/liveblog",
"taxonomy": "site"
},
"livetv": {
"name": "Live TV",
"parent": "tv",
"type": "terms",
"id": "livetv",
"slug": "livetv",
"link": "/livetv",
"taxonomy": "site"
},
"lowdown": {
"name": "The Lowdown",
"relatedContentQuery": "posts/lowdown?",
"parent": "news",
"type": "terms",
"id": "lowdown",
"slug": "lowdown",
"link": "/lowdown",
"taxonomy": "site"
},
"mindshift": {
"name": "Mindshift",
"parent": "news",
"description": "MindShift explores the future of education by highlighting the innovative – and sometimes counterintuitive – ways educators and parents are helping all children succeed.",
"type": "terms",
"id": "mindshift",
"slug": "mindshift",
"link": "/mindshift",
"taxonomy": "site"
},
"news": {
"name": "News",
"grouping": [
"news",
"forum"
],
"type": "terms",
"id": "news",
"slug": "news",
"link": "/news",
"taxonomy": "site"
},
"newsletters": {
"name": "newsletters",
"type": "terms",
"id": "newsletters",
"slug": "newsletters",
"link": "/newsletters",
"taxonomy": "site"
},
"perspectives": {
"name": "Perspectives",
"parent": "radio",
"type": "terms",
"id": "perspectives",
"slug": "perspectives",
"link": "/perspectives",
"taxonomy": "site"
},
"podcasts": {
"name": "Podcasts",
"type": "terms",
"id": "podcasts",
"slug": "podcasts",
"link": "/podcasts",
"taxonomy": "site"
},
"pop": {
"name": "Pop",
"parent": "arts",
"type": "terms",
"id": "pop",
"slug": "pop",
"link": "/pop",
"taxonomy": "site"
},
"pressroom": {
"name": "Pressroom",
"type": "terms",
"id": "pressroom",
"slug": "pressroom",
"link": "/pressroom",
"taxonomy": "site"
},
"quest": {
"name": "Quest",
"parent": "science",
"type": "terms",
"id": "quest",
"slug": "quest",
"link": "/quest",
"taxonomy": "site"
},
"radio": {
"name": "Radio",
"grouping": [
"forum",
"perspectives"
],
"description": "Listen to KQED Public Radio – home of Forum and The California Report – on 88.5 FM in San Francisco, 89.3 FM in Sacramento, 88.3 FM in Santa Rosa and 88.1 FM in Martinez.",
"type": "terms",
"id": "radio",
"slug": "radio",
"link": "/radio",
"taxonomy": "site"
},
"root": {
"name": "KQED",
"image": "https://ww2.kqed.org/app/uploads/2020/02/KQED-OG-Image@1x.png",
"imageWidth": 1200,
"imageHeight": 630,
"headData": {
"title": "KQED | News, Radio, Podcasts, TV | Public Media for Northern California",
"description": "KQED provides public radio, television, and independent reporting on issues that matter to the Bay Area. We’re the NPR and PBS member station for Northern California."
},
"type": "terms",
"id": "root",
"slug": "root",
"link": "/root",
"taxonomy": "site"
},
"science": {
"name": "Science",
"grouping": [
"science",
"futureofyou"
],
"description": "KQED Science brings you award-winning science and environment coverage from the Bay Area and beyond.",
"type": "terms",
"id": "science",
"slug": "science",
"link": "/science",
"taxonomy": "site"
},
"stateofhealth": {
"name": "State of Health",
"parent": "science",
"type": "terms",
"id": "stateofhealth",
"slug": "stateofhealth",
"link": "/stateofhealth",
"taxonomy": "site"
},
"support": {
"name": "Support",
"type": "terms",
"id": "support",
"slug": "support",
"link": "/support",
"taxonomy": "site"
},
"thedolist": {
"name": "The Do List",
"parent": "arts",
"type": "terms",
"id": "thedolist",
"slug": "thedolist",
"link": "/thedolist",
"taxonomy": "site"
},
"trulyca": {
"name": "Truly CA",
"grouping": [
"arts",
"pop",
"trulyca"
],
"parent": "arts",
"type": "terms",
"id": "trulyca",
"slug": "trulyca",
"link": "/trulyca",
"taxonomy": "site"
},
"tv": {
"name": "TV",
"type": "terms",
"id": "tv",
"slug": "tv",
"link": "/tv",
"taxonomy": "site"
},
"voterguide": {
"name": "Voter Guide",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "voterguide",
"slug": "voterguide",
"link": "/voterguide",
"taxonomy": "site"
},
"guiaelectoral": {
"name": "Guia Electoral",
"parent": "elections",
"alias": "elections",
"type": "terms",
"id": "guiaelectoral",
"slug": "guiaelectoral",
"link": "/guiaelectoral",
"taxonomy": "site"
},
"science_category_health": {
"isLoading": true
},
"science_39": {
"type": "terms",
"id": "science_39",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "39",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Health",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Health Archives | KQED Science",
"ogDescription": null
},
"ttid": 41,
"slug": "health",
"isLoading": false,
"link": "/science/category/health"
},
"source_science_1968259": {
"type": "terms",
"id": "source_science_1968259",
"meta": {
"override": true
},
"name": "STAT",
"isLoading": false
},
"source_science_1968038": {
"type": "terms",
"id": "source_science_1968038",
"meta": {
"override": true
},
"name": "Coronavirus",
"isLoading": false
},
"source_science_1968013": {
"type": "terms",
"id": "source_science_1968013",
"meta": {
"override": true
},
"name": "Coronavirus ",
"isLoading": false
},
"source_science_1967987": {
"type": "terms",
"id": "source_science_1967987",
"meta": {
"override": true
},
"name": "Coronavirus",
"isLoading": false
},
"source_science_1967970": {
"type": "terms",
"id": "source_science_1967970",
"meta": {
"override": true
},
"name": "Coronavirus",
"isLoading": false
},
"source_science_1967921": {
"type": "terms",
"id": "source_science_1967921",
"meta": {
"override": true
},
"name": "STAT",
"isLoading": false
},
"source_science_1967925": {
"type": "terms",
"id": "source_science_1967925",
"meta": {
"override": true
},
"name": "InsideClimate News",
"isLoading": false
},
"source_science_1967579": {
"type": "terms",
"id": "source_science_1967579",
"meta": {
"override": true
},
"name": "Coronavirus",
"isLoading": false
},
"source_science_1967769": {
"type": "terms",
"id": "source_science_1967769",
"meta": {
"override": true
},
"name": "NPR",
"isLoading": false
},
"source_science_1967728": {
"type": "terms",
"id": "source_science_1967728",
"meta": {
"override": true
},
"name": "Coronavirus",
"isLoading": false
},
"source_science_1967695": {
"type": "terms",
"id": "source_science_1967695",
"meta": {
"override": true
},
"name": "STAT",
"isLoading": false
},
"source_science_1967710": {
"type": "terms",
"id": "source_science_1967710",
"meta": {
"override": true
},
"name": "NPR",
"isLoading": false
},
"science_3890": {
"type": "terms",
"id": "science_3890",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "3890",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Medical Science",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Medical Science Archives | KQED Science",
"ogDescription": null
},
"ttid": 3890,
"slug": "medical-science",
"isLoading": false,
"link": "/science/category/medical-science"
},
"science_40": {
"type": "terms",
"id": "science_40",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "40",
"found": true
},
"relationships": {},
"featImg": null,
"name": "News",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "News Archives | KQED Science",
"ogDescription": null
},
"ttid": 42,
"slug": "news",
"isLoading": false,
"link": "/science/category/news"
},
"science_4450": {
"type": "terms",
"id": "science_4450",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "4450",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Science",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Science Archives | KQED Science",
"ogDescription": null
},
"ttid": 4450,
"slug": "science",
"isLoading": false,
"link": "/science/category/science"
},
"science_4329": {
"type": "terms",
"id": "science_4329",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "4329",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Coronavirus",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Coronavirus Archives | KQED Science",
"ogDescription": null
},
"ttid": 4329,
"slug": "coronavirus",
"isLoading": false,
"link": "/science/tag/coronavirus"
},
"science_4414": {
"type": "terms",
"id": "science_4414",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "4414",
"found": true
},
"relationships": {},
"featImg": null,
"name": "featured-science",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "featured-science Archives | KQED Science",
"ogDescription": null
},
"ttid": 4414,
"slug": "featured-science",
"isLoading": false,
"link": "/science/tag/featured-science"
},
"science_3977": {
"type": "terms",
"id": "science_3977",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "3977",
"found": true
},
"relationships": {},
"featImg": null,
"name": "STAT",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "STAT Archives | KQED Science",
"ogDescription": null
},
"ttid": 3977,
"slug": "stat",
"isLoading": false,
"link": "/science/tag/stat"
},
"science_5376": {
"type": "terms",
"id": "science_5376",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "5376",
"found": true
},
"relationships": {},
"name": "Science Podcast",
"slug": "science-podcast",
"taxonomy": "program",
"description": null,
"featImg": null,
"headData": {
"title": "Science Podcast | KQED Science",
"description": null,
"ogTitle": null,
"ogDescription": null,
"ogImgId": null,
"twTitle": null,
"twDescription": null,
"twImgId": null
},
"ttid": 5376,
"isLoading": false,
"link": "/science/program/science-podcast"
},
"science_5141": {
"type": "terms",
"id": "science_5141",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "5141",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Podcast",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Podcast Archives | KQED Science",
"ogDescription": null
},
"ttid": 5141,
"slug": "podcast",
"isLoading": false,
"link": "/science/category/podcast"
},
"science_3423": {
"type": "terms",
"id": "science_3423",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "3423",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Science Podcast",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"socialTitle": "Bay Area Science: Stories & Insights with KQED's Science Podcasts",
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": "Our captivating podcasts take you on a journey through the Bay Area's vibrant scientific landscape. Discover groundbreaking research & hear expert insights.",
"title": "Bay Area Science: Stories & Insights with KQED's Science Podcasts",
"ogDescription": null
},
"ttid": 3423,
"slug": "science-podcast",
"isLoading": false,
"link": "/science/category/science-podcast"
},
"science_4368": {
"type": "terms",
"id": "science_4368",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "4368",
"found": true
},
"relationships": {},
"featImg": null,
"name": "COVID-19",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "COVID-19 Archives | KQED Science",
"ogDescription": null
},
"ttid": 4368,
"slug": "covid-19",
"isLoading": false,
"link": "/science/tag/covid-19"
},
"science_4417": {
"type": "terms",
"id": "science_4417",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "4417",
"found": true
},
"relationships": {},
"featImg": null,
"name": "featured-news",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "featured-news Archives | KQED Science",
"ogDescription": null
},
"ttid": 4417,
"slug": "featured-news",
"isLoading": false,
"link": "/science/tag/featured-news"
},
"science_5181": {
"type": "terms",
"id": "science_5181",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "5181",
"found": true
},
"relationships": {},
"featImg": null,
"name": "health",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "health Archives | KQED Science",
"ogDescription": null
},
"ttid": 5181,
"slug": "health",
"isLoading": false,
"link": "/science/tag/health"
},
"science_35": {
"type": "terms",
"id": "science_35",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "35",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Environment",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Environment Archives | KQED Science",
"ogDescription": null
},
"ttid": 37,
"slug": "environment",
"isLoading": false,
"link": "/science/category/environment"
},
"science_505": {
"type": "terms",
"id": "science_505",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "505",
"found": true
},
"relationships": {},
"featImg": null,
"name": "air pollution",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "air pollution Archives | KQED Science",
"ogDescription": null
},
"ttid": 511,
"slug": "air-pollution",
"isLoading": false,
"link": "/science/tag/air-pollution"
},
"science_5197": {
"type": "terms",
"id": "science_5197",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "5197",
"found": true
},
"relationships": {},
"featImg": null,
"name": "arts",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "arts Archives | KQED Science",
"ogDescription": null
},
"ttid": 5197,
"slug": "arts",
"isLoading": false,
"link": "/science/tag/arts"
},
"science_31": {
"type": "terms",
"id": "science_31",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "31",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Climate",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Climate Archives | KQED Science",
"ogDescription": null
},
"ttid": 33,
"slug": "climate",
"isLoading": false,
"link": "/science/category/climate"
},
"science_33": {
"type": "terms",
"id": "science_33",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "33",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Energy",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Energy Archives | KQED Science",
"ogDescription": null
},
"ttid": 35,
"slug": "energy",
"isLoading": false,
"link": "/science/category/energy"
},
"science_36": {
"type": "terms",
"id": "science_36",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "36",
"found": true
},
"relationships": {},
"featImg": null,
"name": "Food",
"description": null,
"taxonomy": "category",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "Food Archives | KQED Science",
"ogDescription": null
},
"ttid": 38,
"slug": "food",
"isLoading": false,
"link": "/science/category/food"
},
"science_392": {
"type": "terms",
"id": "science_392",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "392",
"found": true
},
"relationships": {},
"featImg": null,
"name": "agriculture",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "agriculture Archives | KQED Science",
"ogDescription": null
},
"ttid": 398,
"slug": "agriculture",
"isLoading": false,
"link": "/science/tag/agriculture"
},
"science_194": {
"type": "terms",
"id": "science_194",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "194",
"found": true
},
"relationships": {},
"featImg": null,
"name": "climate change",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "climate change Archives | KQED Science",
"ogDescription": null
},
"ttid": 198,
"slug": "climate-change",
"isLoading": false,
"link": "/science/tag/climate-change"
},
"science_4122": {
"type": "terms",
"id": "science_4122",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "4122",
"found": true
},
"relationships": {},
"featImg": null,
"name": "InsideClimate News",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "InsideClimate News Archives | KQED Science",
"ogDescription": null
},
"ttid": 4122,
"slug": "insideclimate-news",
"isLoading": false,
"link": "/science/tag/insideclimate-news"
},
"science_2936": {
"type": "terms",
"id": "science_2936",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "2936",
"found": true
},
"relationships": {},
"featImg": null,
"name": "NPR",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "NPR Archives | KQED Science",
"ogDescription": null
},
"ttid": 2936,
"slug": "npr",
"isLoading": false,
"link": "/science/tag/npr"
},
"science_512": {
"type": "terms",
"id": "science_512",
"meta": {
"index": "terms_1716263798",
"site": "science",
"id": "512",
"found": true
},
"relationships": {},
"featImg": null,
"name": "children",
"description": null,
"taxonomy": "tag",
"headData": {
"twImgId": null,
"twTitle": null,
"ogTitle": null,
"ogImgId": null,
"twDescription": null,
"description": null,
"title": "children Archives | KQED Science",
"ogDescription": null
},
"ttid": 518,
"slug": "children",
"isLoading": false,
"link": "/science/tag/children"
}
},
"userPermissionsReducer": {
"wpLoggedIn": false
},
"eventsReducer": {},
"fssReducer": {},
"tvDailyScheduleReducer": {},
"tvWeeklyScheduleReducer": {},
"tvPrimetimeScheduleReducer": {},
"tvMonthlyScheduleReducer": {},
"userAccountReducer": {
"user": {
"email": null,
"emailStatus": "EMAIL_UNVALIDATED",
"loggedStatus": "LOGGED_OUT",
"loggingChecked": false,
"articles": [],
"firstName": null,
"lastName": null,
"phoneNumber": null,
"fetchingMembership": false,
"membershipError": false,
"memberships": [
{
"id": null,
"startDate": null,
"firstName": null,
"lastName": null,
"familyNumber": null,
"memberNumber": null,
"memberSince": null,
"expirationDate": null,
"pfsEligible": false,
"isSustaining": false,
"membershipLevel": "Prospect",
"membershipStatus": "Non Member",
"lastGiftDate": null,
"renewalDate": null,
"lastDonationAmount": null
}
]
},
"authModal": {
"isOpen": false,
"view": "LANDING_VIEW"
},
"error": null
},
"youthMediaReducer": {},
"checkPleaseReducer": {
"filterData": {
"region": {
"key": "Restaurant Region",
"filters": [
"Any Region"
]
},
"cuisine": {
"key": "Restaurant Cuisine",
"filters": [
"Any Cuisine"
]
}
},
"restaurantDataById": {},
"restaurantIdsSorted": [],
"error": null
},
"userAgentReducer": {
"userAgent": "Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)",
"isBot": true
},
"requestOutcomesReducer": {
"notFound": []
}
}
